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Chair: E. Neil G. Marsh 
 
 19F NMR is an excellent technique for studying changes in chemical environments due to 
its high sensitivity and large chemical shift dispersion. Since fluorine is not found in most 
biological systems, there is no competition from background signals, a problem that often afflicts 
measurements using 1H, 13C, and 15N NMR. Therefore, it has been broadly applied to investigate 
protein conformational changes and dynamics as well as protein-ligand and protein-membrane 
interactions. In this thesis, 19F NMR has been used to examine the structure and dynamics of 
biologically active peptides, including an antimicrobial peptide and amyloidogenic proteins.  
 Using a series of fluorinated MSI-78 antimicrobial peptides, a detailed examination how 
the structure and dynamics of the peptide changes on binding lipid bicelles was performed using 
19F chemical shifts, solvent isotope effects on chemical shifts, and changes in 19F longitudinal 
and transverse relaxation rates. These results provide a detailed picture of the changes in the 
local chemical environment and peptide dynamics that occur when MSI-78 binds to the lipid 
bilayer. 
 Also described are direct, real-time measurements of amyloid formation for fluorinated 
islet amyloid polypeptide (IAPP) and Aβ, for which fiber formation is linked to type II diabetes 
	   xii 
and Alzheimer’s disease respectively. By using 19F NMR, the consumption of monomeric 
peptides, rather than the formation of fibrils can be monitored. This study showed by comparing 
monomer depletion followed by 19F NMR to fiber formation followed by thioflavin T (ThT) 
fluorescence assay that IAPP fibrillizes without accumulation of oligomeric intermediates. 
Inhibitory assays using 19F NMR have suggested that ThT strongly competes with the amyloid 
inhibitor, epigallocatechin-3-gallate, for binding sites on IAPP fibers. In contrast to IAPP, time 
course studies using 19F NMR have shown that small oligomers of Aβ accumulated. These types 
of experimental measurements are difficult to perform by other techniques, and the additional 
level of detail obtained by measuring the rate of monomer consumption by 19F NMR might 
prove fruitful for further characterization of amyloid formation. Studies described in this thesis 
should contribute to develop the utility of 19F NMR to investigate biological system as well as to 
help find potential therapeutic compounds. 
 
  






Introduction to the Use of 19F NMR as a Probe in Biological System 
 
1.1. Properties of Fluorine Nucleus and Its Advantages in NMR Studies 
 Fluorine is extremely rare in biological systems and has unique physical properties.  
Because it has the highest electronegativity of all the elements, the electronic properties of the C-
F bonds are polarized in the opposite direction from C-H bonds (Figure 1.1). Fluorine is often 
considered as isosteric with hydrogen because the van der Waals radius of fluorine is 1.35 Å, 
similar to that of hydrogen (1.2 Å) even though C-F bond is significantly longer than C-H bond 
(~1.0 Å). Fluorine can usually replace hydrogen in small molecules with minimal effect on their 
binding to enzymes and proteins.   
 
Figure 1.1. The properties of the carbon-hydrogen bond (left) and carbon-fluorine bond (right). The 
van der Waals surfaces are shaded according to the electrostatic potential. The image was taken from 
reference 5.  
 
 Fluorination therefore has been utilized extensively by the pharmaceutical industry to 
improve the pharmacokinetics and bioavailability of drugs (1-3). Because fluorocarbons are 
Anyone who has made scrambled eggs will have had
cause to praise the properties of Teflon. Teflon’s highly
chemically inert and nonstick nature derives from the
perfluorinated polymer polytetrafluoroethylene.
Perfluorocarbons have unique and valuable physical
properties not found in nature. By incorporating
fluorine into proteins, it might be possible to produce
biological molecules with novel and useful properties. 
Address: Department of Chemistry and D ivision of B iophysics,
University of Michigan, Ann Arbor, MI 48109-1055, USA .
E-mail: nmarsh@umich.edu
Chemistry & Biology 2000, 7:R153–R157
1074-5521/00/$ – see front matter 
© 2000 E lsevier Science Ltd. A ll rights reserved.
Fluorine occurs extremely rarely in biological molecules.
Only a handful of naturally occurring organofluorine com-
pounds are known, the majority being ω-fluorinated car-
boxylic acids biosynthesized by the plant Dychapetalum
toxicarium [1]. In contrast, chemists have synthesized many
thousands of fluorinated molecules; indeed, there is a whole
journal devoted to the chemistry of fluorine. The carbon–
fluorine bond is extremely strong (about 14 kcal/mol
stronger than a C–H bond), and perfluorinated carbons are
inert to substitution reactions. For this reason, fluorocarbons
have found important industrial and medical uses as plas-
tics, refrigerants and fire retardants, and as anesthetics. Flu-
orinated molecules have also found many uses in
investigations of biochemical problems, proving to be valu-
able probes of enzyme mechanisms, protein structure and
metabolic pathways.
Several physical properties of fluorine make it attractive
to chemists wishing to investigate biochemical problems.
Firstly, fluorine is extremely small, and for this reason it is
often thought of as isosteric with hydrogen (Figure 1). In
fact, although the van der Waals radius of fluorine is
1.35 Å, which is only 0.15 Å larger than hydrogen, a C–F
bond is significantly longer (~1.4 Å) than a C–H bond
(~1.0 Å), and fluorine is better considered as isosteric
with oxygen. Nevertheless, the substitution of fluorine
for hydrogen is very often sufficiently conservative that
fluorinated analogs of natural compounds are still recog-
nized by the target enzymes or receptors. For example,
fluorinated amino acids such as trifluoromethylmethion-
ine and fluorine-substituted analogs of tryptophan,
phenylalanine and tyrosine are recognized by their
cognate amino acyl-tRNA synthetases and incorporated
into proteins [2].
Secondly, fluorine is the most electronegative element,
and therefore the electronic properties of the C–F bond
are quite different from those of a C–H bond. The dipole
moment of a C–H bond is relatively small and points
towards the carbon, whereas that for a C–F bond is much
larger and points towards the fluorine. Similarly, fluorine
exerts a strong inductive effect that is sufficient to perturb
the reactivity of atoms several bonds removed from the
fluorine. For example, introducing a fluorine atom onto
carbon-4 of proline decreases the pKa of the amino group
by 1.6 pH units, even though the fluorine is three bonds
away from the nitrogen [3].
The naturally occurring isotope of fluorine, 19F, is spin fi
and has excellent nuclear magnetic resonance (NMR) prop-
erties. It is the second most sensitive nucleus after hydro-
gen and exhibits a very wide range of chemical shifts that
are sensitive to the environment of the fluorine [2,4]. This,
combin d with the fact that there is no naturally occurring
background signal, has made fluorine NMR a useful tool for
investigating protein structure and dynamics, and for exam-
ining binding of fluorinated ligands to their targets [2].
Perfluorinated carbon compounds exhibit interesting solu-
bility properties. Partitioning measurements of fluoro-
carbon molecules reveals them to be much more
hydrophobic than their hydrocarbon counterparts. The
partition constant, Π, for the trifluoromethyl group is 1.07,
making it over twice as hydrophobic as a methyl group,
Π = 0.5 [5]. This property of fluorocarbons has been
known for sometime, and has been exploited to increase
the lipophilicity, and hence the bioavailability, of various
drugs. A high-profile example is the weight-loss drug fen-
fluramine that contains a trifluoromethyl group. 
Cross ta l k R153
Towards the nonstick egg: designing fluorous proteins
E Neil G  Marsh
Figure 1
Comparison of the properties of the carbon–hydrogen bond (left) with
the carbon–fluorine bond (right). The van der Waals surface is shaded
according to the electrostatic potential.
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highly chemically inert and hydrophobic, they have been used to modulate the physicochemical 
properties of proteins through the introduction of highly fluorinated amino acids in multiple 
positions (4, 5). In general, however, the substitution of hydrogen by fluorine does not appear to 
greatly change protein structures and activities (5-7).  
 The fluorine-19 (19F) nucleus is a spin ½ nucleus, which exists in 100 % natural 
abundance, and therefore has excellent NMR properties comparable to that of proton NMR (83 
% sensitivity relative to the proton) as shown in Table 1.1. One of the most useful features of 19F 
NMR is the intrinsic sensitivity of the chemical shift of the fluorine nucleus to the local chemical 
environment. Fluorine chemical shift is more sensitive and larger than that of proton (Table 1.1) 
because the fluorine nucleus is surrounded by nine electrons rather than a single electron for 
hydrogen (8). Therefore, protein conformational changes (e.g. folding and unfolding, binding to 
small molecules, other proteins or lipid membrane) can be detected by 1D 19F NMR (6, 7). 
Solvent (H2O/D2O) isotope effects on the fluorine chemical shift are also sensitive to study the 
structural changes of large proteins (7).	  The relaxation properties of the 19F nucleus have also 
been utilized to provide information on protein dynamics. In addition, the large magnetogyric 
ratio translates into high sensitivity in 1D NMR spectroscopy as well as strong dipolar coupling 
that allows 19F-19F and 1H-19F Nuclear Overhauser effects (NOE) to be used to measure the 
distances between nuclei.  
 Another advantage is that fluorine is not found in most biological systems so that there is 
no overlap from background signals, a problem that often afflicts measurements using 1H, 13C, 
and 15N NMR. This advantage potentially allows 19F NMR spectroscopy to be used to study on 
multiple protein complexes as well as protein structural determination in vivo, where signals 
from the protein of interest are often attenuated in other NMR techniques. Therefore, the 
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incorporation of fluorine into biomolecules is a very attractive tool to investigate protein 
conformational changes and dynamics, enzyme mechanism, and protein-ligand and protein-


















1H 26.7519 99.98 500 1.0 13 
13C 6.7283 1.108 125.7 0.0159 250 
15N -2.712 0.37 50.7 0.00134 1700 
19F 25.181 100 470.4 0.83 400 
31P 10.841 100 200.2 0.066 530 
	  
Table 1.1. Properties of spin ½ nuclei. The image was adapted from reference 8. 
 
 
1.2. Fluorinated Amino Acids as Probes in 19F NMR 
 Various fluorinated amino acids have been synthesized, and some of them are now 
commercially available. Chemical structures of some of the 19F labeled amino acid analogs 
utilized in 19F NMR studies in chemical biology are shown in Figure 1.2. Fluorinated aromatic 
amino acid analogs including 4-fluorophenylalanine (4-fPhe) 1 (9-13), trifluoromethyl-
phenylalanine (tfmPhe) 2 (13-16), 5-fluorotryptophan (5-fTrp) 3 (17-21), and 3-fluorotyrosine 
(3-fTyr) 4 (22-25) are commonly used for 19F NMR studies because these analogs are easily 
incorporated into proteins by feeding. The syntheses of these amino acids are well established, 
and so they are generally commercially available. Fluorinated phenylalanine (Phe) 1, 2 and 
tryptophan (Trp) 3 are suitable probes for studying protein folding and unfolding since they are 
often in hydrophobic sites of the protein, thus in a buried environment in which the 19F signal 
would shift or decrease due to the change of surrounding environment, as described in later 
	   4 
sections. 3-fTyr 4 has also been utilized to monitor structural changes and test surface exposure 





Figure 1.2. Representative chemical structures of fluorinated amino acid analogs utilized in 19F 
NMR studies in biological systems. 
 
 
 19F NMR studies have also been performed with fluorinated aliphatic amino acids 
including 5-fluoroleucine 5 (26), trifluoroethylglycine (tfeGly) 6 (27), trifluoromethionine 
(tfMet) 7 (28, 29), and 2-fluorohistidine 8 (30) as 19F reporters to examine protein 
conformational changes. In addition to fluorinated amino acid analogs, fluorinated tags such as 
2,2,2-trifluoroethanethiol (TFET) (7, 31, 32), are a complementary method to add 19F probes into 
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1.3. Synthesis of Fluorinated Proteins and Peptides 
 Incorporation of fluorinated probes into proteins and peptides can be accomplished in two 
ways: chemical modification of existing residues, or incorporation of fluorinated amino acids – 
either synthetically or biosynthetically. Chemical modification with fluorinated tags is often 
performed on nucleophillic side chains, most usually cysteine (Cys), either naturally present or 
introduced by mutagenesis (7, 31, 32). Although the preparation of proteins is generally 
straightforward, the addition of chemical probes might perturb the protein structure and/or 
activity depending on the size of probes.  
 Using fluorinated amino acids with Fluorenylmethyloxycarbonyl (Fmoc) or t-butyloxy-
carbonyl (Boc) protection, peptides or proteins up to 50 residues (depending on sequence) can be 
synthesized by solid-phase peptide synthesis. Recently, native chemical ligation techniques have 
overcome this limitation and are able to synthesize proteins with about 200 hundred amino acids 
with several coupling steps (33-35). While peptide synthesis is straightforward and provides the 
high fidelity to incorporate at specific position(s), it becomes impractical to apply such a 
technique to medium – large size proteins. 
 Alternatively, biosynthetic techniques to substitute unnatural amino acids are applicable 
to incorporate some fluorinated amino acid analogs. An auxotrophic bacterial strain in a defined 
minimal media is often used to incorporate fluorinated amino acids such as 4-fPhe (9-13) 1, 5-
fTrp 3 (17-21), 3-fTyr 4 (22-25), and tfMet 7 (28, 29). Since this technique modifies all locations 
of one amino acid, it often results in the overlapping of signal peaks on 19F NMR and is 
necessary to make mutations to assign 19F signal peaks. In addition, this method usually does not 
achieve 100 % substitution of fluorinated amino acids; therefore, the heterogeneity of 
incorporation often causes difficulty for further studies. Multiple substitutions of fluorinated 
	   6 
amino acids in proteins would be beneficial to monitor different site protein dynamics and 
structural changes at the same time. To study specific positions in the protein, it is necessary to 
incorporate fluorinated amino acids site-specifically.    
 Lastly, Schultz and co-workers pioneered an orthogonal aminoacyl-tRNA synthase and 
tRNA pair for evolving proteins with an expanded genetic code to incorporate non-natural amino 
acids in specific positions on proteins of interest (36, 37). Recently, tfmPhe 2 were successfully 
incorporated into large proteins using this method as well as other non-canonical amino acids 
(13-15).     
 
1.4. Application of Fluorinated Peptides and Proteins in 19F NMR  
1.4.1. Protein Unfolding and Folding 
 One of the most challenging aspects in protein folding is to detect the intermediate 
structures in this process. The difficulties in detecting intermediates are a consequence of their 
transient nature, heterogeneity, and low extent of accumulation. Frieden and colleagues 
overcame these difficulties by using 19F NMR to examine intermediates during the folding 
process of rat intestinal fatty acid binding protein (IFABP) (10, 12). In this study, 4-fPhe 1 was 
incorporated as a 19F probe to monitor the sequential IFABP folding steps using real-time 19F 
NMR measurement (Figure 1.3). By monitoring eight 4-fPhe residues in IFABP, they detected a 
non-native like collapse in regions containing three 4-fPhes (4-fPhe-62, 68, and 93), suggesting 
there are conformational fluctuations during the folding process. The signals from these 
intermediates were decreased through cooperative rearrangement of the intermediates to form the 
final native structure. Because the detection of intermediates in protein folding is usually 
difficult, 19F NMR would serve as a general method for study of protein folding processes.    
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Figure 1.3. Real-time 19F NMR experiments showing the kinetics of refolding of the G121V mutant 
of intestinal fatty acid binding protein labeled with 4-fPhe 1. (a) The crystal structure (Protein Data 
Bank entry 2IFB) of apo-IFABP. The location of eight Phe residues (blue), Trp-82 (gold), and the G121V 
mutation site are shown as red stick. (b) 19F NMR kinetic spectra of 19F labeled G121V IFBP right after 
diluting from 6 M to 1 M urea at 10 °C. Each 19F spectrum corresponding to an average of 64 scans. (c) 
Plot of intensity changes for Phe-2/17, Phe-47 and Phe-62 in short time. (d) Plot of intensity changes of 
the disappearance of unfolding intermediates (Phe-62i/68i), and the appearance of the native folding state 
for Phe-62. The images were adapted from reference 10. 
 
 
1.4.2. Protein-Small Molecule Interactions 
 The high sensitivity of the 19F nucleus to the surrounding environment provides great 
advantages for 19F NMR to investigate the structural changes accompanying proteins binding to 
natural ligands or inhibitors. Recently, the conformational changes of β2-adrenergic receptor 
Real-time Measurements of Refolding of G121V-IFABP Using CD and
Fluorescence. The intermediates observed by 19F-NMR formed
within the experimental dead time (1.5 s), but it is likely that their
formation is faster. To further examine the folding mechanism of
G121V, refolding kinetics were monitored by far-UV CD and by
changes in intrinsic protein fluorescence. Stopped-flow CD indi-
cated a fast folding phase occurred within the dead time of our
instrument (!50 ms), accounting for !1/3 f the secondary struc-
ture formation, whereas a slow phase had a rate constant of 1.6 "
10#3 s#1 (Fig. 4A and Table 2). Con istent with the above obser-
vation, stopped-flow fluorescence shows a fast phase refolding with
a rate constant of 21 s#1 (Fig. 4B and Table 2), followed by a slow
phase with a positive amplitude change (data not shown). The fast
phase indicates collapse of Trp-82, which is spatially adjacent to
clusters of Phe-62, Phe-68, and Phe-93 (Fig. 1A). The above data
imply that the intermediates of Phe-62, Phe-68, and Phe-93 were
formed within milliseconds. The slow phase was monitored by
steady-state fluorescence (Fig. 4C). In agreement with the positive
fluorescence intensity change, the maximum was blue-shifted over
time (Fig. 4C), suggesting more buried structure around trypto-
phan(s). A rate constant of 1.0 " 10#3 s#1 (Fig. 4C Inset) was
observed for the slow phase refolding by using the fluorescence at
327 nm, similar to the rate constants observed for the formation of
native resonances by 19F-NMR.
Discussion
It is generally believed that protein folding occurs after the transient
formation of intermediate structures which then condense to a
molten globule type state and from there to the native stable
structure. Such intermediates are difficult to observe because their
stability is marginal and their concentrations are low. Whereas we
represent the forms that we observe as intermediates, we speculate
that the G121V mutation has disrupted the formation of a nucle-
ation site. In previous studies of the rat IFABP, we have suggested
at least two such sites: one around the D-E turn (Fig. 1A), involving
residues around Gly-65 (15, 16), and the second around the I-J turn,
the last two strand in the protein including Gly-121 (17). Data
presented here attempt to clarify the nature of intermediates by
using a site-directed mutant that slows the formation of one
apparent nucleation site. Surprisingly, a single mutation in a turn
slows the overall folding by over three orders of magnitude and
allows other such sites to be observed. This mutation allows
observation of early events in the folding process by the appearance
and disappearance of resonances arising from specific phenylala-
nine residues.
Fig. 3. Kinetics of refolding of the G121V mutant. (A) Stopped-flow 19F-NMR kinetics of 4-19F-Phe-labeled G121V mutant on dilution from 6 M to 1 M urea at
10°C. The final protein concentration was !50 !M. The time resolution for each spectrum is !2.3 s. (B) Real-time 19F-NMR spectra obtained after manual mixing
from 6 M to 1 M urea at 10°C beginning at !53 s. Each spectrum corresponds to an average of 64 scans (73 s). (C) Short time intensity changes of Phe-2/17, Phe-47,
and Phe-62. (D) Long time intensity changes of the disappearance of intermediates (Phe62i/Phe68i) and the appearance of native Phe-62. The rate constant used
to fit the data for both curves was 7 " 10#4 s#1.
Table 1. Rate constants for the appearance of native resonances and the disappearance of unfolded and intermediate resonances
Residue no.
2/17 93 47 62i/68i/93i (I1) U1 U2 128 68 62i/68i (I2) 62
Rate constant (" 10#4 s-1) 6.63 5.52 7.30 6.83 7.05 7.16 6.55 6.91 6.82 6.62
SD (" 10#4 s#1) 0.31 0.34 0.44 0.97 0.35 0.25 0.56 0.42 0.83 0.90







conformational exch nge n r th molten globule state was
observed before its global unfolding by acid (data not shown).
Although the G121V mutant shows similar chemical shifts and
linewidth changes (data not shown) as WT in acid denaturation
(14), the G121V mutant is much less stable, being almost
completely unfolded at the pH 3.9 where the WT protein is still
compact and native-like (14). Altogether, the data demonstrate
that, whereas the G121V mutant has the same overall structure
as the WT protein, it is less stable under denaturating conditions.
Accumulation of Intermedia es in Ur a Equilibrium U folding. Fig. 2
shows the 19F-NMR spectrum of equilibrium unfolding of G121V-
IFABP labeled with 4-19F-phenylalanine as a function of urea
co centration. Urea unfolding of the mutant shows substantial
accumulation of intermediates (Fig. 2A), which are in slow ex-
chang with both the native and unfolded species. These interme-
d ate concentrations are maximal (!22% of total intensity) near
th mid-point of the glo al dena uration curve at !2.6 M urea (Fig.
1C) when all na ive-lik species are almost g ne (Fig. 2B) and were
identified to ari e from Phe-62, Phe-68, and Phe-93 (SI Fig. 7).
Real-Time Measurements of Refolding of G121V-IFABP Using 19F-NMR.
Because the equilibrium data suggested observable intermediates
in the folding process, refolding of the G121V mutant was followed
in real time by using two different time regimes: from 1.5 s to 185 s
by stopped-flow 19F-NMR (Fig. 3A) and from 53 to 6,000 s (Fig. 3B)
after manual mixing. As seen in Fig. 3A, resonances at "39.5 and
"45.5 ppm, reflecting folding intermediates from Phe-62, Phe-68,
and Phe-93, appeared within the experimental dead time (1.5 s),
and their intensity did not change over the time period from 1.5 s
to 185 s. More than one resonance around "39.5 ppm can be seen,
suggesting more than one conformation in the early stage of folding.
In Fig. 3B, the spectra were collected almost to completion of the
folding process. The time-dependent intensity changes for reso-
nances observed in Fig. 3B are shown in SI Fig. 8), with corre-
sponding rate constants reported in Table 1.
Although the formation of the native structure for each of the
eight phenylalanine residues seems to have approximately the same
rate constants (!7 # 10"4 s"1; Table 1), differences do exist in the
early stage of folding (Fig. 3C), with formation of native structure
around Phe-2/Phe-17 detected at !100 s, followed by Phe-47 at
!200 s, and finally by the appearance of the remaining resonances
as illustrated by the disappearance of the intermediate resonance
(Phe62i/Phe68i) and the simultaneous appearance of the native
resonance of Phe-62 (Fig. 3D). Because of the overlap of Phe-55
with unfolded resonances U1 as labeled in Fig. 3, it was not possible
to measure the rate constant for this residue.
When the real-time refolding of the WT IFABP was monitored,
the folding was completed at the earliest time measured (60 s; SI
Fig. 9) consistent with fluorescence studies showing that folding of
WT IFABP is completed in a few seconds (15).
Fig. 2. Intensities of G121V NMR resonances. (A) 19F-NMR spectra of G121V
IFABP as a functio of urea concentration. The peak at "46.293 ppm is
6-19F-Trp used as a reference. The spectra have not been plotted on the same
scale to see intermediates. (B) Integration of each peak as a function of urea.
Fig. 1. Structure and properties of WT and G121V mutant. (A) The crystal
structure (Protein Data Bank entry 2IFB) of apo-IFABP showing the location of
eight phenylalanine residues (blue), Trp-82 (gold), and the G121V mutation site
(red). The diagram was prepared by using MolMol (11). (B) Superposition of
1D-19F-NMRspectraforWTIFABP(red)a dG121Vmutant (black). (C)Equilibrium
denaturation of WT and G121V IFABP as measured by changes in intrinsic fluo-
rescence as a function of urea concentration. The experiments were performed
at 20°C.
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(β2AR) in complexes with various ligands were identified using 19F NMR (Figure 1.4) (32). 
Three native Cys residues in the cytoplasmic regions of the receptor were covalently linked with 
TFET as 19F probes. 1D 19F NMR spectra showed changes in the relative populations of active 
and inactive states of β2AR due to different ligands binding. The structure-activity relationship 
was determined by 19F signal changes on two different labeling sites (Cys 265 and 327) as shown 
in Figure 1.4.  
 
 
Figure 1.4. Two major conformation changes of β2AR to ligand bindings were determined by 19F 
NMR (a) The structure of active-state of β2AR in the complex with the agonist BI-167107 (Protein Data 
Bank entry 3SN6). (b) Chemical structures, names and pharmacological efficacy of the ligands (left) and 
the relative population of active (red) and inactive (blue) states of β2AR measured by the 1D 19F NMR 
spectra (right). (c) Plot of the relative peak volumes for C265A versus C327A. The relative peak volume 
is calculated as the ratios of the active state volume and the sum of the active and inactive state volumes. 
Ligands are indicated as agonists (black circles with yellow background), biased ligands (red triangle with 
green background), and a neutral antagonist (black square), an inverse agonist (black diamond), and apo 
(open square). The images were taken from reference 32. 
and agonists (6–10), including active-state b2AR
complexes with a G protein mimetic nanobody
(8) and with a heterotrimeric G protein (11). The
b2AR–G protein structure, which has also been
analyzed by electron microscopy (EM) (12), re-
veals the location of the G protein binding site,
showing that the G protein interacts with helices
V and VI, and the intracellular loops ICL2 and
ICL3, but makes no substantial contacts with
helices VII and VIII (Fig. 1, A and B). A com-
parison of inactive and active-state crystal struc-
tures of b2AR, rhodopsin (13), and the A2A
adenosine receptor (14, 15) suggests a common
pattern of structural differences between inactive
and active states in GPCRs (Fig. 1C), where a
coupled motion of helices Vand VI, and changes
in helices III and VII, are accompanied by dis-
tinct side-chain rotamer switches on the cyto-
plasmic side of the protein (16, 17). Activation
of b2AR has been investigated previously with
fluorescence-based biophysical experiments (18–25)
and nuclear magnetic resonance (NMR) (26), and
conformational changes during receptor activa-
tion were observed in helix VI and the cytoplas-
mic surface.
To probe for subtle conformational changes
involved in receptor-ligand binding (27), 19F-NMR
spectroscopy was employed. This highly sensi-
tive method was used to provide informati n
based on the observation of line shapes and chem-
ical shifts of strategically located 19F labels in the
cytoplasmic region of the receptor (Fig. 1, A
and B) (28). Similar approaches have previously
bee successfully applied to studies of a number
of membrane proteins (29–31). Three native cys-
teine residues (Cys2656.27, Cys3277.54, and
Cys341) (32) of b2AR (33) in the cytoplasmic
region of the receptor are accessible for covalent
labeling with 2,2,2 trifluoroethanethiol (TET)
(31), and their NMR signals were unambiguously
assigned through the use of site-specific muta-
genesis of these residues and all other native
cysteine residues that might be affected by TET
(Fig. 2A) (34). To probe for structural changes,
we primarily used singly labeled receptors, which
have reduced complexity of the 19F-NMR spectra
when compared with wild-type TETb2AR (Fig.
2A). Cys2656.27 and Cys3277.54 are located at the
cytoplasmic ends of helices VI and VII, respec-
tively, both of which are known to undergo large
conformational changes during receptor activa-
tion (Fig. 1C). In contrast, Cys341 is located in
the nontransmembrane helix VIII at the C ter-
minus, and b2AR(C265A, C327S,
TETC341) was
observed to be unresponsive to binding of dif-
ferent ligands (Fig. 2B). This C-terminal probe
therefore served as an internal negative control
relative to Cys2656.27 and Cys3277.54 in studies
of the effects from the binding of different phar-
macological ligands.
The 19F-NMR spectra of b2AR(
TETC265,
C327S, C341A) and b2AR(C265A,
TETC327,
C341A) (Fig. 2, C to E) show prominent changes
upon addition of saturating concentrations of a
collection of ligands (table S1) that represent a full
spectrum of ligand efficacy (35). In general, the




consist of two components, suggesting that the
b2AR structure contains two independent equilib-
ria between locally different conformations man-
ifested at these two amino acid positions. Whereas
ligand-free and inverse agonist-bound TETb2ARs
have almost identical spectra, in which the po-
pulations of C327I and C265I are much more
prominent than those of C327A and C265A,
spectra of TETb2AR bound to the full agonist iso-
proterenol exhibit approximately equal populations
at both residues (Fig. 3A). Shifts of this equi-
librium are observed with different agonists bound
to TETb2AR, suggesting that the peaks A and I are
likely to represent the active and inactive state of
both helices VI and VII of b2AR, respectively.
The temperature dependence of the 19F signals
with regard to line width and peak intensity (Fig.
2, C to E, and fig. S4) suggests that the active
state of both helices VI and VII of b2AR exhibits
a larger degree of conformational plasticity than
the inactive state; that is, the active state samples
a wider range of conformers with slightly dif-
ferent chemical shifts, either in a static ensemble
or in a manifold of conformers that also includes
conformational exchange.
The 19F-NMR data were analyzed with a
double-Lorentzian function to obtain quantita-
tive information on the conformational equilib-
ria (Fig. 3A). This revealed that positions and
widths of the NMR peaks remain practically un-
changed for all ligands studied and confirmed
that the major effects of agonist binding are
population shifts from inactive state peaks (I) to
those of active state (A). A plot of relative peak
volumes for Cys265A versus those for Cys327A,
which represent the populations of the active
state in helix VI and helix VII, respectively,
reveals varying degrees of agonist-mediated shifts
toward the active state manifested by Cys2656.27
and Cys3277.54 (Fig. 3B). For most agonists, the
shifts along the two xes follow the same overa l
trend as their reported pharmacological efficacy on
G protein activation (36). For instance, the partial
agonists tulobuterol, clenbuterol, and norepineph-
rine have a less pronounced effect on Cys2656.27
than the full agonist isoproterenol, whereas the
full agonist formoterol elicits a greater shift in
conformational equilibrium on Cys2656.27. These
results suggest that the degree to which agonists
shift the equilibrium toward the active state of
helix VI results in differing G protein signaling
Fig. 3. Relative populations of active (A, red)
and inactive (I, blue) states of b2AR derived
from the 1D 19F-NMR spectra at 280 K. (A)
Peak volumes for the individual components
in the 1D 19F-NMR signals of b2AR(TETC265,
C327S, C341A) and b2AR(C265A,
TETC327,
C341A) obtained by a nonlinear least-squares
fit to a double-Lorentzian function. Th ex-
perimental data and the double-Lorentzian
are indicated by thin and thick black lines,
respectively. The fit used the chemical shift
positions of peaks A and I indicated by the
red and blue vertical lines. (B) Plot of the relative
peak volumes for C265A versus the relative
peak volumes for C327A. The relative peak vol-
umes are the ratios of the volume of peak A and
the sumof the volumes of peaks A and I. Agonists
[tulobuterol, clenbuterol, norepinephrine (NE),
isoproterenol, and formoterol] are shown as black circles highlighted by a yellow background, biased ligands
(carvedilol, isoetharine) as red triangles highlighted by a green background, a neutral antagonist
(alprenolol) as a black square, an inverse agonist (carazolol) as a black diamond, and apo as an open square.
































capacity. The antagonist/weak partial agonist
alprenolol can induce a small shift on Cys2656.27
but has a minimal effect on Cys3277.54, in agree-
ment with previous findings that it is a weak
partial agonist (25, 37). The inverse agonist
carazolol, on the other hand, induces no ap-
parent shifts as compared to the apo form. In con-
trast, the two b-arrestin–biased ligands, isoetharine
and carvedilol, cause large shifts of the equilibria
in Cys3277.54 toward the active state. Interest-
ingly, carvedilol, like other antagonists and inverse
agonists, has little influence on the equilibrium
of Cys2656.27, whereas isoetharine, like ther ago-
nists, also produces a prominent shift of Cys2656.27
toward the active state.
The large activation changes in Cys3277.54
caused by carvedilol and isoetharine suggest
that helix VII primarily affects b-arrestin sig-
naling pathways. This is consistent with the
result of a previous study that b2AR phospho-
rylation by GPCR kinases, which is a pre-
requisite for b-arrestin binding, primarily targets
a region directly adjacent to helix VII on helix
VIII (38). Furthermore, recent crystallographic
(11) and EM studies (12) of a b2AR-Gabg het-
erotrimer complex show that the Ga subunit makes
major contact wit helices V and VI of b2AR,
resulting in a 14 Å outw rd movement of he
cytoplasmic ends of these helices, whereas there
is no contact between Gabg and helix VII (Fig.
1, A and B), suggesting that the conformational
changes in helix VII are not directly involved in
G protein binding and signaling.
To further characterize the environment of
Cys3277.54 in the active state, we evaluated the
effect of the water-soluble paramagnetic relaxation
agent gadopentetic dimeglumine (Magnevist,Bayer
HealthCare Pharmaceuticals, New Jersey, USA)
(39) on individual resonances of b2AR(C265A,
TETC327, C341A) bound to isoproterenol. A
comparison of the line widths of peaks A and I in
the one-dimensional (1D) 19F-NMR spectra at
various Magnevist concentrations revealed that
peak I is more susceptible to the line broadening
by Magnevist than peak A (fig. S1A), indicating
that Cys3277.54 in the inactive state is mor readily
solvent-accessible than in the active state. This
interpretation is consistent with crystal structure
data, where Cys3277.54 was found to be solvent-
exposed in the carazolol-bound structure (6) but
buried in the transmembrane helix bundle of the
receptor in its complexes with a nanobody (8) or
the G protein (11) (fig. S1B).
Additional insight from analysis of the
19F-NMR results can be obt ined by examining
the chemical structures of the agonists and their
interactions with the individual helices in the
b2AR binding pocket (Fig. 4). The majority of
known high-affinity adrenergic ligands have a
common structural motif consisting of an aro-
matic “head g oup” and an thanolamine “tail
group”. The head group (e.g., catechol) of ago-
nists is directly connected to the ethanolamine
tail, whereas antagonists and inverse agonists—
both of which act as competitive inhibitors to
agonists and either have no impact or a negative
impact on the receptor basal activity—have an
additional two-atom linker between the head
and tail groups. Crystal structures of the b2AR
complexes with various ligands (6–11), as well
as biochemical (40–42) and modeling studies
(43, 44) have established that the aromatic head
groups interact with helices V and VI, whereas
the ethanolamine tails are anchored by ionic and
polar interactions at helices III and VII (Fig. 4A
and fig. S2). For agonists, polar interactions of
their head groups with helix V side chains thereby
mediate an inward shift of Pro2115.50, and sub-
sequent conformational changes involving Ile1213.40
and Phe2826.44 (8) result in the activation move
of the cytoplasmic tip of helix VI.
The changes observed by 19F-NMR (Fig. 3)
provide additional insight into correlations be-
tween the chemical structure of the ligands and
their interactions with b2AR. Binding of full
agonists (such as iso roterenol and formoterol)
imparts a large shift in the conformational equi-
librium of both helices VI (Cys2656.27) and VII
(Cys3277.54). Bi ding of partial agonists, which
either completely lack (as in tulobuterol) or have
much weaker (as in clenbuterol) polar features
on their ar matic heads, has a smaller influence
on the conformational equilibrium of helix VI
than full agonists but has almost as much impact
on helix VII. In addition, the b-arrestin–biased
ligands carvedilol and isoetharine, which differ
from their corresponding “unbiased” prototypes
(inverse agonist carazolol and full agonist iso-
proterenol, respectively) only in the tail moieties,
strongly affect the helix VII equilibrium. Another
important observation is that the 1D 19F-NMR
spectrum of b2AR(C265A, C327S,
TETC341)
bound to isoetharine, which is one of the most
potent biased agonists, is similar to those of
b2AR(C265A, C327S,
TETC341) bound to
carazolol and isoproterenol (Fig. 2B). This
shows that the C terminus of the nontransmem-
bran helix VIII, where Cys341 is located, is
not directly involved in the b-arrestin signaling
pathway. In the absence of structural data on a
complex of b2AR with b-arrestin, it is tempting
to further hypothesize from this data that the
position of Cys341 on helix VIII is located
outside f the interface with bound arrestin.
These observations on structure-activity rela-
tionships for b-arrestin–biased b2AR ligands,
and unbiased full and parti l agonists, provide in-
sights into b2AR signaling pathways that suggest
the existence of parallel pathways for G protein
and b-arre tin signaling (fig. S3). Although these
pathways appear interconnected on several le els
and may involve other activation-related rear-
rangements in the cytoplasmic and periplasmic
loops (45), the present 19F-NMR results point
to a high level of decoupling of the two pathways.
The implicated links between ligand structure
and function may serve as a platform for future
rational design of specific ligands.
Given the above observations on the corre-
lation between ligand structure and receptor re-
sponse, a connection can now be made between
Fig. 4. Features of ligand binding in the b2AR
structure and a conceptual model of signaling
pathways to G proteins and arrestins in b2AR activation. (A) Side view of the structure of active-state
b2AR in the complex with the agonist BI-167107 (PDB ID 3SN6), with helices V/VI and III/VII color-
coded orange and blue, respectively, to indicate that they interact with the correspondingly colored
fragments of the ligands in (B). (B) Chemical structures of the ligands used in the current 19F-NMR
studies. Orange highlights the head groups, green the common ethanolamine moieties, and blue the
substituents to the amino group of the ethanolamine tail. Ligand names are shown on the right, with
published pharmacological efficacy indicated in parentheses.


































capacity. The antagonist/we k partial agonist
alprenolol can indu e a small s ift on Cys2656.27
but has a minimal effect on Cys3277.54, in agree-
ment with previous findings that it is a weak
partial agonist (25, 37). T e inverse agonist
carazolol, on the oth r hand, induces no ap-
parent shifts as compared t the apo form. In con-
trast, the two b-arrestin–biased ligands, isoetharine
and carvedilol, cause large shifts of the equilibria
in Cys3277.54 toward the active state. Interest-
ingly, carvedilol, like other antagonists and inverse
agonists, has little influence on the equilibrium
of Cys2656.27, whereas isoetharine, like other ago-
nists, also produces a prominent shift of Cys2656.27
toward the active state.
The large activation changes in Cys3277.54
caused by carvedilol and isoetharine suggest
that helix VII primarily affects b-arrestin sig-
naling pathways. This is consistent with the
result of a previous study that b2AR phospho-
rylation by GPCR kinases, which is a pre-
requisite for b-arrestin binding, primarily targets
a region directly adjacent to helix VII on helix
VIII (38). Furthermore, recent crystallographic
(11) and EM studies (12) of a b2AR-Gabg het-
erotrimer complex show that the Ga subunit makes
major contact with helices V and VI of b2AR,
resulting in a 14 Å outward movement of the
cytoplasmic ends of these helices, whereas there
is no contact between Gabg and helix VII (Fig.
1, A and B), suggesting that the conformational
changes in helix VII are not directly involved in
G protein binding and signaling.
To further characterize the environment of
Cys3277.54 in the active state, we evaluated the
effect of the wat r-soluble par a netic rel xation
agent gadopentetic dimeglumine (Magnevist,Bayer
HealthCare Pharmaceuticals, New Jersey, USA)
(39) on individual resonances of b2AR(C265A,
TETC327, C341A) bound to isoproterenol. A
comparison of the line widths of peaks A and I in
the one-dimensional (1D) 19F-NMR spectra at
various Magnevist concentrations revealed that
peak I is more susceptible to the line broadening
by Magnevist than peak A (fig. S1A), indicating
that Cys3277.54 in the inactive state is more readily
solvent-accessible than in the active state. This
interpretation is consistent with crystal structure
data, where Cys3277.54 was found to be solvent-
exposed in the carazolol-bound structure (6) but
buried in the transmembrane helix bundle of the
receptor in its complexes with a nanobody (8) or
the G protein (11) (fig. S1B).
Additional insight from analysis of the
19F-NMR results can be obtained by examining
the chemical structures of the agonists and their
interactions with the individual helices in the
b2AR binding pocket (Fig. 4). The majority of
known high-affinity adrenergic ligands have a
common structural motif consisting of an aro-
matic “head group” and an ethanolamine “tail
group”. The head group (e.g., catechol) of ago-
nists is directly connected to the ethanolamine
tail, whereas antagonists and inverse agonists—
both of which act as competitive inhibitors to
agonists and either have no impact or a negative
impact on the receptor basal activity—have an
additional two-atom linker between the head
and tail groups. Crystal structures of the b2AR
complexes with various ligands (6–11), as well
as biochemical (40–42) and modeling studies
(4 , 44) have established that the aromatic head
groups interact with helices V and VI, whereas
the ethanolamine tails are anchored by ionic and
polar interactions at helices III and VII (Fig. 4A
and fig. S2). For agonists, polar interactions of
the r head groups with helix V side chains thereby
mediate an inward shift of Pro2115.50, and sub-
sequent conformational changes involving Ile1213.40
and Phe2826.44 (8) result in the activation move
of the cytoplasmic tip of helix VI.
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agonists (such as isoproterenol and formoterol)
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spectrum of b2AR(C265A, C327S,
TETC341)
bound to isoetharine, which is one of the most
potent biased agonists, is similar to those of
b2AR(C265A, C327S,
TETC341) bound to
carazolol and isoproterenol (Fig. 2B). This
shows that the C terminus of the nontransmem-
brane helix VIII, where Cys341 is located, is
not directly involved in the b-arrestin signaling
pathway. In the absence of structural data on a
complex of b2AR with b-arrestin, it is tempting
to further hypothesize from this data that the
position of Cys341 on helix VIII is located
outside of the interface with bound arrestin.
These observations on structure-activity rela-
tionships for b-arrestin–biased b2AR ligands,
and unbiased full and partial agonists, provide in-
sights into b2AR signaling pathways that suggest
the existence of parallel pathways for G protein
and b-arrestin signaling (fig. S3). Although these
pathways appear interconnected on several levels
and may involve other activation-related rear-
rangements in the cytoplasmic and periplasmic
loops (45), the present 19F-NMR results point
to a high level of decoupling of the two pathways.
The implicated links between ligand structure
and function may serve as a platform for future
rational design of specific ligands.
Given the above observations on the corre-
lation between ligand structure and receptor re-
sponse, a connection can now be made between
Fig. 4. Features of ligand binding in the b2AR
structure and a conceptual model of signaling
pathways to G proteins and arrestins in b2AR activation. (A) Side view of the structure of active-state
b2AR in the complex with the agonist BI-167107 (PDB ID 3SN6), with helices V/VI and III/VII color-
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and agonists (6–10), including active-state b2AR
complexes with a G protein mimetic nanobody
(8) and with a heterotrimeric G protein (11). The
b2AR–G protein structur , which has also been
analyzed by electron microscopy (EM) (12), re-
veals the location of the G protein binding site,
showi g that th G protein interacts with helices
V and VI, and the intracellular loops ICL2 and
ICL3, but makes no substantial contacts with
helices VII and VIII (Fig. 1, A and B). A com-
parison of inactive and active-state crystal struc-
tures of b2AR, rhodopsin (13), and the A2A
adenosine receptor (14, 15) suggests a common
pattern of structural differences between inactive
and active states in GPCRs (Fig. 1C), where a
coupled motion of helices Vand VI, and changes
in helices III and VII, are accompanied by dis-
tinct side-chain rotamer switches on the cyto-
plasmic side of the protein (16, 17). Activation
of b2AR has been investigated previously with
fluorescence-based biophysical experiments (18–25)
and nuclear magnetic resonance (NMR) (26), and
conformational changes during receptor activa-
tion were observed in helix VI and the cytoplas-
mic surface.
To probe for subtle conformational changes
involved in receptor-ligand binding (27), 19F-NMR
spectroscopy was employed. This highly sensi-
tive method was used to provide information
based on the observation of line shapes and chem-
ical shifts of strategically located 19F labels in the
cytoplasmic region of the receptor (Fig. 1, A
and B) (28). Similar approaches have previously
been successfully applied to studies of a number
of membrane proteins (29–31). Three native cys-
teine residues (Cys2656.27, Cys3277.54, and
Cys341) (32) of b2AR (33) in the cytoplasmic
region of the receptor are accessible for covalent
labeling with 2,2,2 trifluoroethanethiol (TET)
(31), and their NMR signals were unambiguously
assigned through the use of site-specific muta-
genesis of these residues and all other native
cysteine residues that might be affected by TET
(Fig. 2A) (34). To probe for structural changes,
we primarily used singly labeled receptors, which
have reduced complexity of the 19F-NMR spectra
when compared with wild-type TETb2AR (Fig.
2A). Cys2656.27 and Cys3277.54 are located at the
cytoplasmic ends of helices VI and VII, respec-
tively, both of which are known to undergo large
conformational changes during receptor activa-
tion (Fig. 1C). In contrast, Cys341 is located in
the nontransmembrane helix VIII at the C ter-
minus, and b2AR(C265A, C327S,
TETC341) was
observed to be unresponsive to binding of dif-
ferent ligands (Fig. 2B). This C-terminal probe
therefore served as an internal negative control
relative to Cys2656.27 and Cys3277.54 in studies
of the effects from the binding of different phar-
macological ligands.
The 19F-NMR spectra of b2AR(
TETC265,
C327S, C341A) and b2AR(C265A,
TETC327,
C341A) (Fig. 2, C to E) show prominent changes
upon addition of saturating concentrations of a
collection of ligands (table S1) that represent a full
spectrum of ligand efficacy (35). In general, the




consist of two components, suggesting that the
b2AR structure contains two independent equilib-
ria between locally different conformations man-
ifested at these two amino acid positions. Whereas
ligand-free and inverse agonist-bound TETb2ARs
have almost identical spectra, in which the po-
pulations of C327I and C265I are much more
prominent than those of C327A and C265A,
spectra of TETb2AR bound to the full agonist iso-
proterenol exhibit approximately equal populations
at both residues (Fig. 3A). Shifts of this equi-
librium are observed with different agonists bound
to TETb2AR, suggesting that the peaks A and I are
likely to represent the active and inactive state of
both helices VI and VII of b2AR, respectively.
The temperature dependence of the 19F signals
with regard to line width and peak intensity (Fig.
2, C to E, and fig. S4) suggests that the active
state of both helices VI and VII of b2AR exhibits
a larger degree of conformational plasticity than
the inactive state; that is, the active state samples
a wider range of conformers with slightly dif-
ferent chemical shifts, either in a static ensemble
or in a manifold of conformers that also includes
conformational exchange.
The 19F-NMR data were analyzed with a
double-Lorentzian function to obtain quantita-
tive information on the conformational equilib-
ria (Fig. 3A). This revealed that positions and
widths of the NMR peaks remain practically un-
changed for all ligands studied and confirmed
that the major effects of agonist binding are
population shifts from inactive state peaks (I) to
those of active state (A). A plot of relative peak
volumes for Cys265A versus those for Cys327A,
which represent the populations of the active
state in helix VI and helix VII, respectively,
reveals varying degrees of agonist-mediated shifts
toward the active state manifested by Cys2656.27
and Cys3277.54 (Fig. 3B). For most agonists, the
shifts along the two axes follow the same overall
trend as their reported pharmacological efficacy on
G protein activation (36). For instance, the partial
agonists tulobuterol, clenbuterol, and norepineph-
rine have a less pronounced effect on Cys2656.27
than the full agonist isoproterenol, whereas the
full agonist formoterol elicits a greater shift in
conformational equilibrium on Cys2656.27. These
results suggest that the degree to which agonists
shift the equilibrium toward the active state of
helix VI results in differing G protein signaling
Fig. 3. Relative populations of active (A, red)
and inactive (I, blue) states of b2AR derived
from the 1D 19F-NMR spectra at 280 K. (A)
Peak volumes for the individual components
in the 1D 19F-NMR signals of b2AR(TETC265,
C327S, C341A) and b2AR(C265A,
TETC327,
C341A) obtained by a nonlinear least-squares
fit to a double-Lorentzian function. The ex-
perimental data and the double-Lorentzian
are indicated by thin and thick black lines,
respectively. The fit used the chemical shift
positions of peaks A and I indicated by the
red and blue vertical lines. (B) Plot of the relative
peak volumes for C265A versus the relative
peak volumes for C327A. The relative peak vol-
umes are the ratios of the volume of peak A and
the sumof the volumes of peaks A and I. Agonists
[tulobuterol, clenbuterol, norepinephrine (NE),
isoproterenol, and formoterol] are shown as black circles highlighted by a yellow background, biased ligands
(carvedilol, isoetharine) as red triangl s highlighted by a green background, a neutral antagonist
(alprenolol) as a black square, an inverse agonist (carazolol) as a black diamond, and apo as an open square.
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 Characterization of inhibitors for protein-protein interactions was also recently achieved 
by observing of 19F NMR signal changes (22). The utility of 19F NMR in detecting protein-small 
molecule interactions could contribute as an analytical method to screen libraries of potential 
ligands for therapeutic uses.  
 
1.4.3. Protein-Membrane Interactions 
 Many important biological processes involve interactions between proteins and lipid 
membranes. These interactions are often difficult and challenging to determine due to their 
dynamic and transient nature. Using 19F NMR, Norton and his colleagues have studied 
interaction of the actinoporin equinatoxin II (EqTII), which is a family of sea anemone toxins 
that disrupts the cell membrane by pore formation (Figure 1.5) (21). To elucidate the binding 
interface of EqTII with lipid membranes, five Trp residues in this protein were replaced with 5-
fTrp 3 (using a Trp auxotrophic strain of E. coli) because Trp residues are suggested to make key 
interactions with lipid membranes. Protein structural changes occurring upon the addition of 
lipid micelles or bicelles were followed using 19F NMR. A large 19F chemical shift for Trp 112 
was observed in the presence of phospholipid micelles or bicelles. Further protein structural 
changes on model membranes were observed by following the chemical shift of Trp 116 upon 
the addition of sphingomyelin (SM). Through these experiments, the interaction and orientation 
of EqTII with respect to the lipid membrane could be deduced. Recently, an initial study for the 
interaction of antimicrobial peptide (AMP), MSI-78, with lipid bilayer was also performed in our 
laboratory as described later in this chapter (27, 38). 
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Figure 1.5. 19F NMR studies of the interaction of the actinoporin equinatoxin II with model 
membranes. (a) 19F NMR spectra of 19F labeled EqTII (described as wild type in figure) in DPC micelle 
with the addition of SM (ratio of SM to DPC was depicted next to each spectrum). (b) 19F NMR spectra of 
19F labeled EqTIIs (WT of mutant W149F) in DMPC/DHPC bicelles in the absence or presence of SM. 
(c) Proposed models of the orientation of EqTII upon membrane binding based on 19F chemical shifts. 
The images were taken from reference 21. 
 
 
1.4.4. In-cell Applications 
 Determination of protein dynamics and structural information in living cells is important 
for understanding how proteins function in their natural environment, which can be distinctly 
different from the condition employed in vitro studies. NMR signals from a protein of interest 
are hard to observe due to the crowded environment in the cell. This requires overexpressing the 
protein of interest and growing the cells on nutrients enriched with NMR active nuclei such as 
15N or 13C to overcome the low signal of other cellular components. However, this approach 
resonance shifted upfield by 0.9 ppm, W116 shifted
downfield by 0.4 ppm and W117 shifted downfield
by 0.2 ppm (Figure 4(b)). As a result of its upfield
shift, the W112 resonance was close to that of W149,
but was distinguishable by its sharper linewidth.
These assignments were confirmed by parallel
experiments on the W149F mutant (spectra not
shown).
When a small amount of SM was added the
overall appearance of the spectrum was similar, but
the intensity of the W112 peak decreased and there
was a small broad peak around K47.9 ppm
(indicated in Figure 4(c)). In fact, a weak peak at
this position was visible even in the absence of SM
(Figure 4(b)), and was seen also in corresponding
spectra at 376 MHz of both F-Trp-EqTII and F-Trp-
EqTII-W149F (not shown). Importantly, the same
pattern of shifts was observed when half the
concentration of F-Trp-EqTII was used, indicating
that the EqTII binding capacity of the DPC micelles
was not saturated at the concentration used in
Figure 4. As the ratio of SM to DPC increased, the
sharp W112 peak disappeared and the broad
downfield peak grew (Figure 4(d) and (e)). The
W116 resonance continued to move downfield and
became broader, while W117 was largely unaffected
by SM. When the ratio of SM to DPC reached 1:1, all
peaks in the spectrum (not shown) became quite
broad but the distribution of peak intensities was
similar to that in Figure 4(e) except that the W112
linewidth had become more similar to the others.
A similar pattern of changes was seen at 376 MHz
upon interaction of F-Trp-EqTII and F-Trp-EqTII-
W149F, although the peak at K47.9 ppm was
sharper than at 470 MHz. One possible explanation
for this is that there is some conformational
averaging occurring on the millisecond timescale
that produces more broadening at the higher
observation frequency. In addition, chemical shift
anisotropy contributions to relaxation41,44 will be
more pronounced at the higher field. For the
purpose of this study we have not attempted to
distinguish between these possible sources of
broadening at 470 MHz. The spectra of F-Trp-
EqTII in DPC, with and without SM, showed no
long-term time-dependence, being reproducible
over a period of weeks to months.
The effect of SM on the spectrum of F-Trp-EqTII
in these experiments is likely to be mediated
entirely by SM bound to micelles. SM is very
insoluble in aqueous solution, and when EqTII was
Table 1. 19F NMR relaxation data for Trp residues of EqTII
Trp 376 MHz 470 MHz
T1 (s) T2 (ms) T1 (s) T2 (ms)
W45 0.28 19 0.33 16
W112 0.74 23 0.99 20
W116 0.43 22 0.64 16
W117 0.32 24 0.45 19
W149 0.31 20 0.52 18
Values measured at 376 MHz are the mean of three sets of data, all recorded at 25 8C with a recycle time of 1.5 seconds; ranges
were G0.02–0.03 seconds for T1 and G2 ms for T2. Values at 470 MHz were measured at 21 8C with a recycle time of 3.5 seconds.
A second set of data at 470 MHz was recorded with a more dilute sample (ca one-sixth the concentration of the first sample); the T2
values were similar to those shown in this table, as were the T1 values for W45, W117 andW149. The T1 values for W112 andW116 were
longer (1.37 seconds and 0.76 seconds, respectively).
Figure 4. 19F NMR spectra of F-Trp-EqTII in DPC
micelles with increasing amounts of SM. Spectra were
recorded at 470 MHz and 21 8C. (a) F-Trp-EqTII, pH 5.1,
2K scans; (b) F-Trp-EqTII in DPC micelles. 0.3 mM F-Trp-
EqTII, 123 mM DPC in 50 mM phosphate buffer at pH 6.1
(note that a spectrum of a sample of DPC micelles with
half this concentration of F-Trp-EqTII and pH 6.3 gave
identical chemical shifts); (c) 1.3 mM SM, ratio of SM to
DPC 0.01; (d) 16 mM SM; rati 0.13; (e) 27 mM SM; ratio
0.22. All spectra in DPC micelles, with or without SM,
were run with 32K scans.
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Suppor ing Information) but its HSQC spectrum cannot be
obtained from the cell slurry. The protein signals, however,
appear upon lysis (Figure S2 of the Supporting Information).
We do not understand our inability to reproduce the published
results on UBQ, which has been reported to yield high-resolution
spectra in E. coli.6,42 Our use of a different growth medium is
not the reason because we obtain similar results to those shown
in Figure 3 when we use the media described in the publications.
We also tried expressing the protein at different temperatures
without success. Our studies were conducted on a cold-probe
equipped 500 MHz instrument. Lack of sensitivity does not
explain our inability to detect UBQ in cells because we obtain
the same results with a cold-probe equipped 700 MHz
spectrometer.
Freezing cells prior to in-cell NMR studies has been sug-
gested.6 We prepared another 15N-enriched UBQ sample for in-
cell experiments but stored the sample at -20 °C overnight.
The sample was thawed and used to collect an in-cell spectrum.
The spectrum of native UBQ,40 which is not observed in a fresh
sample (part B of Figure 3), is visible in the previously frozen
sample (Figure S3 of the Supporting Information). Storing the
sample at -80 °C gives the same result. Adding 10% (v/v)
glycerol decreases, but does not always prevent, leakage. We
conclude that cells should not be frozen if they are to be studied
by using in-cell NMR.
3FY-Labeled, 15N-Enriched Chymotrypsin Inhibitor 2
(CI2). This 7 kDa globular protein has one tyrosine. Part A of
Figure 4 shows the 19F spectrum of 3FY-labeled cell slurry.
Three resonances are observed. The sharpest resonance is from
free 3FY. The other two resonances are from CI2. Both have a
chemical shift of -59.2 ppm. One protein resonance is broad
with a width at half height of !1.5 ppm. The other resonance
is sharper and superimposed on the broad resonance. The HSQC
spectrum of the cell slurry (part B of Figure 4) shows a spectrum
almost identical to that of purified CI2.31 The spectrum from
the supernatant collected immediately after the in-cell experi-
ment contains a resonance from both free 3FY and 3FY-labeled
CI2 (part C of Figure 4). The HSQC spectrum of the supernatant
(part D of Figure 4) i alm st identical to the spectrum from
the cell slurry (part A of Figure 4). These data show that CI2
has leaked from the cells, consistent with previous work.38 After
lysis (part E of Figure 4), only free 3FY and a single sharp
resonance from the labeled protein is observed. The HSQC
spectrum of the lysate is identical to the HSQC spectrum from
the cell slurry. Comparing the three 19F spectra suggests that
the broad resonance at -59.2 ppm in the cell slurry is
intracellular CI2 and the superimposed sharper resonance is from
CI2 that has leaked from the cells.
fmF-Labeled CI2. Figure 5 shows the 19F spectra of CI2
labeled at positions 18 and 42 in cells and lysates. The protein
resona ces ave a width at half height of !0.20 ppm in cells.
They shift upfield by 0.15-0.20 ppm and narrow to !0.03 ppm
upon lysis. There are no protein signals from the supernatants
collected after the NMR experiments, indicating that tfmF-
labeled CI2 does not leak. This result is surprising considering
the results from the 3FY-labeled protein (Figure 4). As discussed
below, a lower expression level may explain the absence of
leakage. The small signals near the free tfmF may be a
degradation product of labeled CI2 or a tfmF metabolite.
3FY-Labeled, 15N-Enriched Calmodulin (CAM). This 16 kDa
two-lobed globular protein has two tyrosine residues. Part A of
Figure 6 shows the 19F spectrum of the 3FY-labeled cell slurry.
Three resonances are evident. The sharp resonance is from free
3FY. The other two, one on either side of the 3FY resonance,
are from the protein.43 The HSQC spectrum from the slurry
(part B of Figure 6) shows only metabolite signals.38,39 Parts C
and D of Figure 6 show the 19F spectrum and the HSQC
spectrum from the supernatant collected immediately after the
in-cell NMR experiment. Only free 3FY is observed in the 19F
spectrum, and the HSQC spectrum is nearly devoid of cross-
peaks, indicating that CAM does not leak from the cells. Part
E of Figure 6 shows the 19F spectrum of the clear lysate. The
broad protein resonances observed in the cell slurry narrow on
lysis but the width at half height for the broadest resonance is
(42) Burz, D. S.; Shekhtman, A. PLoS ONE 2008, 3, e2571.
(43) Kitevski-LeBlanc, J. L.; Evanics, F.; Prosser, R. S. J. Biomol. NMR
2009, 45, 255–264.
Figure 4. 19F spectra of 3FY-labeled CI2 (left panels) and 1H-15N HSQC
spectra of 15N-enriched CI2. The panels are labeled as described in the
caption to Figure 1.
Figure 5. 19F spectra of K18tfmF CI2 in cells (green) and lysates (blue)
(A), Y42tfmF CI2 in cells and in lysates (B), and supernatants collected
after the in-cell NMR experiments (C). The asterisks indicate the free tfmF
resonances.
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mixed with a suspension of SM in phosphate buffer
it gave no detectable 1H NMR signal at 600 MHz.
Furthermore, previous experiments have shown
that EqTII bound to SM in aqueous solutions is not
available to cause haemolysis.22 Thus, essentially all
of the SM added to DPC micelles is likely to be
associated with the micelles. Any free SM will be
insoluble and any F-Trp-EqTII associ ted with it
would not be obs rvable in our NMR experiment ,
as confirmed by 1HNMR (data not shown). It is also
reasonable to assume that most of the toxin is
associated with micelles under our experimental
conditions (lipid to toxin molar ratio 500 at the
highest SM co centration). At even lower lip d to
toxin ratios, the majority of the toxin was associated
with the membranes in lipos mes composed of 1:1
PC/SM, with approximately 80% of EqTII36 and
sticholysins I and II33 bound to small and large
unilamellar vesicles, respectively.
To determine whether the order of addition had
any influence, we mixed SM with DPC before
adding F-Trp-EqTII. At an SM to DPC ratio similar
to that shown in Figure 4(d) the W112 peak had not
moved as far downfield as when SM was added to
F-Trp-EqTII already mixed with DPC. This suggests
that the distribution of F-Trp-EqTII and SM across
the micelle population is affected slightly by the
order of addition, although the pattern of chemical
shift changes is the same. The toxin may induce a
change in lipid micelle structure that enables easier
partition of SM into the micelle or easier access of
SM to F-Trp-EqTII, or F-Trp-EqTII may preferen-
tially attract SM tomicelles in which it is embedded.
An impurity peak at K42.3 ppm was evident in
most, but not all, spectra in DPC, with or without
SM (Figure 4) and in bicelles with SM (see below).
Its sharper linewidth suggests that it arose from
an impurity in the lipids, rather than from native
F-Trp-EqTII. This was confirmed by the appearance
of this peak in spectra of DPC micelles and bicelles
in the absence of SM or F-Trp-EqTII. Its T1 at
470 MHz was similar to that of W45 in F-Trp-EqTII
in DPC with 16 mM SM (sample as in Figure 4(d)),
i.e. about 0.4 second.
Interaction with bicelles
Binary bilayered mixed micelles, known as
bicelles, represent a model membrane system
more similar to natural biomembranes than DPC
micelles. They are considered to be discoidal
bilayers typically composed of long-chain
dimyristoylphosphatidylcholine (DMPC) localized
in the planar section, and short-chain dihexanoyl-
phosphatidylcholine (DHPC) stabilizing the torus
of the discs.45–49 Because of the diamagnetic
susceptibility of their pho pholipid co ponents,
bicelles can spontaneously align in the magnetic
field with the bilayer normal perpendicular to the
direction of the field, but this alignment depends on
the temperature, concentration, and long-chain to
short-chain lipid ratio (q). In this study, we have
used bicelles with a small q ratio (0.25), which are
expected to be cylindrical in shape, with a height
around 45 Å and a radius of about 25 Å.47 Although
they are larger than micelles they undergo suffi-
ciently rapid tumbling in solution to allow studies
of bicelle-associated peptides and proteins by
solution-state NMR.48,49
The changes in 19F chemical shift in the
presenc of DMPC/DHPC bicelles were quali-
tatively similar to those in the presence of DPC
micelles, but there were some quantitative
differences. Comparison of 376 MHz spectra of
F-Trp-EqTII in DPC micelles (Figure 5(a)) and
DMPC/DHPC bicelles (Figure 5(b)) showed that
the chemical shift changes for W112 and W116
followed the same pattern, but were larger. Thus,
W112moved slightly further upfield in bicelles such
Figure 5. 19F NMR spectra of F-Trp-EqTII and F-Trp-
EqTII-W149F in DMPC/DHPC bicelles with or without
SM. Spectra were recorded at 376 MHz and 30 8C except
for the micelle spectrum in (a), which was run at 25 8C.
(a) F-Trp-EqTII in DPC micelles; (b) F-Trp-EqTII in
DMPC/DHPC bicelles. 0.3 mM F-Trp-EqTII, 123 mM PC
(23 mM, DMPC, 2 mM DHPC) in 50 mM p osphate
buffer, pH 6.8; (c) F-Trp-EqTII in DMPC/DHPC bicelles,
plus 15 mM SM (ratio of SM to PC 0.13); (d) F-Trp-EqTII-
W149F in DMPC/DHPC bicelles; (e) F-Trp-EqTII-W149F
in DMPC/DHPC bicelles, plus 15 mM SM (ratio of SM to
PC 0.13). With time, the W112 peak narrowed and
appeared to increase in intensity slightly, but did not
change its chemical shift. All spectra in bicelles were run
with 30–50K s ans.
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Supporting Information) but its HSQC spectrum cannot be
obtained from the cell slurry. The protein signals, however,
appear upon lysi (Figur S2 of the Supporting Information).
We d not understand our inability to reproduce the published
results on UBQ, w ich has been reported to yield high-resolution
spectra in E. coli.6,42 Our use of a different growth medium is
not the reason because w obtai similar results to those shown
in Figure 3 whe w use the media described in the publications.
We also tried xpressing the protein at different temperatures
ithout suc ess. Our stu ies w re conducted on a cold-probe
equipped 500 MHz instrume t. Lack of sensitivity does not
explain our inability to d tect UBQ in cells because we obtain
the sam results with a cold-probe equipped 700 MHz
spectrometer.
Freezing cells prior to in-cell NMR studies has been sug-
gest d.6 W prepared another 15N-enriched UBQ sample for in-
c ll ex eriments but stor d the sample at -20 °C overnight.
The sampl w s thawed and used to collect an in-cell spectrum.
The spectrum f native UBQ,40 which is not observed in a fresh
sample (part B of Fig re 3), is visible in the previously frozen
sample (Figure S3 of the Supporting Information). Storing the
sample at -80 °C ives the same result. Adding 10% (v/v)
glycerol decreases, but does not always prevent, leakage. We
conclude that cells sh uld not b frozen if they are to be studied
by using in-cell NMR.
3FY-Labeled, 15N-Enriched Chymotrypsin Inhibitor 2
(CI2). This 7 kDa globul r protein has one tyrosine. Part A of
Figure 4 shows th 19F spectrum of 3FY-labeled cell slurry.
Thre resonances are observed. The sharpest resonance is from
free 3FY. The other tw resonances are from CI2. Both have a
chemical shift of -59.2 ppm. One protein resonance is broad
with a width at half height of !1.5 ppm. The other resonance
is sharper and superimposed on the broad resonance. The HSQC
spectrum of the cell slurry (part B of Figure 4) shows a spectrum
almost identical to that of purified CI2.31 The spectrum from
the supernatant collect d immediately after the in-cell experi-
ent contains a resonance from both free 3FY and 3FY-labeled
CI2 (part C of Figure 4). The HSQC spectrum of the supernatant
(part D of Figure 4) is al ost identical to the spectrum from
th cell slurry (p rt A of Figure 4). These data show that CI2
has leaked from the cells, consistent with previous work.38 After
lysis (part E of Figure 4), only free 3FY and a single sharp
resonance from the lab led protein is observed. The HSQC
spectrum of the lysate is identical to the HSQC spectrum from
the c ll slurry. Comparing the three 19F spectra suggests that
the broad resonance at -59.2 ppm in the cell slurry is
intrac llular CI2 and the superimposed sharper resonance is from
CI2 that has leaked from the cells.
tfmF-Lab led CI2. Figure 5 shows the 19F spectra of CI2
label d at positions 18 and 42 i cells and lysates. The protein
resonances have a width at half height of !0.20 ppm in cells.
They shift upfield by 0.15-0.20 ppm and narrow to !0.03 ppm
upon lysis. There are no protein signals from the supernatants
collected after the NMR experiments, indicating that tfmF-
lab led CI2 does not leak. This result is surprising considering
the results from the 3FY-labeled protein (Figure 4). As discussed
b low, a lower expression l vel may explain the absence of
leakage. Th small signals near the free tfmF may be a
egradation product of lab led CI2 or a tfmF metabolite.
3FY-Labeled, 15N-Enriched C lmodulin (CAM). This 16 kDa
two-lobed globular protein has two tyrosine residues. Part A of
Figure 6 shows th 19F spectrum of the 3FY-labeled cell slurry.
hree resonances ar evident. The sharp resonance is from free
3FY. Th ther two, one on either side of the 3FY resonance,
are from the protein.43 The HSQC spectrum from the slurry
(part B of Figure 6) shows only metabolite signals.38,39 Parts C
and D of Figure 6 s ow the 19F spectrum and the HSQC
spectrum fro the supernatant collected immediately after the
in-c ll NMR experiment. Only free 3FY is observed in the 19F
spectrum, and the HSQC spectrum is nearly devoid of cross-
peaks, indicating that CAM does not leak from the cells. Part
E of Figure 6 shows the 19F spectrum of the clear lysate. The
broad prot in resonances observed in the cell slurry narrow on
lysis but the wi th at half height for the broadest resonance is
(42) Burz, D. S.; Shekhtman, A. PLoS ONE 2008, 3, e2571.
(43) Kitevski-LeBlanc, J. L.; Evanics, F.; Prosser, R. S. J. Biomol. NMR
2009, 45, 255–264.
Figure 4. 19F sp ctra of 3FY-label d CI2 (left panels) and 1H-15N HSQC
spectra of 15N-enriche CI2. The panels are labeled as described in the
caption to Figure 1.
Figure 5. 19F spectra of K18tfmF CI2 in cells (green) and lysates (blue)
(A), Y42tfmF CI2 in cells and in lysates (B), and supernatants collected
after t e in-cell NMR experiments (C). The asterisks indicate the free tfmF
resonances.
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and SM has been reported recently for the unrelated
haemolytic toxin lysenin.55
The fact that significant shifts in the resonances
fromW112 and W116 are observed upon binding of
F-Trp-EqTII to DPC micelles, and even more so,
DMPC/DHPC bicelles, shows that EqTII makes
significant interactions with PC even in the absence
of SM. Although binding to PC is not sufficient to
enable pore formation,13,14,23,54 our results show
that the interaction has as much effect on the
tr ptoph n residues of EqTII as the subsequent
interaction with SM. They also show that EqTII does
not undergo a major conformational change
upon binding to membranes, and thus rule out
the possibility that the pore could be formed by
b-barrel structures of the type seen for bacterial
cytolysins.56
The lack of effect on the W149 19F resonance in
micelles and bicelles, with or without SM, proves to
be very valuable in defining how EqTII binds to
membranes and the extent of any conformational
changes accompanying that binding. F-Trp-EqTII
cannot be lying on the surface of the bicelles or
micelles in such a way that the hydrophobic surface
that is normally protected from solvent by the
N-terminal helix (i.e. strands b1 (residues 32–40)
and b3 (residues 69–75), and to a lesser extent b10
(residues 170–177)) is associated with the lipid
surface, because this would bring W149 into close
proximity to the lipid and affect its chemical shift
(Figure 7(a)). In the model of the tetrameric pore
proposed by Mancheño et al.17 on the basis of EM
images of two-dimensional crystals of sticholysin II,
the a2 helix (residues 129–134 in EqTII) is intimately
associated with the membrane (Figure 7 of
Mancheño et al.). It is possible to orient EqTII such
that this helix, as well as W112 and W116, are close
to the lipid (Figure 7(a)), and this may be a good
model of the micelle-bound and bicelle-bound
EqTII in our experiments. In this orientation W112
and W116 are intimately associated with the
membrane, W117 is the next closest, and W45 and
Figure 7. (a) Possible models of
the orientation of EqTII at the
membrane surface. The magni-
tudes of the 5-F-Trp chemical shift
changes upon membrane binding
are consistent with the left-hand
and middle, but not the right-hand,
orientations. The middle orien-
tation provides the best fit of the
three to the observed shifts. In each
case the closest-to-average struc-
ture of EqTII in solution29 is shown,
with the Trp side-chains coloured
as follows: W112 red, W116
magenta, W117 gold, W149 green,
W45 blue. (b) Close-up view show-
ing the proximity of W149 (green)
to F16 (violet). Given the sensitivity
of 19F chemical shifts to their
environment, the lack of change in
the W149 chemical shift upon
binding to micelles or bicelles
indicates that the N-terminal helix
has not dissociated from the b-
sheet, even in the presence of SM.
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increases signal to noise ratio because label is also incorporated into other components in cell. In 
addition, protein leakage outside of the cell can cause artifacts for NMR measurements (39).  
 Since fluorine atoms usually are not found in biological systems and have 100% naturally 
abundant ½ spin nucleus processing high sensitivity (Table 1.1), 19F NMR is attractive tool to 
investigate protein structures and dynamics in cells. Pielak and his co-workers have successfully 
examined both globular proteins (up to 100 kDa) and disordered proteins that incorporate the 
fluorinated amino acids, tfmPhe 2 and 3-fTyr 4 in detail (Figure 1.6) (13, 25).  
 
 
Figure 1.6. Protein 19F NMR studies in E. coli. Representative 1D 19F NMR spectra of α-synuclein  
(14.5 kDa) labeled with 3-fTyr 4 (a), calmodulin (16 kDa) labeled with 3-fTyr 4 (b), and histidinol 
dehydrogensase (98 kDa) labeled with tfmPhe 2 (c). Supernatant spectra were collected immediately after 
the in-cell spectra and taken to evaluate leakage, and lysate spectra were prepared from the supernatants 
of cleared lysates of in cell samples. The asterisks indicate the free 3-fTyr 4 resonances. Four other 
proteins are also tested in this study. The images were taken from reference 13. 
 
Because natural proteins contain no fluorine, this 100%
abundant spin-1/2 nucleus with its high sensitivity (83% of 1H),
spectral simplicity, and large chemical shift range is attractive
for protein NMR in vitro and in cells.22-25 19F in-cell NMR
was first applied to detect protein mobility in the yeast
Saccharomyces cereVisiae,26-28 and a preliminary study has
been reported in E. coli.29 Here, we describe detailed studies
using this bacterium.
We examine one disordered and five globular proteins
containing 15N and/or 19F. More specifically, we incorporate the
fluorinated amino acid analogues, 3-fluoro-tyrosine (3FY), and
trifluoromethyl-L-phenylalanine (tfmF) into proteins ranging in
size from 7 to 100 kDa.
Materials and Methods
Expression Systems. The ubiquitin (UBQ),6 calmodulin
(CAM),30 and R-synuclein (RSYN) expression systems were gifts
from Alexander Shekhtman (State University of New York at
Albany), Anthony Persechini (University of Missouri, Kansas City),
and Peter Lansbury (Harvard), respectively. pET28a plasmids
(Novagen) containing the gene for the truncated chymotrypsin
inhibitor 2 (CI2)31 or the PDZ332 domain were a gift from Andrew
Lee (University of North Carolina at Chapel Hill). The GFP and
histidinol dehydrogensase (HDH) expression system has been
described.29,33 For 15N enrichment, the plasmids were transformed
into BL-21(DE3-Gold) competent cells. The CAM, CI2, and PDZ3
transformants were spread onto Luria broth agar plates containing
60 µg/mL kanamycin, and the others were spread onto plates
containing 60 µg/mL ampicillin.
15N Enrichment and 3FY Labeling. The procedure was similar
to that described by Khan et al.34 and Li et al.24 Details are given
in the Supporting Information.
tfmF Labeling. Amber stop codons (TAG) were incorporated
at the sites for tfmF labeling by using site-directed mutagenesis
(QuickChange, Stratagene) of the target genes, which are present
in the arabinose-inducible expression vector, pBAD. The labeling
procedure was similar to that described by Hammill et al.35 Details
are given in the Supporting Information.
Preparing for In-Cell NMR. Cultures (usually !100 mL) were
centrifuged at 1 200g for 30 min at room temperature. The cell
pellets were resuspended in 2 mL of LB media. The samples,
comprising 90:10 mixtures of cell slurry:D2O, were placed in 5
mm NMR tubes for data acquisition. Supernatants were collected
by centrifugation (Eppendorf, model 5418, 2 000g for 10 min) after
the experiments to assess leakage.21 The pellets were resuspended
in buffer (50 mM Tris, pH 8.0) to a final volume of 1 mL. Lysates
were made from the resuspended pellets by sonication (Fisher
Scientific, Sonic Dismembrator Model 500) on ice for 10 min with
a duty cycle of 2 s on, 5 s off. The lysate was collected after
centrifugation at 16 000g for 10 min. Viscosities were measured
with a Viscolite 700 viscometer (Hydramotion Ltd., England).
NMR. 15N-1H-HSQC spectra were acquired on a cold-probe
equipped Varian Inova 500 MHz spectrometer at 25 °C. The 1H
dimension had a sweep width of 8 401 Hz and comprised 1 024
complex points. The 15N dimension had a sweep width of 2 200
Hz and comprised 64 complex points. The data were processed
with NMRPipe36 and NMRDraw.37 19F spectra were acquired at
37 °C on a Varian Inova 600 MHz spectrometer equipped with a
5 mm 19F {H} z-gradient probe. The spectra comprised 128 to 2 048
transients, a 30 kHz sweep width, and a 2 s delay before acquisition.
19F chemical shifts are referenced to trifluoroethanol at 0 ppm.
Results
3FY-Labeled, 15N Enriched r-Synuclein (rSYN). There are
four tyrosines in this 140 residue, intrinsically disordered protein,
one at position 39 and three near the C-terminus, at positions
125,133, and 136. We labeled all of these residues with 3FY.
As shown in part A of Figure 1, the 19F spectrum of the cell
slurry shows a broad protein resonance at ! -60 ppm and a
sharp resonance from free 3FY at -59.6 ppm. The assignment
of the RSYN resonance was confirmed by comparison to the
spectrum of the purified protein. The assignment of the free
3FY resonance was confirmed by comparison to the supernatant
spectrum. The 15N-1H HSQC spectrum of the cell slurry (part
B of Figure 1) shows numerous RSYN crosspeaks, consistent
(22) Cellitti, S. E.; et al. J. Am. Chem. Soc. 2008, 130, 9268–9281.
(23) Danielson, M. A.; Falke, J. J. Annu. ReV. Biophys. Biomol. Struct.
1996, 25, 163–195.
(24) Li, C.; Lutz, E. A.; Slade, K. M.; Ruf, R. A.; Wang, G.; Pielak, G. J.
Biochemistry 2009, 48, 8578–8584.
(25) Li, H.; Frieden, C. Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 11993–
11998.
(26) Haggie, P. M.; Brindle, K. M. J. Biol. Chem. 1999, 274, 3941–3945.
(27) Williams, S. P.; Fulton, A. M.; Brindle, K. M. Biochemistry 1993,
32, 4895–4902.
(28) Williams, S. P.; Haggie, P. M.; Brindle, K. M. Biophys. J. 1997, 72,
490–498.
(29) Jackson, J. C.; Hammill, J. T.; Mehl, R. A. J. Am. Chem. Soc. 2007,
129, 1160–1166.
(30) Pervushin, K. V.; Wider, G.; Riek, R.; Wüthrich, K. Proc. Natl. Acad.
Sci. U.S.A. 1999, 96, 9607–9612.
(31) Charlton, L. M.; Barnes, C. O.; Li, C.; Orans, J.; Young, G. B.; Pielak,
G. J. J. Am. Chem. Soc. 2008, 130, 6826–6830.
(32) Petit, C. M.; Zhang, J.; Sapienza, P. J.; Fuentes, E. J.; Lee, A. L.
Proc. Natl. Acad. Sci. U.S.A. 2009, 106, 18249–18254.
(33) Slade, K. M.; Baker, R.; Chua, M.; Thompson, N. L.; Pielak, G. J.
Biochemistry 2009, 48, 5083–5089.
(34) Khan, F.; Kuprov, I.; Craggs, T. D.; Hore, P. J.; Jackson, S. E. J. Am.
Chem. Soc. 2006, 128, 10729–10737.
(35) Hammill, J. T.; Miyake-Stoner, S.; Hazen, J. L.; Jackson, J. C.; Mehl,
R. A. Nat. Protoc. 2007, 2, 2601–2607.
(36) Delaglio, F.; Grzesiek, S.; Vuister, G. W.; Zhu, G.; Pfeifer, J.; Bax,
A. J. Biomol. NMR 1995, 6, 277–293.
(37) Johnson, B. A.; Blevins, R. A. J. Biomol. NMR 1994, 4, 603–614.
Figure 1. 19F spectra of 3FY-labeled RSYN (left panels) and 1H-15N
HSQC spectra f 15N-enriched RSYN (right panels). Panels A and B show
in-cell spectra. The insert in panel A shows the structure of 3FY. Panels C
and D show spectra of supernatants collected immediately after completing
the in-cell spectra. Panels E and F show spectra of supernatants from the
clear lysates. The asterisks indicate the free 3FY resonances. The dashed
vertical line shows the upfield shift on cell lysis.
322 J. AM. CHEM. SOC. 9 VOL. 132, NO. 1, 2010





Suppor i g Inf rmation) b t its HSQC spectru cannot be
obtained from the cell slurry. he protein signals, however,
appear upon lysis (Figure S2 of the Supporting Information).
We do not understand our inability to reproduce the published
results o UBQ, which has been reported to yield high-resolution
spectra in E. coli.6,42 Our use of a different growth medium is
not the reason because we obtain si ilar results to those shown
in Figure 3 when we use the media described in the publications.
We also tried expressing the protein t different temperatures
without success. Our studies were conducted on a cold-probe
equipped 500 MHz instrument. Lack of sensitivity does not
explain our in bility to detect UBQ in cells because we obtain
the same results with a cold-probe equipped 700 MHz
spectrometer.
Freezing cells prior to in-cell NMR studies has been sug-
gested.6 We prepared another 15N-enriched UBQ sample for in-
cell experiments but stored the sample at -20 °C overnight.
The sample was thawed and used to collect an in-cell spectrum.
The spectrum of native UBQ,40 which is not observed in a fresh
sample (part B of Figure 3), is visible in the previously frozen
sample (Figure S3 of the Supp rting Information). Storing the
sample at -80 °C gives the same result. Adding 10% (v/v)
glycerol decreases, but does not always prevent, leakage. We
conclude that cells should not be frozen if they are to be studied
by using in-cell NMR.
3FY-Labeled, 15N-Enriched Chymotrypsin Inhibitor 2
(CI2). This 7 kDa globular protein has one tyrosine. Part A of
Figure 4 shows the 19F spectrum of 3FY-labeled cell slurry.
Three resonances are observed. The sharpest resonance is from
free 3FY. The other two resonances are from CI2. Both have a
chemical shift of -59.2 ppm. One protein resonance is broad
with a width at half height of !1.5 ppm. The other resonance
is sharper and superimposed on the broad resonance. The HSQC
spectrum of the cell slurry (part B of Figure 4) shows a spectrum
almost identical to that of purified CI2.31 The spectrum from
the supernatant collected immediately after the in-cell experi-
ment contains a resonance from both free 3FY and 3FY-labeled
CI2 (part C of Figure 4). The HSQC spectrum of the supernatant
(part D of Figure 4) is almost identical to the spectrum from
the cell slurry (part A of Figure 4). These data show that CI2
has leaked from the cells, consistent with previous work.38 After
lysis (part E of Figure 4), only free 3FY and a single sharp
resonance from the labeled protein is observed. The HSQC
spectrum of the lysate is identical to the HSQC spectrum from
the cell slurry. Comparing the three 19F spectra suggests that
the broad resonance at -59.2 ppm in the cell slurry is
intracellular CI2 and the superimposed sharper resonance is from
CI2 that has leaked from the cells.
tfmF-Labeled CI2. Figure 5 shows the 19F spectra of CI2
labeled at positions 18 and 42 in cells and lysates. The protein
resonances have a width at half height of !0.20 ppm in cells.
They shift upfield by 0.15-0.20 ppm and narrow to !0.03 ppm
upon lysis. There are no protein signals from the supernatants
collected after the NMR experiments, indicating that tfmF-
labeled CI2 does not leak. This result is surprising considering
the results from the 3FY-labeled protein (Figure 4). As discussed
below, a lower expression level may explain the absence of
leakage. The small signals near the free tfmF may be a
degradation product of labeled CI2 or a tfmF metabolite.
3FY-Labeled, 15N-Enriched Calmodulin (CAM). This 16 kDa
two-lobed globular protein has two tyrosine residues. Part A of
Figure 6 shows the 19F spectrum of the 3FY-labeled cell slurry.
Three resonances are evident. The sharp resonance is from free
3FY. The other two, one on either side of the 3FY resonance,
are from the protein.43 The HSQC spectrum from the slurry
(part B of Figure 6) shows only metabolite signals.38,39 Parts C
and D of Figure 6 show the 19F spectrum and the HSQC
spectrum from the supernatant collected immediately after the
in-cell NMR experiment. Only free 3FY is observed in the 19F
spectrum, and the HSQC spectrum is nearly devoid of cross-
peaks, indicating that CAM does not leak from the cells. Part
E of Figure 6 shows the 19F spectrum of the clear lysate. The
broad protein resonances observed in the cell slurry narrow on
lysis but the width at half height for the broadest resonance is
(42) Burz, D. S.; Shekhtman, A. PLoS ONE 2008, 3, e2571.
(43) Kitevski-LeBlanc, J. L.; Evanics, F.; Prosser, R. S. J. Biomol. NMR
2009, 45, 255–264.
Figure 4. 19F spectra of 3FY-labeled CI2 (left panels) and 1H-15N HSQC
spectra of 15N-enriched CI2. he p nels are labeled as described in the
caption to Fi ure 1.
Figure 5. 19F spectra of K18tfmF CI2 in cells (green) and lysates (blue)
(A), Y42tfmF CI2 in cells and in lysates (B), and supernatants collected
a ter the in-cell NMR experiments (C). The asterisks indicate the free tfmF
resonances.
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still >0.5 ppm. The observation of CAM crosspeaks43,44 in the
HSQC spectrum of the lysate (part F of Figure 6) proves that
detectable amounts of the protein are present. The HSQC
spectrum of the lysate also shows that CAM is not fully Ca2+
loaded.43
3FY-Labeled, 15N-Enriched Green Fluorescence Protein
(GFP). This 27 kDa globular pr tein contains 12 tyrosines. The
resonances in the 19F and 15N-1H HSQC spectra are too broad
to detect in cells and lysates (Figure S4 of the Supporting
Information) but SDS-PAGE analysis and the fluorescence of
the samples show that the protein is overexpressed (Figure S1
and Table S1 of the Supporting Information).
tf F-L beled GFP. tfmF might be a better label for larger
globular proteins because the trifluoromethyl group adds
rotational motion that is independent of molecular tumbling.
Th green traces in Figure 7 show the 19F spectra of GFP
labeled at position 39 and position 221 in cells. The 19F
resonances from the two proteins in cells are broad, with
widths at half h ight of !0.4 ppm, but observable. The
corresponding resonances from the purified protein are
narrower with widths of <0.1 ppm. The only resonance in
the supernatant from the cell slurry is from free tfmF, which
shows that labeled GFP does not leak. Lysis caused an upfield
shift of 0.10-0.15 ppm.
tfmF-Labeled Histidinol Dehydrogensase (HDH).29 We ap-
plied the tfmF labeling method to this 98 kDa homodimer.
The 19F spectra are presented in Figure 8. As shown by
comparisons to spectra for the purified protein and the
supernatant, the sharp resonance in the cell slurry spectrum
is from free tfmF and the broad resonance (width at half
height of !1.0 ppm) is from HDH. The only resonance in
the supernatant is from free tfmF, showing that labeled HDH
does not leak.
Discussion
We used NMR to study six proteins enriched in 15N and/or
labeled with 19F in E. coli cells. The prot ins are present in the
cytoplasm [although some RSYN33 and CI2 (Figure S5 of the
Supporting Information) is periplasmic]. Two 19F labeling
strategies were used. One strategy, incorporating 3FY in place
of tyrosine, was accomplished by expressing the protein in 15N-
enriched minimal media containing 3FY, phenylalanine, tryp-
tophan, and N-(phosphomonoethyl) glycine.34 The other strategy
involved an orthogonal tRNA synthase system29 to replace
re idues with tfmF.
A 1D 19F spectrum can be acquired in minutes (compared to
an hour for 15N-1H HSQC spectra shown here), which allows
the study of proteins near their physiological concentrations.
We estimate an intracellular concentration of the tfmF-labeled
(44) Jaren, O. R.; Kranz, J. K.; Sorensen, B. R.; Wand, A. J.; Shea, M. A.
Biochemistry 2002, 41, 14158–14166.
Figure 6. 19F- and 1H-15N HSQC spectra of 15N-enriched, 3FY-labeled
CAM. The panels are labeled as described in the caption to Figure 1.
Figure 7. 19F spectra of tfmF 39 labeled GFP in cells (green) and the
purified protein in solution (blue) (A), tfmF 221 labeled GFP in cells and
the purified protein in solution (B), and supernatants collected after the
in-cell NMR experiments (C). The asterisks indicate the free tfmF
resonances.
Figure 8. 19F spectra of L225tfmF HDH. In-cell sample (A), purified
protein (B), supernatant collected after the in-cell NMR experiments (C).
The asterisks indicate the resonance from free tfmF.
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Supporting Info m tion) but its HSQC spectrum cannot be
obtained from the cell s urry. The protein signals, however,
app ar upon lysis (Fig r S2 of the Supporting Information).
We do no unde stand our ina ility to reproduce the published
results on UBQ, h ch has be n reported to yield high-resolution
spectra in E. coli.6,42 Our use of a d fferent growth medium is
n t the reason eca se we obtain simi r results to those shown
in Figure 3 when we use the media described in the publications.
We als trie expr ssing the p o ein at dif erent temperatures
without su cess. Our studies were conducted on a cold-probe
equipped 500 MHz instrument. Lack of sensitivity does not
xplain o r inabi ity to detect UBQ in cells because we obtain
the sam r sults with a cold-prob equipped 700 MHz
spectrometer.
Fre zing cell pr or to in-c ll NMR studies has been sug-
g st d.6 We prepared an ther 15N-enriched UBQ sample for in-
cell experiments but stored the sample at -20 °C over ight.
The sample was th wed and us d to collect an in-cell spectrum.
The spectrum of native UBQ,40 whic is not observed in a fresh
sample (part B of Figure 3), is visible in the previously frozen
sample (Fi ure S3 of the Supporting Information). Storing the
sample at -80 °C gives the same result. Adding 10% (v/v)
glycer l decreases, but does not always prevent, leakage. We
conclude that cells should not be frozen if they are to be studied
by using in-cell NMR.
3FY-Labeled, 15N-Enric ed Chymotrypsin Inhibitor 2
(CI2). This 7 kDa globular protein has one tyrosine. Part A of
Figure 4 shows the 19F spectrum of 3FY-labeled cell slurry.
Thr e resonances are observed. The sharpest resonance is from
free 3FY. The other two res nances re from CI2. Both have a
chemical shift of -59.2 ppm. One protein resonance is broad
with a width at half height of !1.5 ppm. The other resonance
is sharper and superimposed on the broad resonance. The HSQC
spectrum of the cell slurry (part B of Figure 4) shows a spectrum
almost identical to that of p rified CI2.31 The spectrum from
the supernatant collected imm diately after the in-cell experi-
ment contains a reson ce from both free 3FY and 3FY-labeled
CI2 (part C of Figure 4). The HSQC spectrum of the supernatant
(part D of Figure 4) is almost identical to the spectrum from
the cell slurry (part A of Figure 4). These data show that CI2
has leaked from th cell , c nsistent with previous work.38 After
lysis (part E of Figure 4), only free 3FY and a single sharp
r sonanc from th labeled protein is observed. The HSQC
sp c rum of t e lysate i identical t the HSQC spectrum from
the c ll slurry. Comparing th three 19F spectra suggests that
the broad reso ance at -59.2 ppm in the cell slurry is
intracellular CI2 and the superimposed sharper resonance is from
CI2 that has leaked from the cells.
tfmF-Labeled CI2. Figure 5 shows the 19F spectra of CI2
labeled at positions 18 and 42 in c lls and lysates. The protein
re onanc s have a width at half h ight of !0.20 ppm in cells.
They shift upfield by 0.15-0.2 p m and narrow to !0.03 ppm
up n lysis. There are no protei signals from the supernatants
collected after the NMR experi ents, indicating that tfmF-
labeled CI2 doe not leak. This r sult is surprising considering
the r sults from the 3FY-labeled prot in (Figure 4). As discussed
below, a lower expression level may explain the absence of
leakag . The small ignals near the free tfmF may be a
degradation product of labeled CI2 or a tfmF metabolite.
3FY-Labeled, 15N-Enriched Calmodulin (CAM). This 16 kDa
two-lobed globular protein has two tyrosine residues. Part A of
Figure 6 shows the 19F spectrum of the 3FY-labeled cell slurry.
Three reson nces are evident. The sharp resonance is from free
3FY. The oth r two, one on either side of the 3FY resonance,
are from the protein.43 The HSQC spectrum from the slurry
(part B of Figure 6) shows only metabolite signals.38,39 Parts C
and D of Figure 6 show the 19F spectrum and the HSQC
spectrum from the supernatant collected immediately after the
in-cell NMR experiment. Only fr e 3FY is observed in the 19F
spectrum, and the HSQC spectrum is nearly devoid of cross-
peaks, indicating that CAM does not leak from the cells. Part
E of Figu e 6 shows the 19F sp ctrum of the clear lysate. The
broad protein r sonances obse ved in the cell slurry narrow on
lysis but the width t half height for the broadest resonance is
(42) Burz, D. S.; Shekhtman, A. PLoS ONE 2008, 3, e2571.
(43) Kitevski-LeBlanc, J. L.; Evanics, F.; Prosser, R. S. J. Biomol. NMR
2009, 45, 255–264.
Figur 4. 19F spectra of 3FY-labeled CI2 (left panels) and 1H-15N HSQC
spectra of 15N- nriche CI2. Th panels are labeled as described in the
caption to Figure 1
Figure 5. 19F spectra of K18tfmF CI2 in cells (green) and lysates (blue)
(A), Y42tfmF CI2 in cells and in lysat s (B), and supernatants collected
after the in-c ll NMR experim nts (C). The asterisks indicate the free tfmF
resonances.
324 J. AM. CHEM. SOC. 9 VOL. 132, NO. 1, 2010
A R T I C L E S Li et al.
still >0.5 ppm. The observation of CAM crosspeaks43,44 in the
HSQC spectrum of the lysate (part F of Figure 6) proves that
detectable amounts of the protein are present. The HSQC
spectrum of the lysate also shows that CAM is not fully Ca2+
loaded.43
3FY-Labeled, 15N-Enriched Green Fluorescence Protein
(GFP). This 27 kDa globular protein contains 12 tyrosines. The
resonances in the 19F and 15N-1H HSQC spectra are too broad
to detect in cells and lysates (Figure S4 of the Supporting
Information) but SDS-PAGE analysis and the fluorescence of
the samples show that the protein is overexpressed (Figure S1
and Table S1 of the Supporting Information).
tfmF-Labeled GFP. tfmF might be a better label for larger
globular proteins because the trifluoromethyl group adds
rotational motion that is independent of molecular tumbling.
The green traces in Figure 7 show the 19F spectra of GFP
labeled at position 39 and position 221 in cells. The 19F
resonances from the two proteins in cells are broad, with
widths at half height of !0.4 ppm, but observable. The
corresponding resonances from the purified protein are
narrower with widths of <0.1 ppm. The only resonance in
the supernatant from the cell slurry is from free tfmF, which
shows that labeled GFP does not leak. Lysis caused an upfield
shift of 0.10-0.15 ppm.
tfmF-Labeled Histidinol Dehydrogensase (HDH).29 We ap-
plied the tfmF labeling method to this 98 kDa homodimer.
The 19F spectra are presented in Figure 8. As shown by
comparisons to spectra for the purified protein and th
supernatant, the sharp resonance in the cell slurry spectrum
is from free tfmF and the broad resonance (width at half
height of !1.0 ppm) is from HDH. The only resonance in
the supernatant is from free tfmF, showing that labeled HDH
does not leak.
Discussion
We used NMR to study six proteins enriched in 15N and/or
labeled with 19F in E. coli cells. The proteins are present in the
cytoplasm [although some RSYN33 and CI2 (Figure S5 of the
Supporting Information) is peripl smic]. Two 19F labeling
strategies w re used. One strategy, incorporating 3FY in place
of tyrosine, was accomplished by expressing the protein in 15 -
enriched minimal media containing 3FY, phenylalanine, tryp-
tophan, and N-(phosphomonoethyl) glycine.34 The other strategy
involved an orthogonal tRNA synthase system29 to replace
residues with tfmF.
A 1D 19F spectrum can be acquired in minutes (compared to
an hour for 15N-1H HSQC spectra shown here), which allows
the study of proteins near their physiological concentrations.
We estimate an intracellular concentration of the tfmF-labeled
(44) Jaren, O. R.; Kranz, J. K.; Sorensen, B. R.; Wand, A. J.; Shea, M. A.
Biochemistry 2002, 41, 14158–14166.
Figure 6. 19F- and 1H-15N HSQC spectra of 15N-enriched, 3FY-labeled
CAM. The panels are labeled as described in the caption to Figure 1.
Figure 7. 19F spectra of tfmF 39 labeled GFP in cells (green) and the
purified protein in solution (blue) (A), tfmF 221 labeled GFP in cells and
the purified protein in solution (B), and supernatants collected after the
in-cell NMR experiments (C). The asterisks indicate the free tfmF
resonances.
Figure 8. 19F spectra of L225tfmF HDH. In-cell sample (A), purified
protein (B), supernatant collected after the in-cell NMR experiments (C).
The asterisks indicate the resonance from free tfmF.
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still >0.5 ppm. The observation of CAM crosspeaks43,44 in the
HSQC spectrum of the lysate (part F of Figure 6) proves that
detectable amounts of the protein are present. The HSQC
spectrum of the lysate also shows that CAM is not fully Ca2+
loaded.43
3FY-Labeled, 15N-Enriched Green Fluorescence Protein
(GFP). This 27 kDa globular protein contains 12 tyrosines. The
resonances in the 19F and 15N-1H HSQC spectra are too broad
to detect in cells and lysates (Figure S4 of the Supporting
Information) but SDS-PAGE analysis and the fluorescence of
the samples show that the protein is overexpressed (Figure S1
and Table S1 of the Supporting Information).
tfmF-Labeled GFP. tfmF might be a better label for larger
globular proteins because the trifluoromethyl group adds
rotational motion that is independent of molecular tumbling.
The green traces in Figure 7 show the 19F spectra of GFP
labeled at position 39 and position 221 in cells. The 19F
resonances from the two proteins in cells are broad, with
widths at half height of !0.4 ppm, but observable. The
corresponding resonances from the purified protein are
narrower with widths of <0.1 ppm. The only resonance in
t e supernatant from the cell slurry is from free tfmF, which
shows that labeled GFP does not leak. Lysis caused an upfield
shift of 0.10-0.15 ppm.
tfmF-Labeled Histidino Dehydrogensase (HDH).29 We ap-
plied the tfmF labeling method to this 98 kDa homodimer.
The 19F spectra are presented in Figure 8. As shown by
comparisons to spectra for the purified protein and the
supernatant, the sharp resona c in the cell slurry spectrum
is from free tfmF and the broad resonance (width at half
height of !1.0 ppm) is from HDH. The only resonance in
the supernatant is from free tfmF, showing that labeled HDH
does not leak.
Discussion
We used NMR to study six proteins enriched in 15N and/or
labeled with 19F in E. coli cells. The proteins are present in the
cytoplasm [although some RSYN33 and CI2 (Figure S5 of the
Supporting Information) is periplasmic]. Two 19F labeling
strategies were used. One strategy, incorporating 3FY in place
of tyrosine, was accomplished by xpressing the protein in 15N-
enriched minimal media containing 3FY, phenylalanine, tryp-
tophan, and N-(phosphomonoethyl) glycine.34 The other strategy
involved an orthogonal tRNA s nthase system29 to replace
residues with tfmF.
A 1D 19F spectrum can be acquired in minutes (compared to
an hour for 15N-1H HSQC spectra shown here), which allows
the study of proteins near their physiological concentrations.
We estimate a intracellular co centration of the tfmF-labeled
(44) Jaren, O. R.; Kranz, J. K.; Sorensen, B. R.; Wand, A. J.; Shea, M. A.
Biochemistry 2002, 41, 14158–14166.
Figure 6. 19F- and 1H-15N HSQC spectra of 15N-enriched, 3FY-labeled
CAM. The panels are labeled as described in the caption to Figure 1.
Figure 7. 19F spectra of tfmF 39 labeled GFP in cells (green) and the
purified protein in solution (blue) (A), tfmF 221 labeled GFP in cells and
the purified protein in solution (B), and supernatants collected after the
in-cell NMR experiments (C). The asterisks indicate the free tfmF
resonances.
Figure 8. 19F spectra of L225tfmF HDH. In-cell sample (A), purified
protein (B), supernatant collected after the in-cell NMR experiments (C).
The asterisks indicate the resonance from free tfmF.
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still >0.5 ppm. The observation of CAM crosspeaks43,44 in the
HSQC sp ctrum of the lysate (part F of Figure 6) proves that
detect am unts of the protein are present. The HSQC
spectrum of the lysate also shows that CAM is not fully Ca2+
loaded.43
3FY-Labeled, 15N-Enr ch d Green Flu rescence Protein
(GFP). This 27 kDa globular protein contains 12 tyrosines. The
resonances in the 19F and 15N-1H HSQC spectra are too broad
to detect in cells and lysates (Figure S4 of the Supporting
Information) but SDS-PAGE analysis and he fluorescence of
the samples show that the protein is overexpressed (Figure S1
and Table S1 of the Supporting Information).
tfmF-Labeled GFP. tfmF might be a better label for larger
globular proteins because the trifluoromethyl group adds
rotational motion that is ind pendent of molecular tumbling.
The green traces in Figure 7 show the 19F spectra of GFP
labeled t position 39 and position 221 in cells. The 19F
resonances from the two proteins in cells are broad, with
widths at half height of !0.4 ppm, but observable. The
corresponding resonances from the purified protein are
narrower wit widths of <0.1 ppm. The only resonance in
th supernatant from the cell slurry is from free tfmF, which
shows that labeled GFP does not eak. Lysis cau ed an upfield
shift of 0.10-0.15 ppm.
tfmF-Labeled Histid nol Dehydrogensase (HDH).29 We ap-
plied the tfmF labeling method to this 98 kDa homodimer.
The 19F spectra are presented in Figure 8. As shown by
comparisons to spectra for the purified protein and the
supernatant, the sharp resonance in the cell slurry spectrum
is from free tfmF and the broad resonance (width at half
height of !1.0 ppm) is from HDH. The only resonance in
the supernatant is from fr e tfmF, showing that label d HDH
does not leak.
Discussio
We used NMR t study six proteins enriched in 15N and/or
labeled with 19F in E. coli cells. The proteins are prese t in the
cytoplasm [although s e RSYN33 and CI2 (Figure S5 of the
Supporting Informatio ) is periplasmic]. Two 19F labe ing
strategies were used. One strategy, incorporating 3FY in place
of tyrosine, was accomplish d by expressing th protein in 15N-
e riched minimal media containing 3FY, phenylalanine, tryp-
ophan, and N-(phosphomonoethyl) glycine.34 The oth r strategy
involved n orthogona tRNA sy hase system29 to replace
residues with tfmF.
A 1D 19F spectrum can be acquired in minutes (compared to
an hour for 15N-1H HSQC spectra shown here), which allows
the study of proteins near their physiological concentrations.
We estimate an intracellular concentration of the tfmF-labeled
(44) Jaren, O. R.; Kranz, J. K.; Sorensen, B. R.; Wand, A. J.; Shea, M. A.
Biochemistry 2002, 41, 14158–14166.
Figure 6. 19F- and 1H-15N HSQC spectra of 15N-enriched, 3FY-labeled
CAM. The panels are labeled as described in the caption to Figure 1.
Figure 7. 19F spectra of tfmF 39 labeled GFP in cells (green) and the
purified protein in solution (blue) (A), tfmF 221 labeled GFP in cells and
the purified protein in solution (B), and supernatants collected after the
in-cell NMR experiments (C). The asterisks indicate the free tfmF
resonances.
Figure 8. 19F spectra of L225tfmF HDH. In-cell sample (A), purified
protein (B), supernatant collected after the in-cell NMR experiments (C).
The asterisks indicate the resonance from free tfmF.
J. AM. CHEM. SOC. 9 VOL. 132, NO. 1, 2010 325
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 In these studies, site-specific structural and dynamic information for proteins in cells was 
obtained from analysis of the fluorine chemical shift and line width. They could detect a small 
globular protein using 19F NMR, even though it was difficult to detect same proteins using 15N-
1H HSQC experiments (with use of 15N-enriched proteins), because of the ten-fold increase of 
the rotational correlation times compared to diluted solution. In addition, they were able to 
measure protein leakage outside of cells, which caused artifacts for NMR measurements in their 
previous study (39). In the following studies, they have utilized 19F NMR to understand 
crowding effects on protein stability (25). Since 19F NMR spectra can be acquired in minutes 
(compared to one hour or more for 15N-1H HSQC experiments) on proteins at near physiological 
concentrations, it has the potential to monitor protein modifications involved in signal 
transduction and metabolism in real-time experiments (13).  
 
 
1.5. Biologically Active Peptides 
 As described in Section 1.4, 19F NMR is a unique and powerful tool to study protein 
structural changes, dynamics, and function. The goal of my research is to investigate the 
structure and dynamics of biologically active peptides, including the antimicrobial peptide MSI-
78 (40) and amyloidogenic peptides (human islet amyloid polypeptide (IAPP) (41) and amyloid-
beta (Aβ), whose amyloid formation are associated with type II diabetes and Alzheimer’s 
disease, respectively) using 19F NMR as a primary technique. In this section, the importance of 
further investigating antimicrobial and amyloid peptides are described. 
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1.5.1. Antimicrobial Peptides 
 The emergence of bacterial strains resistant to most of the clinically useful antibiotics has 
provided the motivation to develop new classes of antibiotics to combat these strains effectively. 
AMPs comprise a diverse family of membrane-active peptides and have shown promise as 
therapeutic agents against bacteria, fungi, and viruses. These peptides are formed as part of the 
innate immune system and also implicated in the activation of the adaptive immune response 
against microbes (Figure 1.7). 
 Although AMPs possess highly diverse sequences and structures, they share the property 
of being highly amphipathic, with one face of peptide being hydrophobic and the other face 
being a cluster of positively charged residues. The selectivity of AMPs for bacterial membranes 
arises primarily from electrostatic interactions between positively charged peptide and negatively 
charged phospholipids that predominate in bacterial cell membranes. Eukaryotic cell membranes 
are usually less subject to disruption by AMPs because they contain predominantly neutral 
phospholipids together with cholesterol that also helps in preventing disruption by AMP. Upon 
binding to the bacterial membrane, disruption of the membrane might proceed though a number 
of mechanisms including the formation of pores, membrane thinning, and detergent-like action 
(Figure 1.7).    
 Characterization of peptide-membrane interactions is challenging due to the transient 
nature of these interactions. In addition, the peptide may adopt different orientations with respect 
to the lipid membrane and have different oligomerization states that are concentration dependent. 
The structural models derived from solid-state NMR data are available for some AMPs bounds 
to lipid membranes; these experiments require higher concentration of peptide than their 
physiological active range (42-47). These include studies using fluorine-labeled AMPs to 
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provide information about peptide orientation in membranes. However, these experiments 
require peptide concentrations that are orders of magnitude higher than their physiologically 




Figure 1.7. Summary of the broad range of cellular interactions associated with antimicrobial 
peptides. AMPs disrupt bacterial membranes with a number of mechanisms such as the formation of 
pores, membrane thinning, and detergent-like action. In addition, peptides might also interact with 
specific target proteins within microbial cells and activate the innate immune system. The binding of 
peptides to cell-surface lipopolysaccharides (LPS) molecules and proteolysis contribute to bacterial 
resistance to AMPs. The image was taken from reference 38. 
  
 In previous studies, our group and others have demonstrated that the incorporation of 
highly fluorinated amino acids in multiple sites into AMPs is an effective strategy for modulating 
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For example, we showed that incorporating hexafluoroleucine at four positions in the α-helical 
AMP MSI-78 resulted in increased potency toward some bacterial strains and protection against 
proteolysis when bound to lipid vesicles (49). The Marsh laboratory has now turned its attention 
to using fluorine-containing peptides to probe the interaction of AMPs with membranes by 
exploiting the sensitive NMR properties of the 19F nucleus (27, 40). 
 
1.5.2. Amyloid Peptides 
 The accumulation of misfolded proteins in protein aggregation, known as amyloid, is a 
hallmark of number of human disorders including neurodegenerative disorders such as 
Alzheimer’s diseases and Parkinson’s diseases and metabolic diseases such as type II diabetes 
(52-54). Protein conformational changes would facilitate the formation of amyloid, disrupting 
the regular function of protein and leading to the formation of toxic species. Even though the 
soluble precursor of these amyloidogenic proteins/peptides have diverse structures, such as 
globular proteins or largely unstructured peptides, the amyloid aggregates share common 
characteristics (Figure 1.8) (55). Under pathological conditions, the soluble precursor form of 
these proteins or peptides are triggered to self-assemble into long, linear and often twisted 
structures a few nanometers in diameter (56-58). Amyloid fibers generally exhibit a 
characteristic cross-β X-ray diffraction pattern, which indicates that the amyloid structure is 
composed of β-sheets running perpendicular to the fibril axis (59, 60). They also share the same 
optical behavior on binding affinity to certain dye molecules such as Congo red and Thioflavin T 
(ThT).  
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Figure 1.8. The proposed pathway of amyloid fiber formation. The formation of soluble oligomers is 
suggested to be involved in the amyloid fiber formation and the neurotoxic species. The accumulation of 
precursors result the formation of cross β-sheet sheet structure. The formation of aggregates is shown by 
transmission electron microscopy (TEM) image. It is also suggested that the oligomerization are induced 
on membrane surface, and the oligomeric species would disrupt the membrane by forming 
transmembrane pore or detergent-like process as AMPs (Figure 1.7) (61). 
  
 The most common method for measuring amyloid formation is to track the fluorescence 
increase when ThT binds to the fibers. The fibrillation of amyloid proteins is generally 
considered as a nucleation-dependent polymerization process consisting of two phases: a lag 
phase and an elongation phase (Figure 1.9) (61, 62). During a lag phase in the fibril formation, 
the monomeric peptides associate to form small oligomers. Nucleus formation is a 
thermodynamically unfavorable reaction, representing the rate-limiting step in amyloid fibril 
formation. After nucleation has occurred, the further addition of monomers becomes 
thermodynamically favorable, resulting in rapid growth of amyloid fibrils in the elongation 
period. Similarly, reporters of secondary structures such as circular dichroism (CD), Fourier 





(      500 nm)
Fibril structure (image) by TEM 
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track the formation of amyloid fiber as well as the ThT fluorescence assay.   
 The cytotoxicity of amyloid-related disorders was thought to be due to the insoluble 
amyloid fibrils, but now attention has shifted to soluble oligomeric intermediates formed during 
nucleation, which have recently been suggested to be more neurotoxic (63, 64). Therefore, the 
identification and characterization of oligomeric species formed as intermediates in the amyloid 
pathway is essential not only to understand the mechanism of fiber formation but also to develop 
the therapeutic molecules to treat these diseases. Unfortunately, the details of this process have 
been obscured by the limitations in the methods that can follow this reaction in real-time. 
 
Figure 1.9. Illustration of the nucleation polymerization model for amyloid fibrillogenesis. Soluble 
precursors are self-assembled into oligomeric species in lag phase. The nucleus would elongate through 
the addition of monomers or other oligomers into the fibrils cooperatively and rapidly. The amyloid 
fibrils are theromodynamically stable and the product of this pathway. This process is generally shown as 
sigmoidal curve with ThT fluorescence assay. The image was adapted from reference 61.    
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1.6. Goals 
 Fluorinated amino acids have long been used as a sensitive and nonperturbing NMR 
probes to study protein dynamics and structural changes. Methods to incorporate fluorinated 
amino acids into peptides and proteins are well established and this can be accomplished in a 
variety of ways. The goal of my research is to use 19F NMR as a tool to obtain the detailed 
structural and dynamic information for biologicaly important peptides including antimicrobial 
peptide (MSI-78) and amyloid peptides (IAPP and Aβ). The changes due to MSI-78 binding to 
lipids were measured by 19F chemical shifts, solvent isotope effects on chemical shifts, and 
changes in longitudinal and transverse relaxation measurements of the 19F nucleus (Chapter 2) 
(40). This study has provided a detailed picture of the local changes in the chemical environment 
of peptide dynamics that occurs when MSI-78 binds to the lipid bilayer.  
 I have also demonstrated the utility of 19F NMR to make direct and real-time 
measurements of amyloid formation by monitoring monomeric peptide consumption. By 
comparing monomer depletion by 19F NMR to fiber formation by ThT, I showed that IAPP 
fibrillizes with no formation of oligomeric intermediates (Chapter 3) (41). To further develop the 
usage of 19F NMR, I have also measured the interaction of polyphenolic inhibitor 
(epigallocatechin-3-gallate (EGCG)) with IAPP.  In contrast to IAPP fiber formation, it has been 
possible to detect the formation of small oligomers of Aβ peptides using 19F NMR (Chapter 4).  
 This research aims to contribute to demonstrate the utility of 19F NMR in chemical 
biology. 19F NMR cannot only be applied to studying changes of protein structure and dynamics 
in solution NMR as shown in this thesis but also to investigating these structure changes using 
solid phase NMR. In addition, this technique is able to apply to magnetic resonance imaging 
(MRI) in vivo studies. The long-term goal of using 19F NMR would be to use it as a tool to help 
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find potential therapeutic compounds.   
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Using 19F NMR to Probe Changes in Structure and Dynamics of Membrane-Active 
Peptides Interacting with Lipid Bilayers 
  
2.1. Introduction  
 The work described in this chapter has been published as: “Using Fluorine NMR to Probe 
Changes in Structure and Dynamics of Membrane-Active Peptides Interacting with Lipid 
Bilayers.” Yuta Suzuki, Benjamin C. Buer, Hashim M. Al-Hashimi, and E. Neil G. Marsh (2011) 
Biochemistry, 50 (27): 5979 – 5987 (1). The co-authors were very helpful in conducting this 
research and analyzing the results. Dr. Buer assisted me with NMR and MIC experiments and 
provided two peptides, MSI-F6 and MSI-F7, for this study. Numerous suggestions and guidance 
on NMR came from Prof. Hashimi AI-Hashimi. I also would like to acknowledge Dr. Jeetender 
Chugh for helpful discussions and advice on CPMG experiments. 
 The interaction of small peptides with the lipid bilayer of the cell membrane is important 
in a variety of biological processes (2-7).  These membrane-active peptides may have protective 
properties such as AMPs, anti-cancer and anti-viral peptides, or be involved in pathological 
processes such as cell-penetrating peptides, viral fusion peptides and venom peptides. For all 
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these classes of peptides, interactions between the membrane lipid bilayer and the peptide are 
central to their biological functions.   
 Characterizing peptide-membrane interactions is often challenging because of the 
transient and dynamic nature of these interactions.  The peptide may adopt different orientations 
with respect to the lipid bilayer and different oligomerization states that are concentration-
dependent.  Solid-state NMR experiments have used various NMR-active nuclei to investigate 
the structures and orientations of AMPs bound to lipid membranes (8-13). These include studies 
using fluorine-labeled AMPs to provide information on peptide orientation in membranes. 
However, these experiments require peptide concentrations that are orders of magnitude higher 
than their physiologically active range, so it is not always clear whether such structures represent 
biologically active species.  Solution-phase 19F NMR has proved an informative tool for 
investigating biological interactions; for example in probing the dynamics of soluble proteins 
(14-16) and the immersion depth of lipophilic molecules in lipid bilayers (17, 18). 
 AMPs are a diverse family of membrane-active peptides found in essentially all multi-
cellular organisms.  Although some AMPs have specific intracellular targets (2), most exert their 
antimicrobial activity by binding directly to the microbial membrane and compromising its 
integrity (Figure 1.7) (19-21).  Almost all AMPs are highly amphipathic, with one face of the 
peptide being hydrophobic and the other face presenting a cluster of positively charged residues 
(22-24).  The selectivity of AMPs for bacterial membranes arises primarily from electrostatic 
interactions between the positively charged peptide and the negatively charged phospholipids 
that predominate in bacterial cell membranes. Eukaryotic membranes, which contain 
predominantly neutral phospholipids, are usually less susceptible to disruption by AMPs; the 
presence of cholesterol in eukaryotic membranes also helps prevent membrane disruption by 
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AMPs (25).  Upon association with the membrane, disruption of the bacterial membrane may 
proceed through a number of mechanisms, including the formation of pores, membrane thinning 
and detergent-like action (21, 26, 27).  
 
 
Figure 2.1. The proposed structure and mechanism of MSI-78 on lipid membranes (a) Two views of 
the structure of MSI-78, determined from NMR experiments (29), with peripheral Lys residues shown as 




 My studies have focused on the potent, synthetic AMP, MSI-78 (pexiganan), which 
provides a convenient model system to investigate peptide-membrane interactions.  MSI-78 is 
thought to disrupt bacterial membranes by forming toroidal pores in the lipid bilayer (28), as 
illustrated in Figure 2.1.  Based on a combination of solution and solid-state NMR experiments 
the peptide has been shown to adopt a dimeric α-helical coiled-coil structure (Figure 2.1) in the 
presence of liposomes (29). The dimer interface is formed by contacts between hydrophobic 
residues, and the positively charged lysine (Lys) residues that face the exterior of the structure 
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properties and can be used to study AMP!membrane interac-
tions. For example, we showed that incorporating hexafluoro-
leucine at four positions in the R-helical AMPMSI-78 resulted in
increased potency toward some bacterial strains and protection
against proteolysis when bound to lipid vesicles.32
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be investigated by measuring the transverse relaxation rate (R2) of
the 19F nucleus using CPMG relaxation dispersion experiments.
Here we have extended these measurements to examine the
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CF3 probes at strategic positions throughout the peptide and
measuring the associated changes in chemical shifts, solvent isotope
effects on chemical shifts, and changes in R1 and R2 values.
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Peptide Synthesis.Racemic 4,4,4-trifluoroethylglycine (TfeG)
was purchased from SynQuest Laboratories and enzymatically
resolved (porcine kidney acylase I), resulting in L-4,4,4-trifluoro-
ethylglycine having a >99% enantiomeric excess.38 The pure
amino acid was converted to its t-Boc derivative by standard
procedures. The sequences of MSI-78 derivatives are shown in
Figure 2. Peptides were synthesized manually by either standard
t-Boc procedures on MBHA resin or f-moc procedures on PAL-
PEG resin, as described previously.39,40 Peptides were purified by
reverse-phase high-performance liquid chromatography using a
gradient of water of acetonitrile with 0.1% TFA; excess residual
TFA was removed by chromatography on a Stratosphere SPE
column (Varian) using 0.1% formic acid as the ion-pairing agent.
Stock peptide concentrations were determined using 19F NMR
with a known concentration of TFA as a reference. Peptide





line (DHPC), and dodecylphosphocholine (DPC) were pur-
chased from Affymetrix. Isotropic bicelles were created in PBS
buffer (pH 7.4) with 10% D2O by adding a 3:1 DMPC/DMPG
solution to a solution of DHPC giving a q of 0.5 resulting in a
clear, nonviscous solution.
Determinations of MICs. The peptide minimum inhibitory
concentrations (MICs) againstEscherichia coliK12were determined
Figure 1. (A) Two views of the structure of MSI-78, determined from
NMR experim nts,31 with peripheral lysine residues shown as sticks. (B)
Cartoon illustrating the mechanism for insertion of MSI-78 into a lipid
bilayer to form toroidal pores.
Figure 2. (A) Primary sequence of MSI-78 and the sequences of TfeG-
substituted peptides used in this study. (B) Positions of amino acid
substitutions mapped onto the structure of the MSI-78 dimer formed in
DPC micelles. Substitutions at hydrophilic positions (blue spheres) are
shown on the left; substitutions at hydrophobic positions (red spheres)
are shown on the right.
b)
a)
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interact with hydrophilic lipid head groups. Using a series of MSI-78 peptides that incorporate 
tfeGly 6 (Figure 1.2), a small and sensitive NMR probe, the local structure and dynamics of the 
peptide changes on binding the lipid bilayer were investigated. In previous studies in our 
laboratory (30), the binding of two fluorinated MSI-78 variants incorporating tfeGly at a 
positively charged exterior position (Lys-7) or a hydrophobic position (leucine (Leu)-6) to small 
unilamellar vesicles and bicelles was detected by following changes in the 19F chemical shift and 
measuring the dynamics of peptide the transverse relaxation rate (R2) of the 19F nucleus using 
The Carr-Purcell-Meiboom-Gill (CPMG) relaxation dispersion experiments. Whereas these 
initial studies provided a “proof of concept”, we considered it important to conduct a more 
comprehensive study to determine, more generally, how sensitive fluorine probes are for 
distinguishing chemical environment and local dynamics.  
 In this chapter, I have extended our investigation by synthesizing a series of MSI-78 
variants in which tfeGly has been introduced at strategic positions throughout the 22-residue 
peptide. These peptides are named as MSI-Fn, when n refers to the position in the peptide that 
has been substituted with tfeGly. Guided by the NMR structure of the peptide bound to lipids 
(29), I introduced tfeGly at four hydrophobic positions and at four Lys residues spaced along the 
length of the peptide, including the C-terminal residue Lys-22; I also substituted the N-terminal 
glycine (Gly), which may be expected to show a large change in mobility. The positions that 
were substituted are shown in Figure 2.2. For each peptide, I have measured the changes in 19F 
chemical shifts, longitudinal and transverse relaxation rates (R1 and R2, respectively), and D2O-
induced 19F chemical shifts that occur upon peptide binding to lipid bicelles. This has allowed a 
detailed picture to be obtained of the local changes in chemical environment peptide dynamics 
that occur when MSI-78 binds to the lipid bilayer. 
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Figure 2.2. Substituted positions of tfeGly in MSI-78 (a) The primary sequence of MSI-78 and the 
sequences of tFeGly-substituted peptides used in this study.  (b) The positions of amino acid substitutions 
are mapped on to the structure MSI-78 dimer formed in DPC micelles (32). Substitutions at hydrophilic 
positions (blue balls) are shown on the structure to the left; substitutions at hydrophobic positions (red 




2.2. Experimental Procedures 
2.2.1. Peptide Preparation 
 Racemic tfeGly was purchased from SynQuest Labs and acetylated to enzymatically 
resolved (porcine kidney acylase I) resulting in L-4,4,4-trifluoroethylglycine (tfeGly) having 
>99% enantiomeric excess (31, 32). The pure amino acid was converted to its Boc- or Fmoc- 
derivative by standard procedures. The sequences of MSI-78 derivatives are shown in Figure 2.2. 
Peptides were synthesized manually by either standard Boc procedure on MBHA resin or by 
Fmoc procedure on PAL-PEG resin, as described previously (32-34). Peptides were purified by 
reverse phase high-performance liquid chromatography (HPLC) using a gradient of 
water/acetonitrile with 0.1% trifluoroacetic acid (TFA); excess residual TFA was removed by a 
Stratosphere SPE column (Varian). Stock peptide concentrations were determined using 19F 
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Peptide:                          Sequece                        
MSI-78 :      GIGKFLKKAKKFGKAFVKILKK-NH2
MSI-F1 :      XIGKFLKKAKKFGKAFVKILKK-NH2
MSI-F6 :      GIGKFXKKAKKFGKAFVKILKK-NH2
MSI-F7 :      GIGKFLXKAKKFGKAFVKILKK-NH2
MSI-F9   :    GIGKFLKKXKKFGKAFVKILKK-NH2
MSI-F11 :    GIGKFLKKAKXFGKAFVKILKK-NH2
MSI-F15 :    GIGKFLKKAKKFGKXFVKILKK-NH2
MSI-F18 :    GIGKFLKKAKKFGKAFVXILKK-NH2
MSI-F20 :    GIGKFLKKAKKFGKAFVKIXKK-NH2
MSI-F22 :    GIGKFLKKAKKFGKAFVKILKX-NH2
b)a)
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NMR with a known concentration of TFA as an internal reference. Peptide identities were 
confirmed using Matrix-assisted Laser Desorption/Ionization Mass Spectrometry (MALDI-MS). 
 
2.2.2. Lipid Preparation 
 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC), 1,2-dimyristoyl-sn-glycero-3-
phospho-(1’-rac-glycerol) (DMPG) and 1,2-dihexanoyl-sn-glycero-3-phosphocholine (DHPC) 
were purchased from Avanti Polar Lipids. Dodecylphosphocholine (DPC) was purchased from 
Affymetrix.  Isotropic bicelles were made in PBS buffer, pH 7.4 with 10% D2O by adding a 
solution of 3:1 DMPC/DMPG to a solution of DHPC giving q=0.5 resulting in a clear, non-
viscous solution.  
 
2.2.3. Circular Dichroism 
 CD spectra of peptides were collected with an Aviv 62DS spectropolarimeter using a 0.2 
cm pathlength cell. CD measurements were performed at peptide concentration of 80 – 200 µM 
in 75 mM sodium chloride and 25mM sodium phosphate (pH 7.4) in the presence or absence of 
100 µM SDS micelles at 30 °C. Mean residue ellipticities, [θ], were calculated using [θ] = 
θobsd/10lcn where θobsd is the ellipticity measured in millidegrees, c is the molar concentration, l is 
the cell path length in centimeters, and n is the number of residues in the peptide. All the 
peptides exhibited CD spectra characteristic of unstructured peptides in plain buffer, which 
converted to spectra characteristic of extensively helical peptides upon addition of 100 mM 
sodium dodecyl sulfate (SDS), as shown in the plots in Figure 2.3. 
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2.2.4. MIC Determinations  
 The peptide minimum inhibitory concentrations (MICs) against E. coli K12 were 
determined by the microdilution antimicrobial assay procedure, using 96-well plates in replicates 
of four, as described previously (35).  
 
2.2.5. Proton NMR spectroscopy 
 Samples were prepared in PBS, pH 6.0, containing 10% D2O, 100 mM DPC and 400 µM 
peptide. A water suppression pulse sequence (WET) was employed in the acquisition of NMR 
spectra (Figure 2.4). 
 
2.2.6. 19F NMR spectroscopy 
 All 19F NMR experiments were performed at 30 °C using a Varian Inova 500 MHz NMR 
spectrometer equipped with a double-tuned 1H-19F room-temperature probehead. Peptide and 
lipid samples were prepared with 10% D2O in PBS, pH 7.4. All experiments were performed at a 
constant peptide concentration of 400 mM unless indicated otherwise and referenced to TFA at 0 
ppm. To measure solvent isotope-induced changes in chemical shift, peptide and lipid samples 
were first prepared with 10% D2O in PBS, pH 7.4. The samples were then lyophilized overnight 
and re-dissolved in either 90% D2O. The solvent-induced changes were referenced to TFA at 0 
ppm as an external standard in PBS, pH 7.4, 10% D2O.  
 19F CPMG relaxation dispersion experiments were performed for the peptides in the free 
state and in the presence of lipid bicelles (200 mM total lipid concentration, q=0.5, long chain 
lipids 3:1 mol/mol DMPC/DMPG and short chain lipid being DHPC). CPMG delays (τcp) were 
varied from 0.5 to 10.0 ms with each data point recorded as a series of standard 1-D transverse 
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relaxation rate measurements with T2 delays of 0.05, 0.1, 0.2, 0.4, 0.8 and 1.6 ms for free peptide 
and 0.0125, 0.025, 0.05, 0.1, 0.2 and 0.4 ms for bicelle-bound peptide.  The pulse width was 7.9 
ms.  Data sets were recorded with acquisition time of 1 s in T1 along with a 10 s pre-scan delay.  
16 scans, net acquisition time of 17 min/data point, were required to achieve adequate signal-to-
noise ratios for peptides in the free state; 32 scans, net acquisition time of 35 min/data point, 
were required to achieve adequate signal-to-noise ratios for peptides bound to bicelles. 19F spin-
lattice relaxation times (T1) were acquired by an inversion recovery sequence (180° – τ - 90°) 
using a total of six τ values of 0.0625, 0.125, 0.25, 0.5, 1.0, 2.0 s.  Data were processed and 
analyzed using VNMRJ software and plotted using the Kaleidagraph software package. All other 
experimental details have been described previously (30, 36). 
 
2.3. Results and Discussion  
2.3.1. Effects of tfeGly Substitution on Secondary Structure and Biological Activity 
 The feasibility of using fluorine-labeled amino acids to probe the chemical environment 
and dynamics of membrane-bound peptides containing tfeGly was demonstrated previously in 
our laboratory (30). tfeGly provides a useful probe, as it is relatively small (approximately 
comparable to valine), is commercially available, and is readily incorporated into peptides. The 
C-3 methylene group affords one degree of rotational motion to the trifluoromethyl group, but on 
the time scale of our experiments, backbone dynamics are likely to dominate its NMR behavior. 
Although substitution of hydrophilic residues, such as Lys, with tfeGly obviously cannot be 
considered as conservative, numerous experiments with AMPs have shown that their biological 
properties and structure depend primarily on their overall physicochemical properties and are not 
highly dependent on sequence.  
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 Substitution of tfeGly at different positions in these peptides does not appear to cause any 
gross structural changes or changes in biological activity. The peptides all appear to adopt a 
predominantly random coil structure in plain buffer (Figure 2.3a), and exhibit extensively helical 
CD spectra in the presence of SDS micelles (Figure 2.3b). The mean residue ellipticities, θ222, of 
the peptides varied by less than 10% (20200 cm2 dmol-1 residue-1 > θ222 > 21900 cm2 dmol-1 
residue-1) between the different peptides and are similar to that of MSI-78 (θ222 = 20700 cm2 
dmol-1 residue-1). The MIC values for all the peptides were within the range of 3 – 6 µg/mL 
against E. coli K12 strains; any differences in MICs between the parent MSI-78 peptide (37) and 
the tfeGly-labeled peptides were not statistically significant (Figure 2.3c). 
 
 
Figure 2.3. Effects of tfeGly substitution on secondary structure and biological activity (a) CD 
spectra of MSI peptides in plain buffer (b) CD spectra of MSI peptides in buffer containing 100 mM SDS 
micelles (c) MICs against E. coli K12 for MSI peptides. 
 
 
 As a further check on the structural integrity of the tfeGly-labeled peptides, one-
dimensional proton NMR spectra of the peptides were recorded for the peptides bound to DPC 
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region, characteristic of structured peptides. As expected, small changes between the spectra of 
each tfeGly-labeled peptide and MSI-78 were observed, which may reflect small local structural 
changes and/or slight differences in sample preparation. The resonances from the three Phe side 
chains in the peptide could clearly be distinguished and were very similar in each case, indicating 
that the hydrophobic core of the dimeric peptide bundle remains intact. Resonances from the 
aliphatic side chains were obscured by signals from DPC micelles. 
 
Figure 2.4. Proton NMR spectra of MSI peptides bound to DPC micelles. 
 
2.3.2. Sensitivity of 19F Chemical Shifts to the Position of Fluorination 
 In the absence of lipids, all the peptides, except MSI-F1, exhibited a sharp triplet in the 
19F NMR spectrum between 11.40 and 11.73 ppm relative to TFA (Figure 2.5 and Table 2.1). 
The resonance for MSI-F1, in which Gly is substituted with tfeGly, is shifted significantly 
downfield at 12.15 ppm. This is likely due to the influence of the positively charged amino group 
at the N-terminus (Table 2.1). 
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Figure 2.5. Sensitivity of 19F chemical shifts to the position of fluorination (a) Representative 19F 
NMR spectra illustrating changes in chemical shift and peak width that occur when tfeGly-substituted 
peptides bind to lipid bicelles.  The upper trace in pair of spectra is for the free peptide and the lower trace 
for the peptide bound to bicelles. Spectra were recorded at 30 °C at pH 7.4 in PBS buffer with 10% D2O 
and referenced to TFA. (b) Chemical shift changes, Δδ, associated with peptide binding to bicelles plotted 




 I then examined the binding of the fluorinated MSI-78 variants to lipid bicelles, which 
are commonly used as a model membrane system. As described previously (30), for these studies 
bicelles are preferable to small unilamellar vesicles (SUVs), which are also commonly used to 
study AMP-membrane interactions. Bicelles are more stable than SUVs and present a flat, rather 
than highly curved, surface for peptide binding. All the peptides exhibited distinct changes in 
their 19F chemical shifts upon binding to bicelles, which appeared as broadened single peaks 
(Figure 2.5). 
 The change in chemical shift was highly dependent on the position of the tfeGly residue 
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The positions that exhibited the largest upfield shifts, ranging from 0.9 to 1.3 ppm, are those at 
hydrophobic positions that are deeply buried in the core of the coiled coil (Figure 2.6). The Lys 
positions, which project out from the coiled coil and interact with the lipid head groups, 
exhibited smaller upfield shifts ranging from 0.06 to 0.26 ppm (Figure 2.5). Two positions seem 
to deviate from this general trend. Substituting tfeGly at the N-terminal Gly position (MSI-F1) 
results in a large downfield shift of 1.2 ppm; MSI-F15, in which alanine (Ala) is substituted by 




Table 2.1. 19F Chemical shifts, R1 and R2 values for MSI-F peptides. a chemical shift relative to TFA  
b value at 1/τcp = 2000 Hz   
 
 
 Although 19F chemical shifts are influenced by various factors (38), the “anomalous” 
chemical shift of MSI-F15 might be explained by the fact that the tfeGly side chain is expected 
to protrude toward the charged face of the α-helix (Figure 2.6). Its chemical shift is likely to be 
influenced by the positively charged Lys residues that are adjacent to it; this could result in 
deshielding of the nucleus and thereby shift the resonance to lower field. In contrast, substitution 
of Ala-9 with tfeGly (MSI-F9) places the side chain pointing into the hydrophobic core (Figure 




aδ  bound 
(ppm) 
R1free    (Hz) R1bound  (Hz) bR2free    (Hz) bR2bound  (Hz) 
MSI-F1 Gly 12.13 13.41 1.40 ± 0.05 2.55 ± 0.06 1.7 ± 0.1 27 ± 1 
MSI-F6 Leu 11.64 10.29 2.18 ± 0.05 3.09 ± 0.04 3.7 ± 0.2 58 ± 9 
MSI-F7 Lys 11.65 11.38 2.31 ± 0.03 3.10 ± 0.14 3.7 ± 0.2 22 ± 2 
MSI-F9 Ala 11.73 10.57 2.37 ± 0.05 3.10 ± 0.14 4.1 ± 0.2 43 ± 3 
MSI-F11 Lys 11.55 11.49 2.30 ± 0.04 3.06 ± 0.05 4.1 ± 0.2 27 ± 3 
MSI-F15 Ala 11.47 11.56 2.26 ± 0.05 3.86 ± 0.11 3.9 ± 0.1 49 ± 3 
MSI-F18 Lys 11.52 11.46 2.23 ± 0.05 3.24 ± 0.07 3.1 ± 0.1 29 ± 2 
MSI-F20 Leu 11.60 10.69 2.05 ± 0.03 3.12 ± 0.09 2.8 ± 0.2 36 ± 2 
MSI-F22 Lys 11.40 11.25 1.53 ± 0.06 2.27 ± 0.05 2.1 ± 0.2 20 ± 0.4 
tfeGly  11.62  0.54 ± 0.03  1.1 ± 0.1  
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2.6), presumably resulting in a more shielded environment. The downfield shift observed when 
tfeGly is at the N-terminal position is harder to explain. Possibly, in its folded state, the N-
terminus of the peptide is less well solvated so that the deshielding effect of the positively 
charged amino terminus is greater. The N-terminus is also in the proximity of the amino group of 
the C-terminal Lys of the peptide forming the opposite strand of the coiled coil, which could also 




Figure 2.6. Space filling models of the MSI-78 dimer illustrating the chemical environment of the 
positions substituted by tfeGly. Residues substituted by tfeGly are colored blue (hydrophilic) and red 
(hydrophobic).  Other hydrophobic and hydrophilic residues are colored yellow and green respectively.  
For clarity, the substituted positions are only shown on one peptide of the dimer.  The two structures are 
related to each other by a ~ 180° rotation about the vertical axis. 
 
 Changes in 19F chemical shift provide a simple way of detecting binding at 
concentrations that are close to those at which the peptide is biologically active. For MSI-78, 
spectral shifts were apparent for all the tfeGly-labeled peptides, regardless of the position of the 
label. In these studies, spectra were recorded on a 500 MHz spectrometer at a peptide 
concentration of 400 µM to facilitate CPMG experiments; however, 40 µM tfeGly-labeled 
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only 2 min to acquire. Another advantage is that the wide range of chemical shift changes 
observed potentially allows multiple peptides to be studied in one experiment (or multiple 
fluorine probes to be introduced into one peptide), so that more complex multicomponent 
interactions can be studied. 
 
2.3.3. Changes in Solvent Exposure upon Binding to Lipid Bicelles 
 The 19F chemical shift is sensitive to the isotopic composition of the solvent, e.g., 
whether H2O or D2O (14, 16), and this provides a means to investigate changes in solvent 
exposure that may occur when MSI-78 binds to lipid bilayers. In the absence of bicelles, 
changing the solvent composition from 10% D2O to 90% D2O results in the 19F chemical shift 
for each of the peptides moving fairly uniformly upfield by 0.08 to 0.11 ppm (Figure 2.7). In the 
presence of bicelles, the chemical shift changes, Δδ(H2O – D2O), (Δδ (H2O – D2O) = δH2O – δD2O), are 
more variable and range from 0.01 to 0.08 ppm (changes of ≤ 0.01 ppm were not considered 
significant).  
 In theory, positions that are deeply buried should exhibit no changes in chemical shift 
with a change in the solvent, whereas positions that are completely exposed should exhibit 
changes similar to those observed for the unbound peptides. Inspection of the data reveals this to 
be qualitatively true: positions 7, 11, 18, and 22, which are occupied by Lys in MSI-78, exhibit 
the largest chemical shift changes (Δδ = 0.08 – 0.06 ppm). These are somewhat smaller than 
those observed for the free peptide, indicating that interactions with the lipid head groups may 
reduce the level of solvent exposure. In contrast, at positions 6, 9, 15, and 20, which are occupied 
by hydrophobic residues in MSI-78, Δδ (H2O – D2O) is very small, -0.01 to 0.03 ppm. This indicates 
a very low degree of solvent exposure in the bound state and provides support for the proposed 
	   39 
structural model of MSI-78 in which these positions form part of the hydrophobic core of the 
coiled coil peptide dimer in the membrane. 
 
Figure 2.7. Changes in solvent exposure upon binding to lipid bicelles determined by solvent isotope 
effect (a, b) Representative 19F NMR spectra (MSI-F9) illustrating changes in chemical shift that occur in 
solvent isotope effect (H2O/D2O). Peptide is in 10% (v/v) D2O (red) and 90% D2O (black) in free solution 
(a) and in bicelles (b). (c) Solvent isotope effects on 19F chemicals shift (Δδ(H2O – D2O)) plotted as a function 
of label position.  Black bars: peptides in free solution; white bars: peptides bound to lipid bicelles.  
 
 
 Effects of solvent isotopes (H2O vs D2O) on the fluorine chemical shift demonstrate that 
this technique also provides a simple but effective probe of peptide-membrane interactions (14, 
16). In this case, it is evident that, even when embedded in the membrane, the Lys positions 
remain predominantly solvated whereas the hydrophobic positions are extensively shielded from 
the solvent. This supports the model in which MSI-78 forms toroidal pores in the lipid bilayer 
(28), in which the Lys side chains interact with hydrophilic lipid headgroups. 
 
2.3.4. Changes in Peptide Dynamics Probed by 19F Longitudinal and Transverse Relaxation 
Rates 
 Various studies of fluorinated proteins have shown that 19F longitudinal relaxation rates 
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(14, 16), and these measurements have been used to probe protein structure and folding. 
Therefore, I also investigated how R1 changed when the peptides bound to bicelles. The R1 
values for the free peptides range from 1.4 to 2.4 Hz, with the terminal residues exhibiting the 
lowest R1 values (Table 2.1). The R1 values increase fairly uniformly for the peptides on binding 
bicelles with R1 values ranging from 2.3 to 3.9 Hz (Table 2.1). It appears that longitudinal 
relaxation measurements are not especially sensitive to differences in the local chemical 
environment for this particular system. 
 The transverse relaxation rates of the free peptides (R2f) were measured using a CPMG 
experiment in which 1/τcp was varied from 100 to 2000 Hz. For all the peptides, R2 values are 
similar and are independent of τcp (Figure 2.8a), as expected for an unstructured peptide in free 
solution. The experimental R2 values (Figure 2.8b) generally agree well with that calculated for a 
random coil peptide in free solution (30); however, residues at the N- and C-termini exhibit 
significantly slower R2f values (Figure 2.8b and Table 2.1). This indicates that the ends of the 
peptide are more mobile than the center, which would be expected for an unstructured peptide 
chain. 
 The transverse relaxation rates were measured for each peptide bound to bicelles, R2b, 
using the same set of CPMG pulse sequences. Under the conditions used in the experiment, 
nearly all of the peptide was bound to the lipid bilayer (as shown in Figure 2.5, no signal for the 
free peptide could be detected). As discussed previously (30, 39, 40), when τcp is short relative to 
the residence time, τb, of the peptide in the lipid, the observed R2b values reflect the intrinsic 
relaxation rates of the 19F nuclei unencumbered by chemical exchange. Under these conditions, 
differences in R2b may be attributed to changes in the local dynamics of the peptide. 
 
	   41 
 
 
Figure 2.8. Observed transverse relaxation rates, R2,observed, for MSI-F peptides in free solution (a) 
plotted as a function of CPMG pulsing rate (1/τcp). Symbols used are MSI-F1 (); MSI-F6 (p); MSI-F7 
(n); MSI-F9 (); MSI-F11 (p); MSI-F15 (n); MSI-F18 (); MSI-F20 (p); MSI-F22 (n). (b) plotted 
as a function of sequence. The data were obtained using 1/τcp = 2000 Hz so that the chemical exchange 
component is removed. The calculated R2 = 3.7 Hz for free peptide is indicated by the dashed line. 
Hydrophilic and hydrophobic residues are colored blue and red, respectively. 
 
 
 The observed R2b values for all the peptides were essentially invariant for values of 1/τcp 
greater than 250 Hz, consistent with our previous results (30). At longer pulse intervals, R2b 
appears to increase, indicative of chemical exchange (Figure 2.9a). However, at these time 
scales, the experiment approaches the limits of sensitivity because of interconversion between in-
phase and antiphase magnetization during the spin echo period, as well as loss of signal intensity 
due to chemical exchange. Therefore, measurements are accompanied by large uncertainty in the 
value of R2b, and τb cannot be reliably determined from the data. However, the experiment does 
allow us to put an upper limit on the rate at which the peptide dissociates from the membrane 
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Figure 2.9. Observed transverse relaxation rates, R2,observed, for MSI-F peptides bound to lipid 
bicelles (a) plotted as a function of CPMG pulsing rate (1/τcp). Symbols used are MSI-F1 (); MSI-F6 
(p); MSI-F7 (n); MSI-F9 (); MSI-F11 (p); MSI-F15 (n); MSI-F18 (); MSI-F20 (p); MSI-F22 
(n). (b) plotted as a function of sequence. The data were obtained using 1/τcp = 2000 Hz so that the 
chemical exchange component is removed.  The calculated R2 = 50.8 Hz for the peptide bound to lipid 
bicelles (assuming relaxation is only due tumbling of bicelles) is indicated by the dashed line. 




 The transverse relaxation rates measured for the CF3 reporter group varied significantly 
depending upon the location of the reporter nuclei (Figure 2.9b). The R values for each of the 
peptides determined at a 1/τcp of 2000 Hz are listed in Table 2.1. The hydrophobic positions 
exhibit the fastest relaxation rates (e.g., Leu-6, R2b = 58 Hz; Ala-15, R2b = 49 Hz), indicating that 
these residues, which are predicted to be in the hydrophobic core of the coiled coil, are relatively 
immobile. Moreover, the relaxation rates are close to the theoretical value, ~50 Hz, predicted if 
relaxation is dominated by the tumbling motion of the lipid bicelle. Hydrophilic positions, which 
are predicted to be on the surface of the coiled coil and interact with lipid headgroups, exhibit 
slower relaxation rates, indicating that these positions have greater mobility. The R2b values do 
not vary greatly along the length of the peptide [e.g., Gly-1 (28 Hz), Lys-11 (27 Hz), and Lys-18 
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that the N-terminus is quite well structured when bound to the lipid and does not appear to 
undergo fraying on the time scale of these experiments. This is consistent with the significant 
degree of solvent protection observed for the N-terminus in the solvent isotope effect study. The 
C-terminus of the peptide is more dynamic, but compared to that of the free peptide, it is clearly 
less mobile and better structured. 
 The changes in chemical shifts and transverse relaxation rates observed when the 
peptides bind to bicelles appear to be independent of each other. Thus, although the positions 
occupied by Ala-9 and Ala-15 both appear to be quite immobile (R2b = 43 and 49 Hz, 
respectively), Ala-9 shifts downfield by 1.15 ppm whereas Ala-15 shifts slightly upfield by 0.11 
ppm. The chemical shifts of N- and C-terminal positions change in opposite directions (1.19 and 
0.10 ppm, respectively) even though both positions exhibit similar mobilities as judged by their 
R2b values (Figure 2.9). 
 From the measurements of transverse relaxation rates along the peptide backbone, I have 
obtained detailed information about the local dynamics of MSI-78 bound to the lipid bilayer. The 
hydrophobic positions of the amphipathic peptide that form the core of the coiled coil are the 
least dynamic positions. This suggests a well-packed core in which side chain rotations are 
restricted. The positively charged face of the coiled coil, which interacts with the hydrophilic 
lipid headgroups, is more dynamic, although far less so than in the unbound peptide. Moreover, 
positions toward the center of the peptide appear to be less dynamic than the ends of the peptide. 
This would be consistent with the peptides forming toroidal pores in the lipid bilayer, as has been 
deduced for MSI-78. If I assume the peptide sits centrally in the pore, the constriction of the 
peptide by the lipid bilayer would by greatest at the center of the pore, where the opening is 
narrowest. 
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 The 19F transverse relaxation data provide new and more detailed information about the 
local dynamics of peptide upon binding to a lipid membrane. The changes in 19F chemical shifts 
can only be interpreted qualitatively using the structural model of MSI-78 determined by NMR 
(29). However, density functional theory methods have been used to calculate 19F chemical shifts 
for a large number of fluorinated small molecules (41, 42) with a reasonable degree of accuracy. 
In a study particularly pertinent to these experiments, it was found that hindered rotation of CF3 
groups led to an upfield shift of the 19F signal (42). Future advances in computational methods 
will likely allow 19F chemical shifts in fluorinated peptides and proteins to be calculated. This 
would permit the relationship among structure, dynamics, and chemical shift to be quantitatively 
understood, providing a further tool for analyzing peptide-membrane interactions. 
 
2.4. Conclusion  
 Studies in this chapter demonstrate that 19F NMR provides a relatively sensitive and 
general technique for investigating the interactions of peptides and proteins with their membrane 
targets. Using a series of MSI-78 peptides that incorporate tfeGly, a small and sensitive NMR 
probe, I investigated how the local structure and dynamics of the peptide changes on binding the 
lipid bilayer.  In particular, the chemical shift and transverse relaxation rates are highly sensitive 
to the position of the fluorine label in the peptide and provide information about changes in local 
peptide motions. Future work will aim toward using 19F NMR to study peptide-membrane 
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Alternative Pathways of Human Islet Amyloid Polypeptide Aggregation Distinguished by 
19F NMR-Detected Kinetics of Monomer Consumption 
 
3.1. Introduction 
 The work described in this chapter has been published as: “Alternative Pathways of 
Human Islet Amyloid Polypeptide Aggregation Distinguished by 19F NMR-Detected Kinetics of 
Monomer Consumption.” Yuta Suzuki, Jeffrey R. Brender, Kevin Hartman, Ayyalusamy 
Ramamoorthy, and E. Neil G. Marsh (2012) Biochemistry, 51 (41), 8154 – 8162 (1). The co-
authors were very helpful in conducting this research and analyzing the results. Dr. Hartman 
assisted me with fluorescent experiments and acquiring electron microscopy data. Numerous 
suggestions and guidance on experiments came from Dr. Jeffrey R. Brender and Prof. 
Ayyalusamy Ramamoorthy.  
 The formation of amyloid fibers is associated with a wide range of pathologies including 
Alzheimer’s disease, Parkinson’s disease, and type II diabetes (2). Under pathological 
conditions, amyloidogenic proteins self-assemble into long fibrillar structures with a 
characteristic β-sheet core (3-5). Although a detailed mechanism is lacking for most 
amyloidogenic proteins, amyloidogenesis is believed to be a complex, multi-step process, 
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typically involving the formation of energetically unfavorable intermediates before the formation 
of the final amyloid product (Figure 1.8) (6-9).  
 Because amyloid formation is such a complex process, a full understanding of the 
pathology caused by amyloid formation requires establishing both the identity of intermediates 
along the amyloid pathway and the kinetics of their formation. The actual identity of the species 
responsible for toxicity is elusive and has been the subject of much debate since the discovery of 
amyloid plaques more than a century ago (8-10). A current hypothesis holds that small to 
intermediate size (~5-6 nm in diameter) oligomers may be responsible for much of the toxicity of 
amyloid proteins (7, 9). For the Aβ protein, probably the best studied amyloidogenic protein, 
oligomers of this type have been isolated both in vitro and in situ from tissue samples of 
Alzheimer’s patients. While a large body of literature exists linking small oligomers of this type 
to the pathological action of other amyloidogenic proteins besides Aβ, their actual existence in 
many other amyloidogenic proteins has largely been inferred rather than directly tested (8). For 
IAPP in particular, the existence of small oligomeric species of this type is controversial (8, 9). 
Most attempts at detection has used the conformation-specific antibody A11, whose specificity 
towards non-Aβ oligomers has been called into question (8), as it appears to give both false 
positives and false negatives under some conditions (8, 11-14). Attempts at direct detection of 
these oligomers have largely been negative, although these experiments have used an 
equilibrium approach that may not detect transient oligomers (15, 16). In the absence of well-
defined targets, research attempting to attenuate amyloid-linked toxicity has been substantially 
impeded. 
 Towards this end, various methods have recently been exploited to monitor the kinetics 
of amyloid fibril formation including fluorescence (17-20), NMR (21, 22), 2D-infrared (23, 24), 
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and mass spectroscopy (25, 26). The most common method for measuring amyloid formation 
exploits the increase in fluorescence when the dye, ThT binds to the fibers.  Although the ThT 
assay is simple and relatively sensitive, it does not accurately distinguish between oligomeric 
species (27). Therefore, it is not particularly useful by itself to investigate amyloidogenic 
intermediates. Similarly, reporters of secondary structures such as CD, Fourier transform infrared 
and multidimensional NMR spectroscopy have difficulty in detecting the underlying spectral 
signature of the intermediate species, which may be transient and not form a majority of the total 
population. 
 On the other hand, real-time 1H NMR measurements, in theory, allow the signal from 
each species to be resolved and analyzed independently.  Unfortunately, 1H NMR is relatively 
insensitive to changes in structure due to small chemical shift dispersion associated with the 1H 
nucleus. Whereas 13C and 15N experiments are more sensitive to environmental changes, the low 
sensitivity of these nuclei makes it difficult to acquire data sufficiently rapidly to track 
intermediates during aggregation. In contrast, 19F combines both excellent sensitivity and large 
chemical shift dispersion, making it an excellent reporter for changes in the chemical 
environment (28, 29). Thus 19F NMR has been broadly applied to investigate protein 
conformational changes and dynamics as well as protein-ligand and protein-membrane 
interactions in biological systems  (30-42) as described in chapter 1. Whereas the properties of 
19F NMR spectroscopy are attractive for amyloid research, applications to amyloid proteins have 
been relatively limited (43, 44). In particular, detailed time-resolved studies of protein 
aggregation or inhibition assays using 19F NMR have not been performed. 
 In this chapter, I demonstrate the utility of 19F NMR to provide a direct, sensitive and 
real-time measurement of amyloid formation by the highly amyloidogenic peptide, IAPP, which 
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is achieved by monitoring the consumption of monomeric protein rather than the formation of 
fibrils by dye binding.  IAPP is a 37-residue peptide hormone secreted from pancreatic β-cells 
along with insulin to contribute to glycemic control (45). However, an insoluble fibril form of 
IAPP is found in the pancreas of up to 90% of patients with type II diabetes that may contribute 
to the pathology of the disease (8, 9, 46, 47). Using real-time 19F NMR in combination with other 
techniques to measure conformational changes during the aggregation pathway, I show IAPP 
forms fibers from monomeric IAPP at pH 7.3 without an appreciable buildup of small oligomeric 
intermediates during aggregation, in contrast to most amyloidogenic proteins (7). However, this 
pathway can be altered towards the formation of non-fibrillar intermediates using inhibitors such 
as EGCG. 
 
3.2. Experimental Procedures 
3.2.1. Peptide Preparation 
 Peptide (IAPP-tfmPhe23) was synthesized manually in the free acid form by solid-phase 
Fmoc-based chemistry using pseudoproline dipeptides to disrupt aggregation during synthesis, as 
described previously (48). Fluorinated Phe, tfmPhe 2 (Figure 1.2) was used to replace Phe at 
position 23.  
Peptide sequence: KCNTATCATQRLANFLVHSSNN(tfmPhe)GAILSSTNVGSNTY 
 The disulfide bridge between Cys2 and Cys7 in IAPP was formed on the resin using 
thallium (III) trifluoroacetate as a mild oxidant, and cleaved from resin using 95% TFA (48). 
Crude peptides were dissolved in 35% acetic acid (v/v) and purified on a reverse-phase HPLC 
using a Waters semi-preparative C18 column equilibrated in 0.045% HCl. The peptides were 
eluted with a linear gradient of 0% to 80% acetonitrile at a flow rate of 10 ml/min. Peptide 
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identity was confirmed using MALDI-MS. 
 
3.2.2. Sample Preparation 
 To remove preformed aggregates, the purified peptide was dissolved in 
hexafluoroisopropanol followed by the removal of the solvent by lyophilization. A 850 µM stock 
solution was made before each set of experiments by first dissolving the lyophilized peptide in 
0.1 mM HCl (pH 4.0). The stock solution was then passed though a 0.22 µm filter before dilution 
into the final buffer solution immediately before the start of each experiment. The concentrations 
of peptide stock solutions were determined by the absorbance of tyrosine 37 in water (ε = 1215 L 
mol-1 cm-1 at 280 nm) (49). All experiments were performed at a constant peptide concentration 
of 85 µM. The final solutions contained 20 mM sodium phosphate, 50 mM NaCl (pH 7.3), 10% 
D2O, and various concentrations of EGCG, ThT, and 1-Ethyl-3-(3-
dimethylaminopropyl)carbodiimide hydrochloride (EDC) and N-hydroxysulfosuccinimide 
(Sulfo-NHS) as indicated in the figure captions. For NMR measurements, 19F chemical shifts 
were referenced to an internal standard of trifluoroethanol (TFE) (100 µM, at 0 ppm). 
 
3.2.3. Kinetic Studies Using 19F NMR Spectroscopy 
 All 19F NMR experiments were performed using a Varian VNMRS 500 MHz NMR 
spectrometer equipped with a double-tuned 1H-19F probe. After the addition of peptide into the 
NMR solution, a series of 19F spectra were recorded without spinning. Each 19F spectrum takes 
116 s using 64 transients (25°C and 37 °C) or 232 s using 128 transients (10 °C) with a 1.0 s 
pulse delay between each transient. Line broadening of 3.0 Hz was used to process the final 
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spectra. All of the samples were pre-equilibrated at the indicated temperatures before mixing 
with peptide stock solution. Origin 8.5 was used for plotting and fitting the data (50).  
 
3.2.4. Kinetic Studies Using ThT Fluorescence 
 The kinetics of IAPP amyloid formation was measured using the increase in fluorescence 
intensity observed when the amyloid specific dye ThT binds to the amyloid fibrils. The samples 
were prepared as described above for the NMR solution except that 100 uM ThT was premixed 
with buffer solution before the addition of peptide. Time traces were recorded with a FluoroMax-
2 spectrofluorometer using a 440 nm excitation filter and a 485 nm emission filter at a constant 
temperature without shaking. 
 
3.2.5. Kinetic Studies Using Circular Dichroism 
 CD measurements were performed with an Aviv 62DS spectropolarimeter using a 0.1 cm 
pathlength cell. The samples were prepared as described above for the NMR solution. Mean 
residue ellipticities, [θ], were calculated using [θ] = θobsd/(10lcn) where θobsd is the ellipticity 
measured in millidegrees, c is the molar concentration, l is the cell path length in centimeters, 
and n is the number of residues in the peptide. Full spectra were smoothed by Savitzky-Golay 
smoothing (5 point window). 
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3.2.6. Transmission Electron Microscopy 
 Aliquots were directly taken from the NMR or ThT samples at the time-points indicated. 
6 µL aliquots were incubated onto Formvar-coated copper grids (Ernest F. Fullam, Inc., Latham, 
NY) for 2 min, washed five times with 6 µL of deionized water, and then negatively stained for 1 
min with 2% uranyl acetate. Samples were imaged using a Philips CM10 Transmission Electron 
Microscope. 
 
3.3. Results and Discussion 
3.3.1. 19F NMR Sensitively Measures Monomer Consumption During Aggregation 
 To study fibril formation using 19F NMR, I synthesized a 19F-labeled IAPP (IAPP-
tfmPhe23) in which Phe23 is substituted by tfmPhe. Phe23 is solvent exposed in the unstructured 
monomeric peptide (19, 51), but is believed to be become buried when the peptide forms 
aggregates (3, 19, 52, 53). The 19F chemical shifts and line-widths of the trifluoromethyl groups 
should change significantly as the peptide changes its secondary structure and oligomerization 
state, as has been observed for other fluorinated peptides and proteins (39-41). In particular, if 
oligomeric intermediates on the amyloid-forming pathway accumulate to an appreciable extent 
they should be detectable by NMR, provided they are not so large that their line-widths are 
broadened excessively, as is the case for amyloid fibers (21). Furthermore, the 19F signal is 
sufficiently sensitive to monitor peptide aggregation at low concentrations that allows a direct 
comparison with other methods for following aggregation such as CD or fluorescence 
spectroscopy (Figure 3.1).  
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Figure 3.1. Cartoon showing the sensitivities of each method. 
 
 
 The sensitivity of the 19F chemical shift of the tfmPhe23 group to changes in environment 
was investigated by examining the 19F spectra in different environments (Figure 3.2). A 
detectable change was noticed for almost all changes in environment, including a substantial 
change in the chemical shift in urea, even though IAPP is considered to be natively unfolded 
(51). 
 The consumption of monomeric IAPP-tfmPhe23 (initial concentration 85 µM in 20 mM 
sodium phosphate, 50 mM NaCl pH 7.3) during amyloid fibrillogenesis was monitored by 19F 
NMR (Figure 3.3).  The monomeric peptide exhibits a single sharp peak near 14.7 ppm in the 
NMR spectrum. As expected, the signal intensity due to the monomeric peptide decreased in 
intensity over time in the characteristic sigmoidal manner observed in many studies of amyloid 
fiber formation (54-56). No signal was observed due to the large amyloid fibers as the peaks are 
broadened beyond detection.  To determine the sensitivity of this method, the rate of monomer 
consumption was detected by measuring changes in 19F NMR signal intensity changes at three 
different temperatures: 10, 25 and 37 °C (Figure 3.3).  As expected, both the lag time and 






Oligomers Large Oligomers Amyloid Fibrils
Structure Change by CD
Fibril structure (image) by TEM 
Monomeric peptides
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temperatures (37 °C) and accelerated aggregation rates, I was able to monitor monomer 
consumption during aggregation efficiently using this technique 
 
Figure 3.2. Environmental sensitivity of the tfmPhe23 group. 19F NMR spectra of IAPP-tfmPhe23 were 
acquired under various conditions after 5 minutes of incubation at 25 °C: (a) 20 mM sodium phosphate, 
50 mM NaCl, 10% D2O, pH 7.3 (b) 90% D2O, 20 mM sodium phosphate, 50 mM NaCl, pH 7.3 (c) 100 
μM HCl, 10% D2O, pH 4 (d) 8M Urea, 10% D2O  (e) 100 mM SDS, 20 mM sodium phosphate, 20 mM 
NaCl, 10% D2O, pH 7.3, (f) 90% DMSO, 10% D2O. Spectra were referenced to an external TFE standard 
(in solution of 20 mM Pi, 50 mM NaCl, pH 7.3) at 0 ppm.  




Figure 3.3. Kinetics of the disappearance the IAPP-tfmPhe23  monomer followed by 19F NMR. (a) 
Stacked plots of 19F NMR spectra (TFE = 0.0 ppm). The experiment was conducted at 10 °C (left), 25 °C 
(center), and 37 °C (right) at pH 7.3 (b) Plots of peak intensity of the main resonance from (A) as a 
function of time. Solid lines represent sigmoidal fits to the 19F data. (C) Contour plot of the 19F NMR 
spectra at 37 °C showing the absence of new peaks. 
 
 
3.3.2. IAPP-tfmPhe23 Forms Fibers from Monomers without Accumulation of Non-
fibrillar Intermediates  
 No additional peaks were observed in the 19F spectrum of the peptide during the time-
course of the experiment, even at 10 °C where fibril formation is slowest (Figure 3.3). The 
position of the main resonance also did not change over the course of the experiment (Figure 
3.3c), consistent with fluorescence studies that show Phe-23 remains exposed during the lag-
phase of aggregation (19). It was also confirmed that tfmPhe23 is actually sensitive to the 
formation of small oligomers, were they to be formed in significant concentrations by cross-
linking IAPP-tfmPhe23 with EDC/sulfo-NHS (58). In contrast to IAPP-tfmPhe23 alone, 
a)
b) c)
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additional peaks can clearly be seen downfield of the main peak when IAPP-tfmPhe23 is 
incubated with various concentration of EDC/sulfo-NHS (Figure 3.4). The intensity of the 
additional peaks increase with time as the main peak decreases, confirming its presence is the 




Figure 3.4. Changes in the 19F spectra of IAPP-tfmPhe23 upon cross-linking. (a, b) Intensity change 
with time of the main peak at 14.73 ppm and the second peak at 14.76 ppm with 40 mM (a) and 10 mM 
(b) EDC/Sulfo-NHS. (c) Superposition of the first and final spectra of IAPP-tfmPhe23 with 40 and 10 
mM EDC/Sulfo-NHS. The position of the second peak at 14.76 ppm is indicated by an arrow. 
 
   
 It is also important to note that even if an oligomer population is not directly detectable 
by 19F NMR because it is either structurally inhomogeneous (which would broaden the signal), 
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too large to be detected by NMR, or the IAPP-tfmPhe23 19F NMR shift is unaffected by 
oligomerization, it still may be indirectly detected by a comparison of the monomer loss curves 
observed by 19F NMR and the ThT and CD measurements of amyloid formation. If large 
oligomers or undetectable oligomers accumulate to a significant extent, a delay between the 
disappearance of monomer (as measured by NMR) and the appearance of fibrils (as measured by 





Figure 3.5. Comparison of the rates of monomer consumption and fiber formation (a) Overlay of 
kinetic traces from 19F NMR (black), ThT fluorescence (red) at 37 °C. Error bars indicate S.E.M. (n=4). 
(b) Overlay of kinetic traces from obtained 19F NMR (black), ThT fluorescence (red), and CD (blue) at 25 
°C. Error bars indicate standard error of measurement (n=4 for NMR and CD and n=5 for ThT). The close 
correspondence between the curves suggests fiber formation closely follows monomer consumption at 25 




To test this possibility, I followed the aggregation of similarly prepared samples of IAPP-
tfmPhe23 by ThT fluorescence, CD spectroscopy, and 19F NMR (Figure 3.5, parameters from the 
sigmoidal fit can be found in Table 3.1). The rate of monomer consumption of IAPP-tfmPhe23 
closely matches the rate of amyloid formation when performed under identical buffer and peptide 
concentrations at 25 and 37 °C (Figure 3.5). The ThT and NMR curves match well at 37°C 
(t1/2=18.8±0.8 and 16.8±1.6, respectively, p=0.30) and the CD and NMR curves match very 
	   61 
closely at 25°C (t1/2=91.8±6.3 and 91.9±3.1, respectively, p=0.99). A relatively small (in this 
context) but statistically significant (p=0.02) difference was observed between the ThT and 
NMR curves at 25 °C (t1/2=64.3±6.9 and 91.9±3.1, respectively). This small difference in the 
kinetics between the two measurements may be caused by differences between the shape and 
size of the NMR tube and fluorescence cuvette, as interactions between sample and container 
surfaces are known to nucleate amyloid formation (60-62). This difference is magnified at the 
slower nucleation rates occurring at lower temperatures (60).  
 
 
Table 3.1. Parameters from the sigmoidal fit of Figure 3.5. 
 
The fact that the NMR, CD, and ThT curves closely track each other suggests the 
monomeric peptide is converted into a large, mostly β-sheet, ThT-reactive species without the 
substantial accumulation of non-fibrillar intermediates. The absence of a substantial population 













25°C t1/2 dx 
ThT 64.3±6.9 17.4±1.3 
NMR 91.9±3.1 24.9±1.4 
CD 91.8±6.3 22.8±1.4 
   
37°C t1/2 dx 
ThT 18.8±0.8 4.2±0.2 
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has been observed for many other amyloidogenic proteins (17, 63, 64). For example, many 
intermediate species are formed during the aggregation of Aβ, including a distinct α-helical 
intermediate (12, 17, 63-65). Systems that are known to have non-fibrillar oligomeric 
intermediates typically show a much larger difference in rates of monomer depletion and fiber 
formation.  For example, the midpoints of the monomer consumption and fiber formation curves 
of Aβ can differ by an order of magnitude (17). Similarly, monomer consumption and fiber 
formation curves of the curli protein CsgA differ by a factor of 2 (22). The correspondence 
between the curves suggests any transient oligomers that are formed by IAPP-tfmPhe23 
comprise only a minor population of the total at any given point in time. 
The close coincidence of the midpoints of aggregation determined by the 19F NMR and 
the ThT and CD measurements impose fairly stringent requirements on the type of non-fibrillar 
oligomers that can be formed. However, the data do not distinguish between certain kinetic 
mechanisms. For example, our data cannot exclude the presence of large, off-pathway oligomers 
whose concentration does not change appreciably in the lag-phase of aggregation (15, 16). In 
addition, transient oligomers that do not accumulate to a significant extent will not be observed 
in the experiment (16).  
Transmission electron microscopy (TEM) images acquired at the mid- and end-points of 
aggregation also support this conclusion (Figure 3.6). Images taken at the mid-point of 
aggregation show fibers that are similar in morphology to those found at the end-point but with a 
smaller density of fibers on the grid (Figure 3.6b). Non-fibrillar aggregates large enough to be 
resolved in the TEM image, such as the spherical and annular intermediates frequently detected 
for α-synuclein and Aβ and implicated in toxicity, are noticeably absent (7, 65).  
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Figure 3.6. TEM images of IAPP-tfmPhe23 after ½ (a) and complete (b) depletion of the 19F signal 
intensity at 25 °C. Scale bars represent 500 nm. 
 
 
3.3.3. 19F NMR Measurement of the Interaction of Polyphenolic Inhibitor, EGCG with 
IAPP without Interference from External Probe, ThT  
 Having demonstrated the utility of 19F NMR to follow the kinetics of amyloid formation, 
the technique was used it to investigate the mechanism by which EGCG (Figure 3.7a) inhibits 
IAPP-tfmPhe23 amyloid formation.  EGCG is the most abundant catechin found in tea and is a 
potent antioxidant, making it a potential therapeutic for many disorders. It has been reported that 
EGCG inhibits fiber formation in vitro for many amyloidogenic proteins including Aβ, α-
synuclein, and polyglutamine peptides (66-71). Meng et al recently showed that EGCG not only 
inhibits IAPP amyloid formation effectively but is one of the few small molecule compounds 
that also disaggregates IAPP amyloid fibrils in vitro (68). However, the mechanism of inhibition 
by EGCG is not known for IAPP (68). Optical measurements of fiber inhibition by EGCG and 
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other polyphenols are complicated by the background signal from these compounds and, 
potentially, by competitive binding with extrinsic probes like ThT (67, 72-75). In contrast, 
measurements of the rate of monomer consumption by 19F NMR are easily quantified and are not 
affected by the nature of the inhibitor. 
 The kinetics of IAPP-tfmPhe23 aggregation were studied in the presence of 0.2, 0.5, 1.0, 
and 5.0 molar equivalents of EGCG by 19F NMR and ThT fluorescence (Figure 3.7b and c).  It is 
apparent from both the 19F and ThT measurements that EGCG inhibits fiber formation in a dose-
dependent manner.  However, a comparison of the data in Figures 3.7b and 7c reveals some 
important differences between the ThT and 19F NMR measurements of the apparent effects of 
EGCG. When IAPP is incubated with an excess of EGCG (green lines in Figures 3.7b and c), the 
ThT assay shows a complete inhibition of fiber formation while the 19F NMR measurement 
shows a slow but steady decrease at longer time-periods. This delay between the disappearance 
of monomer and the appearance of fibrils is consistent with the production of large non-fibrillar 
aggregates that are not fluorescent when incubated with ThT (66).  
 
 
Figure 3.7. EGCG inhibits IAPP-tfmPhe23 amyloid fibrillogenesis (a) Structure of EGCG.  (b, c) 
Time course for peptide aggregation followed by 19F NMR (b) and ThT fluorescence (c) of IAPP-
tfmPhe23 alone (85 µM, black) and at 1:5 (red) 1:2 (blue), 1:1 (magenta), 5:1 (57) molar ratios of EGCG 
to IAPP at pH 7.3, 37°C. Solid lines represent sigmoidal fits to the 19F data. 100 µM ThT is present in the 
ThT samples (c) but is absent in the NMR samples (b).  
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This interpretation is supported by the analysis of TEM images taken at the end-points of 
aggregation, which show the appearance of large non-fibrillar aggregates at higher 
concentrations of EGCG but with a greatly reduced density of fibers (Figure 3.8). However, the 
TEM images are not definitive by themselves as EGCG by itself polymerizes over time to form 
aggregates with a similar morphology as the aggregates seen in Figure 3.8 (Figure 3.9) (17). 
While the delay between the disappearance of monomer and the appearance of fibrils is 
indicative of the formation of large non-fibrillar aggregates, sub-stoichiometric amounts of 
EGCG shift the 19F NMR curve to later times relative to ThT measurements (blue and pink 
curves in Figure 3.7b and 3.7c, 0.5 and 1 equivalent of EGCG respectively). This result seems to 
imply that the monomer disappears after the appearance of fibrils at low concentrations of 
EGCG.  This apparent contradiction is most likely due to interfence by EGCG with ThT binding 
assay as discussed below.  
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Figure 3.8. TEM images of IAPP-tfmPhe23 aggregation as a function of EGCG concentration. TEM 
images after the complete depletion of the 19F signal for IAPP-tfmPhe23 in the presence of (a) 0.2 eq, (b) 
0.5 eq, (c) 1.0 eq, and (d) 5.0 eq of EGCG in the absence of ThT. Scale bars represent 500 nm. 
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Figure 3.9. TEM images of aggregate formation by EGCG in the absence of IAPP-tfmPhe23. (a) 
phosphate buffer alone (20 mM Pi, 50 mM NaCl, pH 7.3), (b) 425 µM EGCG in phosphate buffer, and (c) 
425 µM EGCG with 100 µM THT in phosphate buffer. Samples were incubated for 3 hours at 37 °C 
before acquisition. Scale bars represent 500 nm. 
 
 
3.3.4. ThT and EGCG Competitively Bind to IAPP Fibers 
 In Figure 3.7, 100 µM ThT is present during the ThT assay but not in the NMR 
measurements. To determine more accurately the effect of ThT on EGCG inhibition, we first 
determined if ThT by itself has any effect on amyloid aggregation. The rate of disappearance of 
monomer was not significantly changed by the presence of ThT (Figure 3.10), indicating that 
ThT by itself does not affect the kinetics of fiber formation.   
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Figure 3.10. Effect of ThT for amyloid fiber formation (a) Overlay of kinetic traces from 19F NMR 
(black: 0 µM ThT and red: 100 µM ThT) and ThT fluorescence (blue: 100 µM ThT). Solid lines represent 




 However, although ThT has little effect on the rate of monomer depletion on its own, it 
may indirectly influence the rate of aggregation by significantly attenuating the inhibitory effect 
of EGCG.  If ThT competes for the same binding site as EGCG on the amyloid fiber, the 
decrease in the amount of bound EGCG in the ThT assay would be reflected in lower levels of 
inhibition. This effect would not be observable when EGCG is in great excess of ThT (green 
lines Figure 3.7b and 3.7c).   
 To check for this possibility, the 19F measurements were performed using the same 
concentration of ThT as in the ThT assay (100 µM, Figure 3.11). In samples with EGCG, the 
addition of ThT causes a substantial shift of the NMR curves to earlier times, indicating 
monomer depletion happens at a faster rate in samples with EGCG when ThT is present (Figure 
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3.11). This shift is not observed in samples without EGCG. This finding indicates that while ThT 
has little effect on the rate of aggregation by itself, it significantly attenuates the inhibitory effect 
of EGCG, consistent with ThT effectively competing with EGCG for binding to IAPP fibrils.  
Similarly, the observation that high concentrations of EGCG prevent amyloid fiber formation 
(Figure 3.7c) may be attributed to effective competition of EGCG for ThT binding sites when it 
is in sufficient excess over ThT.  
 
 
Figure 3.11. Competition for amyloid binding between ThT and EGCG (a) Overlay of kinetic traces 
from 19F NMR (black: 0 µM ThT and red: 100 µM ThT) and ThT fluorescence (blue: 100 µM ThT) in the 
presence of 1 equivalents of EGCG to peptide. Solid lines represent sigmoidal fits to the 19F data. (b) t1/2 
from kinetic traces. (a). (c) Kinetic traces obtained under the same conditions as (a) but performed in the 
presence of 0.5 equivalents of EGCG. (d) t1/2 from kinetic traces (c). (e) Cartoon schematic of competitive 
binding effect between ThT and EGCG. 
	   70 
3.3.5. EGCG Diverts Amyloid Aggregation to Non-fibrillar Aggregates  
 Given the many proposed modes of action of polyphenolic compounds against 
amyloidogenic proteins, it is difficult to determine the precise mechanism by which EGCG 
inhibits IAPP amyloid formation. The chemical shift of IAPP-tfmPhe23 was unchanged by the 
presence of either EGCG or ThT, indicating neither compound binds to the monomeric peptide, 




Figure 3.12. EGCG and ThT do not likely interact with monomeric IAPP-tfmPhe23. 19F NMR 
spectra of (a) IAPP-tfmPhe23 alone, (b) IAPP-tfmPhe23 with 85 µM EGCG, (c) with 100 µM THT (c). 
Spectra were acquired at pH 7.3, 37°C after 5 minutes of incubation. 
 
  
 As shown in Figure 3.11, competition between EGCG and ThT introduces significant 
artifacts when the ThT concentration is close to the peptide concentration.  This is an important 
observation, because ThT is commonly used at relatively high concentrations in aggregation 
studies.  However, when the concentration of ThT was lowered to 10 µM, competition between 
ThT and EGCG was lessened and it was possible to obtain accurate results for both the rate of 
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the monomer is almost completely consumed in the presence of EGCG during the lag-time 
before the formation of fibers (Figure 3.13). This result is in striking contrast to the kinetics 
observed in the absence of EGCG, where fiber formation and monomer consumption occur 
virtually simultaneously.  
 
 
Figure 3.13. Competition between ThT and EGCG is decreased at lower ThT concentration. 
Overlay of kinetic traces from 19F NMR (black: 0 µM ThT and red: 10 µM ThT) and ThT fluorescence 
(blue: 10 µM) with 1eq. of EGCG. Solid lines represent sigmoidal fits to the 19F data. 
 
 
 The delay between monomer consumption and fiber formation suggests that EGCG 
stabilizes the formation of non-fibrillar aggregates that are too large to be detected by NMR (66). 
To test this possibility, the reverse reaction was examined by testing the ability of EGCG to 
disaggregate IAPP-tfmPhe23 amyloid fibrils using 19F NMR and ThT fluorescence. As Figure 
3.14 shows, the addition of a 5-fold molar excess of EGCG after the formation of IAPP amyloid 
fibrils caused a significant decrease in ThT fluorescence suggestive of the breakup of fibrils.  
However, no signals due to IAPP-tfmPhe23 were observed by 19F NMR after the addition of 
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EGCG (Figure 3.14), as would be expected if the fibers were completely broken up by EGCG to 
the monomeric peptide or small oligomers. An examination of the TEM images of supports this 
conclusion (Figures 3.15). TEM images taken at the end-point of aggregation show small 
aggregates that are much shorter in length (Figures 3.15 b) than the regular fibers formed by 
IAPP (Figures 3.15 a) that are similar to those found with Aβ and α-synuclein incubated with 
EGCG.  Instead of stabilizing the monomeric state, EGCG apparently diverts aggregation of 
IAPP towards large oligomers with a different morphology than the amyloid fiber (Figure 3.16). 
In this respect, the interaction of EGCG with IAPP is similar to many but not all amyloidogenic 




Figure 3.14. Disaggregation of amyloid fibrils due to the addition of EGCG (a) Kinetic traces from 19F 
NMR (black) and ThT fluorescence (red) measurements at 37 °C. Disaggregation of amyloid fibril 
formation was complete by the addition of 5 equivalents of EGCG at the time point indicated. Solid lines 
represent sigmoidal fits to the 19F data. 
 




Figure 3.15. EGCG disrupts preformed fibers of IAPP-tfmPhe23. TEM images acquired just before 
the addition of 5 equivalents of EGCG to preformed fibers of IAPP-tfmPhe23 (a) and after complete 





Figure 3.16. Cartoon schematic of disaggregation of amyloid fiber due to the addition of EGCG. 
EGCG disaggregates amyloid fiber to incompletely into large oligomers but not fully into monomeric 
peptides. 
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3.4. Conclusion 
These studies demonstrate the utility of using 19F NMR to follow fibrillogenesis in real-
time by observing the rate of monomer consumption. Most of the methods typically used for 
monitoring the kinetics of aggregation measure the rate of appearance of the final product. By 
providing an additional independent measurement of the starting material, 19F NMR can help 
distinguish between alternative pathways of aggregation, a task that is difficult to accomplish by 
other methods. Since fluorine is not found in most biological systems, there is no competition 
from background signals, a problem that often afflicts measurements using 1H, 13C, and 15N 
NMR.  The absence of a fluorophore simplifies detection and analysis of amyloid formation by 
other techniques.  Therefore, the use of 19F NMR should be applicable for automated screening 
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Resolution of Oligomeric Species during the Aggregation of Aβ1-40 Using 19F NMR 
 
4.1. Introduction 
 The work described in this chapter is currently in preparation for publication. The co-
authors were very helpful in conducting this research and analyzing the results. Numerous 
suggestions and guidance on experiments came from Dr. Jeffrey R. Brender and Prof. 
Ayyalusamy Ramamoorthy. I also would like to thank Dr. Janarthanan Krishnamoorthy for 
expertise for NMR experiments, Molly Soper and Prof. Brandon Ruotolo for expertise and 
analysis of the ESI-IMMS, and Dr. Yunlong Zhou and Prof. Nicholas Kotov for expertise and 
use of the AFM microscopy.  
 The accumulation of misfolded proteins is a common pathological feature of a number of 
human disorders, including neurodegenerative disorders such as Alzheimer’s disease and 
Parkinson’s disease and several metabolic diseases such as type II diabetes. Under pathological 
conditions, the soluble precursor form of these proteins is triggered to self-assemble into amyloid 
fibers (Figure 1.8 and 1.9) (1). These are long, linear and often twisted structures a few 
nanometers in diameter and many nanometers in length (2). The morphologies of amyloid fibers 
show a characteristic cross-β sheet X-ray diffraction pattern indicating a cross β-sheet 
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conformation of β-sheets running perpendicular to the fibril axis (2, 3).  
 In Alzheimer’s disease, the amyloid plaques are largely composed of the Aβ peptide. Aβ 
peptides are derived from proteolytic cleavage of the amyloid precursor protein (APP) to 
produce peptides varying from 36-43 amino acids in length, of which Aβ1-40 is the most common 
(4). Because pathogenic mutations in the APP lead to early onset versions of Alzheimer’s 
diseases and aggregated forms of Aβ1-40 are toxic in vivo and also to some extent in mouse 
models, Aβ plaque formation has been proposed to be the ultimate upstream cause of 
Alzheimer’s disease (amyloid cascade hypothesis) (5-7). The process of amyloid formation has 
been repeatedly shown for multiple amyloidogenic proteins to disrupt the regular function of 
tissue. Unfortunately, how this occurs has been obscured by our lack of knowledge about the 
aggregation process itself (4). In particular, identifying potentially toxic species in Aβ has been 
difficult because of the heterogeneity of the samples and inter-conversion among species (8). 
NMR is an attractive method for following the reaction in real-time because of the strong 
relationship between chemical shift and peptide structure. However, applications of real-time 
NMR to amyloid formation have been limited (9, 10). This is largely due to the complexities of 
one dimensional 1H spectra and the difficulties in obtaining multidimensional spectra within the 
aggregation time-frame.  
 19F NMR is an attractive alternative because of the excellent sensitivity of the 19F nucleus 
to small changes in conformation. The high sensitivity of 19F chemical shift to the chemical 
environment enables the use of simple 1D spectra to detect the changes of protein conformations 
(11-19). In addition, fluorine is extremely rare in biological systems so that there is no 
competition from background signals, a problem that often afflicts measurements of the most 
commonly used nuclei including 1H, 13C, and 15N. This advantage also allows difficult studies 
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including those involving multiple protein complexes as well as in vivo applications, where 
signals from protein of interest are often attenuated in other NMR techniques. 
 In chapter 3, I used this approach to study the oligomerization of IAPP, an amyloidogenic 
polypeptide implicated in β-cell death in type II diabetes (20). 19F NMR showed aggregation of 
IAPP is essentially an all-or-nothing event; monomeric IAPP is rapidly converted to fibrillar 
IAPP without the buildup of intermediates detected by 19F NMR. This finding is in agreement 
with other studies of IAPP aggregation, which show small oligomers of less than 100 kDa do not 
build up to an appreciable extent during aggregation (21-23).  
 By contrast, many off- and on-pathway oligomeric intermediates of Aβ have been 
isolated both in vitro and in situ from tissue samples of Alzheimer’s patients. Characterization of 
these oligomeric species is particularly important as a current hypothesis holds that small to 
intermediate size (~5−6 nm in diameter) oligomers may be responsible for much of the toxicity 
of amyloid proteins (24, 25). In this chapter, I have demonstrated 19F NMR real-time 
measurements to investigate the formation of small oligomeric intermediates during the 
formation of amyloid fibers from Aβ1-40. 
 
4.2. Experimental Procedures 
4.2.1. Synthesis of Fmoc-L-trifluoromethionine 
 The synthesis of Fmoc-L-homocysteine (Fmoc-hCys-OH) was based on a modified 
version of the procedure of Jiang et al (26). Bis-L-homocysteine was purchased from Toronto 
Research Chemicals Inc. A dioxane solution of Fmoc N-hydroxysuccinimide ester (Fmoc-Osu) 
was added dropwise with vigorous stirring into L-homocysteine in 10% w/v NaHCO3 (aq) 
overnight. After adjustment of the pH to 4 using citric acid, dioxane was removed under reduced 
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pressure followed by extraction with ethyl acetate (3x). The ethyl acetate layers were combined, 
dried over anhydrous sodium sulfate, and evaporated under reduced pressure to yield the 
product. It was then dissolved into a Dimethylformamide (DMF)/H2O solution followed by the 
addition of 1.5 eq. of tris(2-carboxyethyl)phosphine (TCEP), and the reaction mixture stirred 
overnight. DMF was then removed under reduced pressure and the aqueous solution was 
extracted with ethyl acetate (3x) to yield pure product. The overall yield for the two steps was 60 
% without any purification step. The analytical data for Fmoc-hCys-OH matched as previously 
reported (26, 27). 
 Fmoc-L-trifluoromethionine (Fmoc-tfMet-OH) was then synthesized from Fmoc-hCys-
OH using the procedure developed by Togni and his colleagues (28). Togni reagent (1-
Trifluoromethyl-3,3-dimethyl-1,2-benziodoxole) was purchased from TCI America. Briefly, a 
solution of Fmoc-L-homocysteine in methanol was cooled to -78 °C, and then 1 eq of Togni 
reagent was added dropwise with vigorous stirring. After completion of reaction overnight, the 
reaction mixture was dried under vacuo and purified by flash chromatography to yield desired 
product. The analytical data for Fmoc-tfMet-OH matched as previously reported (29).  
 
4.2.2. Peptide Preparation 
 Aβ1-40-tfMet35 peptide was synthesized manually by solid-phase Fmoc-based chemistry 
using a dimethoxybenzyl (Dmb) dipeptide, Fmoc-Val-(Dmb)Gly-OH (at position 36 and 37), to 
disrupt aggregation during synthesis. Fmoc-tfMet-OH was substituted for Met at position 35. 
The peptide was cleaved from the resin using 92.5 % TFA, 2.5 % H2O, 2.5 % ethanedithiol, and 
2.5 % anisole. The crude peptide was dissolved in 20 % acetic acid (v/v) and the purified by 
reverse-phase HPLC using a Waters semi-preparative C18 column equilibrated in 0.045% HCl. 
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The peptides were eluted with a linear gradient of 0% to 80% acetonitrile at a flow rate of 10 
ml/min. The identity of the target fraction was confirmed using MALDI-MS, which gave 
corresponding to the correct mass of 4384. 
 
4.2.3. Sample Preparation 
 To remove preformed aggregates, the purified peptide was dissolved in 2 % ammonium 
hydroxide followed by removal of the solvent by lyophilization. The lyophilized peptide was 
first dissolved in 1 mM NaOH and sonicated for 15 min. The peptide solution was then buffered 
into 20 mM sodium phosphate (pH 7.4) and 10% D2O to final peptide concentrations. The 
sample solution was then passed though a 0.22 µm filter immediately before the start of each 
experiment.  
 
4.2.4. 19F NMR Spectroscopy 
 All 19F NMR experiments were performed using a Varian VNMRS 500 MHz NMR 
spectrometer equipped with a double-resonance 1H 19F probe. 5 mm Shigemi NMR tubes 
(Shigemi Inc, BMS-005V) were used for this study. A series of 19F spectra were recorded 
without spinning immediately after filtration of sample at 37 °C as described above. For time 
course experiments, each 19F spectrum was obtained from 512 scans with a 1.0 s recycle delay 
between each transient. To measure solvent isotope-induced changes in chemical shifts, samples 
were first prepared with 10% D2O in PBS (pH 7.4) and measured as mentioned above. The 
samples were then diluted with D2O to prepare 70% D2O samples. 19F chemical shifts are 
referenced to 100 µM trifluoroethanol (TFE) at 0 ppm, and 19F signal intensity was normalized to 
TFE. A line broadening of 2.0 Hz was used to process the final spectra. Origin 8.5 and 
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Mestrenova were used for plotting the data.  
 The hydrodynamic radius of the initial conformation of the 46 µM sample was 
approximated by the measuring the diffusion constant of the corresponding resonance by 
diffusion ordered spectroscopy (DOSY). 19F DOSY experiments of the 19F nucleus were carried 
out using the gradient-compensated stimulated echo (GCSTE) sequence with squared gradient 
pulses of constant duration (2 ms) and a variable gradient amplitude along the longitudinal axis 
(30). Other experimental parameters include a 90° pulse width of 9.5 µs, a gradient stabilization 
delay of 0.5 ms, a stimulated-echo delay of 50 ms, a recycle delay of 0.5 s, and a spectral width 
of 25.51 kHz. Radio frequency pulses were phase cycled to remove unwanted echoes. 2048 
transients were collected for each gradient and 10 gradients were used for each sample for a total 
experimental time of approximately 6 hours. The stability of the sample was confirmed by 
comparison of the 19F spectra at the beginning and end of the DOSY experiments. All spectra 
were processed with 3 Hz exponential line broadening prior to Fourier transformation. The 
diffusion coefficients were determined from the slope of a log plot of the intensity as a function 
of gradient strength using the Stejskal-Tanner equation (31). The hydrodynamic radius was then 
calculated from the diffusion coefficient using the Einstein-Stokes relation and the viscosity of 
water at 25 °C. 
 
4.2.5. Circular Dichroism 
 CD measurements were performed with an Aviv 62DS spectropolarimeter using a 0.1 cm 
pathlength cell. Samples were prepared as described above for the NMR samples. Molar CD per 
residue values were calculated using ε= θobsd/(3298lcn) where θobsd is the ellipticity measured in 
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millidegrees, c is the molar concentration, l is the cell path length in centimeters, and n is the 
number of residues in the peptide. 
 
4.2.6. Atomic Force Microscopy 
 Aliquots were directly taken from sample prepared as described above on SiO2 substrates 
at the time-points indicated. This sample was diluted five times before use. Samples were imaged 
using a Nanoscope III (Digital Instruments/Veeco Metrology Group).  
 
4.2.7. Electrospray Ionization Ion Mobility Mass Spectrometry  
 Protein ions were generated using a nESI source and optimized to allow transmission of 
noncovalent protein complexes unless stated otherwise. Nanoflow electrospray capillaries were 
prepared in-house as previously described (32). To generate protein complex ions, an aliquot of 
the sample (ca. 5 µL) was sprayed from the nESI emitter using capillary voltages ranging from 
1.4 – 1.6 kV, with the source operating in positive ion mode and the sample cone operated at 20 
V. The mass spectra were acquired with the following settings and tuned to avoid ion activation 
and preserve non-covalent protein–ligand complexes. The bias voltage was 40 V, with backing 
pressure at 5.39 mBar and ToF pressure at 9.74 × 10-7 mBar. The traveling-wave IM separator 
was operated at a pressure of approximately 3.5 mbar of nitrogen and helium. Mass spectra were 
calibrated externally using a solution of cesium iodide (100 mg/mL) and analyzed using 
Masslynx 4.1 and Driftscope 2.0 software (Waters). Samples were prepared by mixing an aliquot 
of the NMR sample with 100 mM ammonium acetate at pH 7.0 at 1:1 ratio followed by filtration 
through a 100 or 30 kDa membrane as described. 
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4.3. Results 
4.3.1. Design and Synthesis of Aβ1-40-tfMet35 
To study the process of Aβ aggregation using 19F NMR, a 19F-labeled Aβ1-40 peptide 
(Aβ1-40-tfMet35) was synthesized in which Met-35 was replaced by tfMet 7 (Figure 4.1). Met-35 
was chosen as a probe site because a fluorine nucleus on the flexible side-chain of Met 
undergoes additional motional averaging compared to other more rigid, fluorinated amino acids 
like tfmPhe 2. The additional flexibility of the tfMet side-chain is important as the motional 
averaging contributes to a smaller effective rotational correlation time, which increases the 




Figure 4.1. Preparation of Aβ1-40-tfMet35 (a) Synthesis of Fmoc-tfMet-OH. (b) Sequence of Aβ1-40-
tfMet35. tfMet replaces Met35 in Fmoc-based peptide synthesis. 
 
 
To construct the Aβ1-40-tfMet35 peptide, Fmoc-tfM-OH was first synthesized with the use 
of Togni reagent for trifluoromethylation as shown in Figure 4.1 (28). This optimized synthetic 
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for racemization. Aβ1-40-tfMet35 peptide was then synthesized using an optimized Fmoc 
procedure with Fmoc-tfMet-OH. The 19F chemical shifts and line-widths of the trifluoromethyl 
groups should change significantly as the peptide changes either its secondary structure or 
oligomerization state, as has been observed for other fluorinated peptides and proteins (20). In 
particular, if oligomeric intermediates on the amyloid-forming pathway accumulate to an 
appreciable extent they should be detectable by NMR, provided they are not so large that their 
line-widths are broadened excessively, as is the case for amyloid fibers (9).  
 
4.3.2. Aβ1-40-tfMet35 reversibly forms oligomers immediately after preparation at high 
concentration 
 Recent studies have shown that the pathway of Aβ1-40 amyloid formation is strongly 
dependent on the initial concentration (33, 34). To examine these differences, two samples of 
Aβ1-40-tfMet35 were prepared at concentrations of 46 µM and 182 µM and their aggregation 
followed in parallel. The 19F NMR spectra of both samples immediately after preparation are 
shown in Figure 4.2. Both spectra show a single intense resonance at 35.85 ppm (Figure 4.2a, b), 
which DOSY experiments show corresponds to a species with a hydrodynamic radius of 1.28 nm 
(Figure 4.2c). This value is nearly identical to previous values obtained for non-aggregated Aβ1-
40 in buffer (1.29 nm) and in NaOH (1.32 nm) (35) and similar to single molecule measurements 
of monomeric  Aβ1-40 (0.9 nm) (36). The main resonance in the 19F spectra at the initial time 
point therefore is very likely to correspond to the monomeric peptide in both samples. 
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Figure 4.2. Characterization of Aβ1-40-tfMet35 immediately after preparation. (a, b) 19F NMR spectra 
of (a) 182 µM and (b) 46 µM samples of  Aβ1-40-tfMet35. A small additional peak not present in the low 
concentration sample is marked with an asterisk.  (c) 19F DOSY experiment of 46 µM immediately after 
preparation. (d) 19F spectra following dilution from 182 (black) to 45 µM (red) 19F signal intensities are 
normalized to an internal TFE standard. (e) CD spectra of 182 µM and 46 µM Aβ1-40-tfMet35 at the initial 
time-point and the influence of filtration and dilution to 46 µM on the 182 µM sample. (f, g) AFM images 
of 46 µM (f) and 182 µM (g) samples of Aβ1-40-tfMet35 on SiO2 substrates at the initial time-point. 
f)
1 μm 1 μm
g)
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e)
c) d)
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 However, differences in the two samples are apparent even at this initial time point. Rod-
like short protofibers can be seen at the initial time-point in atomic force microscopy (AFM) 
images of the high concentration sample (Figure 4.2g) while they are conspicuously absent in the 
low concentration sample (Figure 4.2f). Consistent with this finding, the high concentration 
sample shows a strong β-sheet component in the CD spectrum, as expected of protofibers (Figure 
4.2e).  However this signal is absent in the low concentration sample. The change in the CD 
spectra after filtration through 100 KDa cutoff membrane in the high concentration sample 
confirmed the β-sheet component arises from larger oligomers (Figure 4.2e).  The presence of 
large oligomeric species at the initial time point can also be indirectly inferred from the 19F 
spectra (Figure 4.2d). The intensity of the 182 µM sample is 44% less than the 46 µM sample 
after normalization for concentration, consistent with the formation of large, NMR-invisible 
protofibers which give rise to the β-sheet CD spectra and are observed in the AFM images. 
Perhaps surprisingly in light of the large thermodynamic favorability of β-sheet formation in 
amyloid fibers (36), oligomer formation of this type appears to be reversible. The CD spectrum 
after dilution from 182 µM to 46 µM reverts to a largely random coil conformation (Figure 4.2e) 
and the normalized intensity increases upon dilution (Figure 4.2d). Similarly, a small additional 
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4.3.3. Early time evolution of Aβ1-40-tfMet35 aggregation monitored by 19F NMR, CD, and 
AFM 
 The time evolution of the 19F NMR spectra of Aβ1-40-tfMet35 is noticeably different than 
the two-state kinetics seen for IAPP-tfmPhe23 as described in chapter 3 (20). Figures 4.3, 4.4, 
and 4.5 show peak intensity as a function of time for both samples. The singlet at 35.85 ppm in  
Figure 4.3 (the red dots in Figure 4.5) represents the monomeric peptide. In both the high and 
low concentration samples, the monomer concentration drops exponentially without a noticeable 
lag phase (10). This behavior is quite different from the behavior observed for IAPP-tfmPhe23. 
In IAPP-tfmPhe23, the kinetics for monomer consumption were sigmoidal; the intensity of the  
IAPP-tfmPhe23 monomer peak remained constant for a significant lag phase before dropping 
sharply (20). The sigmoidal kinetics observed for monomer depletion by 19F NMR reflected the 
kinetics of fiber formation, with close correspondence between the rate of monomer depletion 
measured by 19F NMR and CD measurements of secondary structure and ThT measurements of 
fiber formation (20). Similarly, time-lapse TEM images of fiber formation of IAPP-tfmPhe23 
show only that the density of fibers increases as time progresses; non-fibrillar oligomers do not 
form a major population at any time (20). 
 For Aβ1-40-tfMet35, on the other hand, it is clear that the pathway is more complex, with 
intermediates accumulating very early in the lag phase of amyloid formation (Figure 4.5). This is 
apparent from both analysis of the CD spectra and from the appearance of new peaks in the 19F 
spectra. First, a slow conversion of peptide in the random coil conformation (200 nm) to another 
species characterized by a minimum at 205 nm in the CD spectrum occurs on roughly the same 
time scale as the decrease in peak intensity seen in 19F NMR (Figure 4.5 and 4.6) in the low 
concentration sample. While the close correspondence between the kinetics of conformational  
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Figure 4.3. Monitoring of Aβ1-40-tfMet35 aggregation by 19F NMR. Samples at different concentrations 
(182 µM (left) and 46 µM (right)) are measured in parallel. The signal intensity of each spectrum was 
normalized to an internal TFE standard. 
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change and rate of monomer depletion is similar to the two state kinetics exhibited by IAPP-
tfmPhe23, the minima at 205 nm do not correspond to the known CD spectra of Aβ1-40 amyloid 
fibers (37). Instead, a minimum at 205 nm matches the CD spectra of several types of purified 
non-fibrillar oligomers of Aβ1-40 (37). 
 
Figure 4.4. Contour plots of Figure 4.3. Time is labeled on the y-axis in hours. 
 
 Detection of oligomers by analysis of the CD spectra is more difficult in the high 
concentration sample. The CD spectrum at the initial time point for this concentration resembles 
the CD spectra of fibers due to the initial presence of protofibers in the sample (Figure 4.2e). 
Since the protofibers are not detected in the 19F NMR experiment, any conformational changes 
within the protofibers would be reflected in the CD spectra but not in the 19F NMR spectra. 
Similarly, the conversion of random coil monomers to random coil oligomers would be seen in 
the 19F NMR spectra but not in the CD spectra. The combination of these two factors makes a 
quantitative analysis difficult.  However, the CD spectra at high concentration of Aβ1-40-tfMet35 
change more rapidly than the 19F NMR spectra, which likely some conversion of the NMR-
invisible protofibers into a conformation with a larger fraction of β-sheet takes place.  





Figure 4.5. Kinetics of aggregation as followed by major and minor peaks in the 19F NMR spectra 
and CD. (a) 182µM and (b) 46 µM Aβ1-40-tfM35 and (c) minor peaks in the 182µM sample. 19F NMR 
values are normalized to the initial intensity of the monomer at 35.85 ppm. CD spectra are normalized to 
the initial and final values at 215 or 205 nm as indicated. 
 
 
 While analysis of the CD spectra does not directly show oligomer formation, direct 
evidence of early oligomer formation can be seen in the 19F spectra. A small peak at 35.82 ppm 
can be seen as a shoulder of the monomeric peak at 35.85 ppm in both samples which resolves 
into a well-defined peak as the intensity of the monomer peak decreases (Figure 4.3). The 
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samples and decaying (Figure 4.5c). This time profile is characteristic of a kinetic intermediate 
and suggests at least one type of non-fibrillar oligomer is formed early during the lag phase for 
amyloid formation. 
 
Figure 4.6. Time evolution of the CD spectra for (a) 182 μM and (b) 46 μM Aβ1-40-tfMet35. 
 
4.3.4. Characterization of Aβ1-40-tfMet35 Aggregates After Monomeric Precursor 
Consumption  
 After the disappearance of the monomeric peak, both samples undergo a quiescent period 
in which the signal intensity of the 19F NMR spectra is very low (from approximately 672-840 
hours for the 46 µM sample and from approximately 400-672 for the 182 µM sample). After this 
period, two new peaks begin to appear in the 19F NMR spectra of both samples. In the low 
concentration sample, two new peaks are clearly visible at 35.77 and 35.73 ppm (Figure 4.3 and 
4.4). The same peaks are visible in the high concentration sample, as well as two minor peaks 
near 35.65 and 35.57 ppm. The AFM images taken after 12 hours and 45 days are similar (Figure 
Saturday, November 17, 12
Saturday, November 17, 12
Saturday, November 17, 12Saturday, November 17, 12
b)a)
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4.7), suggesting the aggregates corresponding to the new peaks are significantly smaller than the 
protofibers visible in the AFM images (Figure 4.2).   
 To characterize these new oligomeric peaks, we attempted to estimate the molecular 
weight of Aβ1-40-tfMet35 aggregates by ultrafiltration and electrospray ionization ion mobility 
mass spectrometry (ESI-IMMS) experiments (Figure 4.8) (24, 38). The molecular mass 
corresponding to the new peaks was initially estimated by recording the 19F NMR spectra of the 
low concentration sample following filtration through a series of ultrafiltration membranes 
(Figure 4.8a-c).  Filtration through a 30 KDa cutoff membrane attenuated the signal, which was 
even more significant following filtration through a 100 KDa cutoff membrane.  The degree of 
attenuation was significantly higher for the 35.73 ppm peak, indicating the aggregate 
corresponding to the 35.73 ppm peak is likely larger than the 35.77 ppm aggregate.  
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Figure 4.7. AFM images acquired during the aggregation of 182 μM Aβ1-40-tfMet35 at the indicated 
times (a) Time 0 (Initial time point), (b) 6 hours, (c) 24 hours, and (d-f) at the end of time-course 
experiment. AFM images are taken for height (a-d) and phase (e-f).   
  
 ESI-IMMS experiments showed similar results (Figure 4.8d and e). The ESI-IMMS 
chromatogram of fresh samples of high concentration sample shows a single grouping of peaks 
corresponding to the +3 and +4 charge states of Aβ1-40-tfMet35 along with sodium and sodium 
phosphate adducts (due to 20 mM phosphate buffer), consistent with a peptide that is monomeric 
after ionization. After 35 days (high concentration) or 52 days (low concentration) incubation 
and filtration through a 100 kDa filter, the monomeric peaks disappear and a broad set of peaks 
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corresponding to unresolved, high molecular weight oligomers is observed instead. These peaks 
disappear after filtration through a 30 KDa cutoff membrane, consistent with the NMR results. 
The filtration experiments therefore suggest both peaks correspond to aggregates between 30 and 
100 KDa in size.   
  
Figure 4.8. Size determination of oligomeric aggregates observed by 19F NMR and ESI-IMMS. The 
low concentration sample (46 µM) at the end of time course experiment was acquired without filtration 
(a), after filtering through a 100 KDa cutoff membrane (b), or after a 30 KDa cutoff membrane (c). (d) 
ESI-IMMS chromatograms of 182 µM of Aβ1-40-tfM35 sample immediately after preparation (bottom), at 
the end of the aggregation experiment after filtration through a 100 KDa membrane (middle), and after 
filtration through a 30 KDa membrane (top). The peaks adjacent to the main peak represent sodium and 
sodium/phosphate adducts. (e) Zoom into 300 – 1900 m/z of (d). 
 
 The CD spectra at the final time-point show a large population of β-sheet structure, 
particularly for the high concentration sample (Figure 4.6). However, the CD spectra also include 
substantial contributions from large aggregates not visible in the 19F NMR spectra. For this 
reason, it is difficult to identify the secondary structure of the new peaks in the 19F NMR spectra 
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binding compound provided additional confirmation of the existence of β-sheets in the sample. 
Orange G is a derivative of Congo Red that specifically intercalates between stacked β-sheets 
(39). Addition of 5 equivalents of Orange G to the high concentration sample at the end of the 
aggregation experiment resulted in an immediate decrease of the peak at 35.73 ppm (Figure 4.9). 
Prolonged incubation resulted in the complete disappearance of the peak at 35.73 ppm. At the 
same time, the intensity of the peak at 35.77 ppm strongly increases. Since Orange G specifically 
binds to the interface between β-sheets, these changes suggest both peaks correspond to 
structures that contain a β-sheet binding site.  The shift in intensity from 35.73 ppm to 35.77 ppm 
is suggestive of the inter-conversion of one type of oligomer to another by Orange G. Since the 
intercalation of Orange G is likely to disrupt the interface between β-sheets, the shift in the 
equilibrium towards the 35.77 ppm aggregate suggests the interface between β-sheets in the 
35.77 ppm aggregate may be more exposed than in the 35.73 ppm aggregate.  A similar type of 
disruption has been reported for Aβ1-40 with another intercalating agent, in which it was shown 
that EGCG unfolds the C-terminal β-sheet but leaves the N-terminal β-sheet intact (40).  
 
 
Figure 4.9. Binding of 5 equivalent orange G to aged samples of 182 µM Aβ1-40-tfMet35 as followed 
by 19F NMR. The signal intensity of each spectrum was normalized to an internal TFE standard. 
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 Finally, I examined the solvent exposure of the Met35 side-chain by examining the 
influence of solvent isotope effect (H2O/D2O) on the 19F chemical shift of Aβ1-40-tfmMet35. 
Fluorine is weak hydrogen bond acceptor, and as such the 19F nucleus is sensitive to isotope 
effects from exchange of H2O to D2O (20). The shift for both peaks at the end of the aggregation 
experiment is 0.06 ppm (Figure 4.10), which is similar to the shift for the trifluoroethanol 
internal standard (0.09 ppm). The D2O exchange experiment therefore indicates tfmMet35 is 
relatively solvent exposed at this time point, at least for the fraction of the sample that shows a 
visible NMR peak. Notably, this result is not consistent with current triangular models of Aβ1-40 
amyloid fibers, in which the C-terminus is sequestered within an internal cavity within the fiber 
(41, 42). However, it is consistent with several current models of smaller protofibers and non-




Figure 4.10. Solvent isotope effect on 19F chemical shifts for freshly prepared (a) and aged samples 
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4.4. Discussion 
 Several oligomeric, non-fibrillar structures of Aβ1-40 and Aβ1-42 are highly neurotoxic, 
and as such, have been heavily investigated as downstream or upstream agents of Alzheimer’s 
disease (25, 44). While detailed structural studies of Aβ oligomers are beginning to emerge (43, 
45, 46), most structural and toxicity studies have by necessity required stable and relatively pure 
preparations of Aβ oligomers (47). Since the aggregation of Aβ naturally tends to lead to a 
heterogeneous mixture of oligomers and fibers, either purification steps or specialized 
conditions, such as the addition of SDS (48), low temperature (49), or chemical cross-linkers (37, 
50), that are designed to trap specific oligomers are usually necessary for these studies. It is 
frequently difficult to observe the full pathway from monomeric peptide to oligomer species to 
the amyloid fiber form under these conditions. Purification also disturbs the equilibrium between 
Aβ species which can obscure the normal kinetic pathway. Therefore while these non-fibrillar 
structures are commonly referred to as “intermediates”, the actual relationship of almost all non-
fibrillar structures along the aggregation pathway is still poorly defined (51).  
 Elucidating the oligomeric aggregates in a pathway is often an essential step for 
understanding any biochemical process (51). The kinetics of amyloid formation typically shows 
a characteristic sigmoidal pattern; amyloid formation is slow or non-existent during an early lag 
phase before a period of rapid growth. The simplest model to explain this behavior is nucleation 
dependent polymerization, in which the lag-phase reflects the time for a critical concentration of 
energetically unfavorable nuclei to form. However, for a process as complex as amyloid 
formation many kinetic models are also consistent with an apparent lag phase (52). By directly 
monitoring the rate of monomer depletion during aggregation through 19F NMR along with other 
biophysical techniques, we are able to show that the early phase of fiber formation actually 
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consists of at least two distinct steps. In the first step, the monomeric protein is almost entirely 
converted into a high molecular weight intermediate with a high β-sheet content and proto-
fibrillar morphology that is not detectable by 19F NMR. This step occurs without a discernible 
lag-phase at high temperature, in agreement with previous measurements of monomer depletion 
during Aβ1-40 aggregation (10). This behavior is not consistent with a simple nucleation 
dependent polymerization model and suggests a more complex model involving an on- or off-
pathway intermediate is necessary. 
 The appearance of multiple intermediates was directly detected in the 19F NMR spectra. 
One particular type of oligomeric intermediate appears and disappears early in the experiment 
before the disappearance of the monomer. After the disappearance of this oligomer and a 
substantial delay, several different types of other low-molecular weight oligomers begin to 
appear that are in apparent coexistence with the proto-fibrillar species. At least two major types 
of oligomers between 30 and 100 kDa in size can be identified at this later stage based on the 19F 
NMR signal and filtration experiments. The first species to appear is smaller than the second, 
later, oligomer detected, but both likely possess a β-sheet structure based on amyloid dye binding 
experiments. At least two more minor populations of oligomers in the second step of aggregation 
can also be detected in addition to these two major populations. A heterogeneous mixture of 
small oligomers therefore exists in pseudo-equilibrium with fibers and protofibers during early 
stages of aggregation.  
 
4.5. Conclusion  
 19F NMR was shown to be useful in the identification of oligomeric species of Aβ1-40. 
Both initial reversible oligomer formation and at least two types of non-reversible time-
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dependent aggregation could be detected. It was also possible to show that one oligomer is larger 
than the other and furthermore that the rate of formation and relative yields of these oligomers 
was dependent on the starting concentration. These types of experimental measurements are 
difficult to perform by other techniques, and the additional level of detail obtained by measuring 
the rate of monomer depletion by NMR may prove fruitful for further characterization and 
screening. The presence of multiple oligomers revealed by our results could enable high-
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Conclusions and Future Directions 
  
5.1. Conclusions 
 Fluorine is spin ½ nucleus, which exists in 100 % natural abundance, and has excellent 
NMR properties that are comparable to those of hydrogen. It also exhibits a wide range of 
chemical shifts that are sensitive to the surrounding chemical environment of 19F nucleus. In 
addition, fluorine is rarely found in biological system, so there is no competition from 
background signals, which is often a problem when using nuclei such as 1H, 13C, and 15N. 
Therefore, 19F NMR is an invaluable tool for investigating structural changes and dynamics of 
proteins, as well as for examining the binding of ligands to proteins. With these attractive 
advantages, fluorine atom has been used as a tool to study proteins and peptides by incorporating 
fluorinated amino acid analogs (1-20) and fluorinated chemical labels (2, 21, 22). Using these 
advantages of 19F NMR, I have examined the structure and dynamics of biologically active 
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5.1.1. Investigation of AMP Interaction with Lipid Bilayer Using 19F NMR    
 The antimicrobial peptide MSI-78 was used as a model system for studying the 
interactions of bioactive peptides with membranes.  Using a series of MSI-78 peptides that 
incorporate tfeGly 6, a small and sensitive 19F probe, local structural and dynamic changes that 
occur upon peptide binding to the lipid bilayer were investigated (23).  The fluorinated MSI-78 
analogs exhibited position-specific changes in 19F chemical shift ranging from +1.28 to –1.35 
ppm upon binding to lipid bilayer.  The largest upfield shifts are associated with the most 
hydrophobic positions in the peptide.  Changes in solvent isotope effects on 19F chemical shifts 
were observed for the peptides that are consistent with MSI-78 forming a solvent-inaccessible 
hydrophobic core upon binding to the lipid bilayer.  Transverse relaxation measurements of the 
19F nucleus, using the CPMG pulse sequence, were used to examine changes in the local 
mobility of MSI-78 that occurs on binding to the lipid bilayer. Positions in the hydrophobic core 
of the peptide-membrane complex show the greatest decrease in mobility, whereas residues that 
interact with lipid head groups are more mobile.  The most mobile positions are at the N- and C-
termini of the peptide.  The various experiments by 19F NMR including the changes in 19F 
chemical shifts, solvent isotope effects on chemical shifts, and changes in 19F longitudinal and 
transverse relaxation rates, provide support for the proposed mechanism of membrane disruption 
by MSI-78, and reveal new details of the dynamic changes that accompany membrane binding.  
 
5.1.2. Investigation of Amyloid Fibril Formation Using 19F NMR    
 Amyloid formation, a complex process involving many intermediate states, is proposed 
to be the driving force for amyloid-related toxicity in common degenerative diseases. Alternative 
pathways of aggregation were distinguished by using 19F NMR to monitor monomer 
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consumption along with complementary measurements of fibrillogenesis. The utility of this 
technique is demonstrated by tracking amyloid formation in the type II diabetes-related IAPP as 
well as Alzheimer-related peptide Aβ1-40.  
 A combination of 19F NMR, ThT fluorescence assays, and CD spectroscopy were able to 
show that IAPP fibrillizes without an appreciable build up of non-fibrillar intermediates (24). To 
further demonstrate the utility of 19F NMR, the influence of the polyphenolic amyloid inhibitor, 
EGCG, on the IAPP aggregation pathway was examined (24). Polyphenols have been shown to 
strongly inhibit amyloid formation in many systems. However, spectroscopic measurements of 
amyloid inhibition by these compounds can be severely compromised by background signals and 
competitive binding with extrinsic probes. The 19F NMR studies described in this thesis suggest 
that ThT strongly competes with EGCG for binding sites on IAPP amyloid fibers. By comparing 
the rates of monomer consumption and fiber formation, it was found that EGCG stabilizes non-
fibrillar large aggregates during fibrillogenesis.  
 In contrast to IAPP, studies on fluorine-labeled Aβ1-40 peptide have shown the build-up of 
new signals corresponding to small oligomeric aggregates formed on the pathway to Aβ1-40 
fibrils. The concentration dependence of fiber formation was also investigated by 19F NMR and 
correlated with structural changes determined by CD studies. In the presence of small oligomers 
detected by 19F NMR, the co-existence of larger oligomers, protofibrils, and amyloid fibrils are 
also observed by AFM images. By providing an additional independent measurement of the rate 
of monomeric peptide consumption, a task that is difficult to accomplish by conventional 
methods, 19F NMR can help differentiate between alternative pathways of aggregation for further 
investigation of amyloid formation pathway of other amyloidogenic peptides and proteins.  
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5.2. Future Directions 
 The research presented here provides valuable information to the field of protein and 
peptide structural changes and dynamics. These findings will hopefully contribute to the more 
widespread use of 19F NMR in chemical biology.  
 For antimicrobial peptides, future work will aim toward using 19F NMR to study peptide-
membrane interactions in vivo at physiologically relevant concentrations as well as structural 
determination using solid-state 19F NMR to examine interactions with whole bacterial cells. For 
amyloid peptide studies, 19F NMR would be applicable for automated screening to find potential 
therapeutics in amyloid-related disorders. Although the throughput would be relatively slow, the 
lowering of false-positive rates would partially compensate for this. As well as AMPs, it would 
be very interesting to study peptide structural changes due to the interaction of membranes 
during amyloid fiber formation.  
 Since many techniques are available to incorporate fluorine probes into peptides and 
proteins, this technique would be applicable for proteins that are difficult to study with other 
techniques, either because of their size or because they adopt inherently disordered structures. 
The use of 19F NMR for in vivo studies is a particularly attractive, but challenging, application 
due to the lack of fluorine in biological systems. 
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